<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.1 20151215//EN"  "JATS-archivearticle1.dtd"><article article-type="research-article" dtd-version="1.1" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xmlns:xlink="http://www.w3.org/1999/xlink"><front><journal-meta><journal-id journal-id-type="nlm-ta">elife</journal-id><journal-id journal-id-type="publisher-id">eLife</journal-id><journal-title-group><journal-title>eLife</journal-title></journal-title-group><issn pub-type="epub" publication-format="electronic">2050-084X</issn><publisher><publisher-name>eLife Sciences Publications, Ltd</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">60445</article-id><article-id pub-id-type="doi">10.7554/eLife.60445</article-id><article-categories><subj-group subj-group-type="display-channel"><subject>Research Article</subject></subj-group><subj-group subj-group-type="heading"><subject>Developmental Biology</subject></subj-group><subj-group subj-group-type="heading"><subject>Stem Cells and Regenerative Medicine</subject></subj-group></article-categories><title-group><article-title>Myogenin is an essential regulator of adult myofibre growth and muscle stem cell homeostasis</article-title></title-group><contrib-group><contrib contrib-type="author" corresp="yes" id="author-195279"><name><surname>Ganassi</surname><given-names>Massimo</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0003-3163-9707</contrib-id><email>massimo.ganassi@kcl.ac.uk</email><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="con1"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-195281"><name><surname>Badodi</surname><given-names>Sara</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0002-8407-8336</contrib-id><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="fn" rid="con2"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-195280"><name><surname>Wanders</surname><given-names>Kees</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">http://orcid.org/0000-0003-3209-9853</contrib-id><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="con3"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-29085"><name><surname>Zammit</surname><given-names>Peter S</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">http://orcid.org/0000-0001-9562-3072</contrib-id><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="other" rid="fund3"/><xref ref-type="other" rid="fund4"/><xref ref-type="other" rid="fund5"/><xref ref-type="other" rid="fund6"/><xref ref-type="other" rid="fund7"/><xref ref-type="other" rid="fund8"/><xref ref-type="fn" rid="con4"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" corresp="yes" id="author-28077"><name><surname>Hughes</surname><given-names>Simon M</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0001-8227-9225</contrib-id><email>simon.hughes@kcl.ac.uk</email><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="other" rid="fund1"/><xref ref-type="other" rid="fund2"/><xref ref-type="fn" rid="con5"/><xref ref-type="fn" rid="conf1"/></contrib><aff id="aff1"><label>1</label><institution>Randall Centre for Cell and Molecular Biophysics, King’s College London</institution><addr-line><named-content content-type="city">London</named-content></addr-line><country>United Kingdom</country></aff><aff id="aff2"><label>2</label><institution>Blizard Institute, Barts and The London School of Medicine and Dentistry, Queen Mary University of London</institution><addr-line><named-content content-type="city">London</named-content></addr-line><country>United Kingdom</country></aff></contrib-group><contrib-group content-type="section"><contrib contrib-type="editor"><name><surname>Munsterberg</surname><given-names>Andrea</given-names></name><role>Reviewing Editor</role><aff><institution>University of East Anglia</institution><country>United Kingdom</country></aff></contrib><contrib contrib-type="senior_editor"><name><surname>Stainier</surname><given-names>Didier YR</given-names></name><role>Senior Editor</role><aff><institution>Max Planck Institute for Heart and Lung Research</institution><country>Germany</country></aff></contrib></contrib-group><pub-date date-type="publication" publication-format="electronic"><day>01</day><month>10</month><year>2020</year></pub-date><pub-date pub-type="collection"><year>2020</year></pub-date><volume>9</volume><elocation-id>e60445</elocation-id><history><date date-type="received" iso-8601-date="2020-06-26"><day>26</day><month>06</month><year>2020</year></date><date date-type="accepted" iso-8601-date="2020-09-30"><day>30</day><month>09</month><year>2020</year></date></history><permissions><copyright-statement>© 2020, Ganassi et al</copyright-statement><copyright-year>2020</copyright-year><copyright-holder>Ganassi et al</copyright-holder><ali:free_to_read/><license xlink:href="http://creativecommons.org/licenses/by/4.0/"><ali:license_ref>http://creativecommons.org/licenses/by/4.0/</ali:license_ref><license-p>This article is distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution License</ext-link>, which permits unrestricted use and redistribution provided that the original author and source are credited.</license-p></license></permissions><self-uri content-type="pdf" xlink:href="elife-60445-v2.pdf"/><abstract><p>Growth and maintenance of skeletal muscle fibres depend on coordinated activation and return to quiescence of resident muscle stem cells (MuSCs). The transcription factor Myogenin (Myog) regulates myocyte fusion during development, but its role in adult myogenesis remains unclear. In contrast to mice, <italic>myog<sup>-/-</sup></italic>zebrafish are viable, but have hypotrophic muscles. By isolating adult myofibres with associated MuSCs, we found that <italic>myog</italic><sup>-/-</sup> myofibres have severely reduced nuclear number, but increased myonuclear domain size. Expression of fusogenic genes is decreased, Pax7 upregulated, MuSCs are fivefold more numerous and mis-positioned throughout the length of <italic>myog<sup>-/-</sup></italic>myofibres instead of localising at myofibre ends as in wild-type. Loss of Myog dysregulates mTORC1 signalling, resulting in an ‘alerted’ state of MuSCs, which display precocious activation and faster cell cycle entry ex vivo, concomitant with <italic>myod</italic> upregulation. Thus, beyond controlling myocyte fusion, Myog influences the MuSC:niche relationship, demonstrating a multi-level contribution to muscle homeostasis throughout life.</p></abstract><kwd-group kwd-group-type="author-keywords"><kwd>muscle fiber</kwd><kwd>stem cell</kwd><kwd>myogenin</kwd><kwd>cell size</kwd><kwd>niche</kwd><kwd>adult</kwd></kwd-group><kwd-group kwd-group-type="research-organism"><title>Research organism</title><kwd>Zebrafish</kwd></kwd-group><funding-group><award-group id="fund1"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100000265</institution-id><institution>Medical Research Council</institution></institution-wrap></funding-source><award-id>G1001029</award-id><principal-award-recipient><name><surname>Hughes</surname><given-names>Simon M</given-names></name></principal-award-recipient></award-group><award-group id="fund2"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100000265</institution-id><institution>Medical Research Council</institution></institution-wrap></funding-source><award-id>MR/N021231/1</award-id><principal-award-recipient><name><surname>Hughes</surname><given-names>Simon M</given-names></name></principal-award-recipient></award-group><award-group id="fund3"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100000265</institution-id><institution>Medical Research Council</institution></institution-wrap></funding-source><award-id>MR/P023215/1</award-id><principal-award-recipient><name><surname>Zammit</surname><given-names>Peter S</given-names></name></principal-award-recipient></award-group><award-group id="fund4"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100000265</institution-id><institution>Medical Research Council</institution></institution-wrap></funding-source><award-id>MR/S002472/1</award-id><principal-award-recipient><name><surname>Zammit</surname><given-names>Peter S</given-names></name></principal-award-recipient></award-group><award-group id="fund5"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100011724</institution-id><institution>Muscular Dystrophy UK</institution></institution-wrap></funding-source><award-id>RA3/3052</award-id><principal-award-recipient><name><surname>Zammit</surname><given-names>Peter S</given-names></name></principal-award-recipient></award-group><award-group id="fund6"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100007393</institution-id><institution>Association Française contre les Myopathies</institution></institution-wrap></funding-source><award-id>AFM17865</award-id><principal-award-recipient><name><surname>Zammit</surname><given-names>Peter S</given-names></name></principal-award-recipient></award-group><award-group id="fund7"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100009824</institution-id><institution>FSH Society</institution></institution-wrap></funding-source><award-id>FSHS-82013-06</award-id><principal-award-recipient><name><surname>Zammit</surname><given-names>Peter S</given-names></name></principal-award-recipient></award-group><award-group id="fund8"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100009824</institution-id><institution>FSH Society</institution></institution-wrap></funding-source><award-id>FSHS-82017-05</award-id><principal-award-recipient><name><surname>Zammit</surname><given-names>Peter S</given-names></name></principal-award-recipient></award-group><funding-statement>The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.</funding-statement></funding-group><custom-meta-group><custom-meta specific-use="meta-only"><meta-name>Author impact statement</meta-name><meta-value>Cellular and molecular analyses reveal how Myogenin controls muscle stem cell quiescence and growth of adult muscle fibres.</meta-value></custom-meta></custom-meta-group></article-meta></front><body><sec id="s1" sec-type="intro"><title>Introduction</title><p>Maintenance of adult skeletal muscle depends on the ability of multinucleated myofibres to grow and regenerate, thereby ensuring optimal functionality throughout life. To facilitate this homeostasis, adult vertebrate muscle contains a specialised population of precursors cells, muscle stem cells (MuSCs), also termed satellite cells, located between the basal lamina and sarcolemma of most adult myofibres (<xref ref-type="bibr" rid="bib54">Mauro, 1961</xref>). Like other stem cells, MuSCs are mitotically dormant in normal circumstances but poised to respond to functional demand for new myonuclei throughout adult life (<xref ref-type="bibr" rid="bib80">Relaix and Zammit, 2012</xref>; <xref ref-type="bibr" rid="bib75">Purohit and Dhawan, 2019</xref>). The transcription factor Pax7 is considered a canonical quiescent MuSC marker across several vertebrate species and its expression is maintained during the progression to activation and proliferation, before downregulation at the onset of myogenic differentiation (<xref ref-type="bibr" rid="bib4">Berberoglu et al., 2017</xref>; <xref ref-type="bibr" rid="bib7">Buckingham and Relaix, 2015</xref>; <xref ref-type="bibr" rid="bib10">Chen et al., 2006</xref>; <xref ref-type="bibr" rid="bib30">Hammond et al., 2007</xref>; <xref ref-type="bibr" rid="bib36">Hollway et al., 2007</xref>; <xref ref-type="bibr" rid="bib40">Kawakami et al., 1997</xref>; <xref ref-type="bibr" rid="bib87">Seale et al., 2000</xref>; <xref ref-type="bibr" rid="bib88">Seger et al., 2011</xref>; <xref ref-type="bibr" rid="bib100">Zammit et al., 2006</xref>; <xref ref-type="bibr" rid="bib66">Olguin and Olwin, 2004</xref>). Null mutations for Pax7 severely affects MuSC maintenance and muscle regeneration in amniotes, amphibia and teleosts (<xref ref-type="bibr" rid="bib4">Berberoglu et al., 2017</xref>; <xref ref-type="bibr" rid="bib10">Chen et al., 2006</xref>; <xref ref-type="bibr" rid="bib68">Oustanina et al., 2004</xref>; <xref ref-type="bibr" rid="bib79">Relaix et al., 2006</xref>; <xref ref-type="bibr" rid="bib87">Seale et al., 2000</xref>). In adult zebrafish, Pax7<sup>+</sup> MuSCs contribute to regeneration of myofibres upon muscle damage, being the functional counterparts of MuSCs in mammals (<xref ref-type="bibr" rid="bib4">Berberoglu et al., 2017</xref>; <xref ref-type="bibr" rid="bib36">Hollway et al., 2007</xref>; <xref ref-type="bibr" rid="bib72">Pipalia et al., 2016</xref>).</p><p>Proper function of the MuSC pool depends on a dynamic balance between quiescence and activation and is sustained by feedback signalling from surrounding muscle (<xref ref-type="bibr" rid="bib53">Mashinchian et al., 2018</xref>; <xref ref-type="bibr" rid="bib24">Forcina et al., 2019</xref>). In response to stimuli, quiescent MuSCs activate and become muscle progenitor cells (MPCs), which proliferate, differentiate and fuse to contribute myonuclei to pre-existing multinucleated myofibres: a process that resembles aspects of myogenesis by embryonic myoblasts and relies on an intricate molecular network comprising both extrinsic and intrinsic mechanisms (<xref ref-type="bibr" rid="bib7">Buckingham and Relaix, 2015</xref>). Among many converging factors, the members of the Myogenic Regulatory Factor (MRF) family of transcription factors, Myod, Myf5, Mrf4 and Myogenin (Myog), are key regulators of vertebrate muscle gene expression during both early and adult myogenesis (<xref ref-type="bibr" rid="bib101">Zammit, 2017</xref>; <xref ref-type="bibr" rid="bib32">Hernández-Hernández et al., 2017</xref>). In adult muscle, Myod and Myf5 are mainly expressed in MuSC and are crucial for efficient activation and proliferation (<xref ref-type="bibr" rid="bib13">Cooper et al., 1999</xref>; <xref ref-type="bibr" rid="bib46">Kuang et al., 2007</xref>; <xref ref-type="bibr" rid="bib59">Megeney et al., 1996</xref>; <xref ref-type="bibr" rid="bib91">Soleimani et al., 2012</xref>), whereas Mrf4 accumulates in mature myofibres and contributes to ensure their homeostatic size regulation (<xref ref-type="bibr" rid="bib61">Moretti et al., 2016</xref>; <xref ref-type="bibr" rid="bib94">Voytik et al., 1993</xref>).</p><p>Knockout of the <italic>Myog</italic> gene in mouse leads to severe muscle deficiencies and, in contrast to the other MRFs, is neonatal lethal (<xref ref-type="bibr" rid="bib31">Hasty et al., 1993</xref>; <xref ref-type="bibr" rid="bib62">Nabeshima et al., 1993</xref>), thus making it difficult to investigate Myog function in detail. As in embryogenesis, <italic>Myog</italic> expression is upregulated in proliferating MuSCs that then rapidly undergo myogenic differentiation (<xref ref-type="bibr" rid="bib99">Zammit et al., 2004</xref>) and its expression appears reciprocally balanced with that of <italic>Pax7</italic> (<xref ref-type="bibr" rid="bib65">Olguin et al., 2007</xref>; <xref ref-type="bibr" rid="bib81">Riuzzi et al., 2014</xref>; <xref ref-type="bibr" rid="bib100">Zammit et al., 2006</xref>; <xref ref-type="bibr" rid="bib66">Olguin and Olwin, 2004</xref>). However, depletion of mouse Myog in myoblasts does not block accumulation of differentiation markers in vitro, but cell biological aspects such as myotube formation were not explored (<xref ref-type="bibr" rid="bib58">Meadows et al., 2008</xref>). We recently expanded this observation, reporting that, despite being dispensable for myogenic differentiation, Myog is essential for most myocyte fusion and its functional depletion leads to formation of mononucleated myofibres and reduced myotome growth during zebrafish embryonic/larval stages (<xref ref-type="bibr" rid="bib26">Ganassi et al., 2018</xref>). Moreover, modulation of rodent Myog expression shifts muscle enzyme activity towards oxidative metabolism, alters exercise capacity and is required for neurogenic atrophy (<xref ref-type="bibr" rid="bib23">Flynn et al., 2010</xref>; <xref ref-type="bibr" rid="bib58">Meadows et al., 2008</xref>; <xref ref-type="bibr" rid="bib60">Moresi et al., 2010</xref>; <xref ref-type="bibr" rid="bib20">Ekmark et al., 2003</xref>; <xref ref-type="bibr" rid="bib38">Hughes et al., 1999</xref>), suggesting a broad Myog role in regulating adult muscle homeostasis. Nevertheless, whether Myog acts on myofibre, MuSC or both has remained elusive. Importantly, in contrast to mouse, zebrafish <italic>myog<sup>-/-</sup></italic> mutant adult fish are alive, albeit displaying hypotrophic muscle (<xref ref-type="bibr" rid="bib26">Ganassi et al., 2018</xref>). Congruent with the fish phenotype, almost complete depletion of mouse <italic>Myog</italic> after birth results in decreased muscle size (<xref ref-type="bibr" rid="bib45">Knapp et al., 2006</xref>; <xref ref-type="bibr" rid="bib58">Meadows et al., 2008</xref>), thereby confirming a conserved vertebrate role for Myog in regulating bulk muscle growth and maintenance.</p><p>Here, to explore the role of Myog in adult muscle, we analysed <italic>myog</italic><sup>-/-</sup> mutant zebrafish and deployed our recently developed method to isolate viable single myofibres with associated MuSCs, allowing culture of muscle progenitor cells (MPCs). Morphometric analysis showed that <italic>myog</italic><sup>-/-</sup> muscle has reduced myofibre growth and nuclear accretion compared to siblings (sibs), revealing increased myonuclear domain size. Adult <italic>myog<sup>-/-</sup></italic> muscle exhibited upregulation of <italic>pax7a</italic> and <italic>pax7b</italic> expression along with supernumerary MuSCs, that were randomly distributed throughout myofibre length compared to sib MuSCs, which localise mainly at myofibre ends, suggesting an altered MuSC niche. Ex vivo analysis of <italic>myog</italic><sup>-/-</sup> MuSCs revealed elevated phosphorylation of ribosomal protein S6, concomitant with reduced expression of the mTOR inhibitors <italic>tsc1a</italic> and <italic>tsc1b</italic>, indicating enhanced mTORC1 activity, which marks MuSCs that have left deep quiescence to enter into an ‘alert’ pseudo-activated state (<xref ref-type="bibr" rid="bib82">Rodgers et al., 2014</xref>). Congruently, cultured myofibres from mutants yielded increased numbers of MPCs with an accelerated proliferative phase, marked by upregulated expression of <italic>pax7a</italic>, <italic>pax7b</italic>, and <italic>myod</italic>. Together, our study demonstrates that Myog plays a crucial role in adult muscle growth and MuSC homeostasis.</p></sec><sec id="s2" sec-type="results"><title>Results</title><sec id="s2-1"><title>Adult <italic>myog<sup>-/-</sup></italic> myofibres are small with fewer nuclei but increased nuclear domain size</title><p>Adult zebrafish bearing the <italic>myog<sup>kg125</sup></italic> nonsense mutant allele (<italic>myog</italic><sup>-/-</sup>), which reduces <italic>myog</italic> mRNA, eliminates Myog protein and is presumed null, are viable but have reduced muscle bulk (<xref ref-type="bibr" rid="bib26">Ganassi et al., 2018</xref>). In contrast, <italic>myog<sup>kg125/+</sup></italic> heterozygous siblings (sib) are indistinguishable from wild-type sibs and are used as paired controls throughout the current study. Gene expression analysis on dissected adult trunk muscle confirmed continued significant downregulation of <italic>myog</italic> mRNA in <italic>myog</italic><sup>-/-</sup> fish compared to co-reared sib controls (<xref ref-type="fig" rid="fig1">Figure 1A,B</xref>) in line with the nonsense-mediated decay reported previously (<xref ref-type="bibr" rid="bib26">Ganassi et al., 2018</xref>). Levels of mRNA encoded by the terminal myogenesis genes <italic>mymk (tmem8c)</italic>, <italic>mymx</italic> and <italic>mrf4 (myf6)</italic> were downregulated by 52%, 38% and 68%, respectively, in <italic>myog</italic><sup>-/-</sup> compare to the relative expression in sib, as during the embryonic stage, suggesting a continuous muscle defect in adulthood (<xref ref-type="fig" rid="fig1">Figure 1B</xref>). To explore further the muscle defect at a cellular level, we isolated single myofibres from juvenile (1 mpf; months post-fertilisation) and adult (8 mpf) <italic>myog</italic><sup>-/-</sup> and sibs (<xref ref-type="fig" rid="fig1">Figure 1C</xref>). Both juvenile and adult mutant myofibres were on average 20% and 50% shorter than those in control, respectively, demonstrating an early onset growth deficit in <italic>myog<sup>-/-</sup></italic>, with lifecourse worsening (<xref ref-type="fig" rid="fig1">Figure 1C,D</xref> and <xref ref-type="fig" rid="fig1s1">Figure 1—figure supplement 1A,B</xref>). Despite significant 50% reduction in overall fibre length, sarcomere length was unaffected in adult <italic>myog</italic><sup>-/-</sup> myofibres, as in embryonic myofibres (<xref ref-type="fig" rid="fig1">Figure 1E</xref>; <xref ref-type="bibr" rid="bib26">Ganassi et al., 2018</xref>). In contrast, myofibres isolated from the adult hypomorphic <italic>myog<sup>fh265</sup></italic> mutants (<xref ref-type="bibr" rid="bib34">Hinits et al., 2011</xref>; <xref ref-type="bibr" rid="bib26">Ganassi et al., 2018</xref>) were indistinguishable from those of age-matched sibs (<xref ref-type="fig" rid="fig1s1">Figure 1—figure supplement 1C</xref>). The number of nuclei associated with each isolated myofibre appeared greatly reduced in <italic>myog</italic><sup>-/-</sup> mutants compared to sibs (<xref ref-type="fig" rid="fig1">Figure 1F</xref> and <xref ref-type="fig" rid="fig1s1">Figure 1—figure supplement 1D</xref>). Indeed, nuclear numbers per unit length were reduced fourfold in mutants (<xref ref-type="fig" rid="fig1">Figure 1G</xref>). Congruently, calculation of the average number of nuclei associated with each adult myofibre by multiplying the number of nuclei/unit length by the length revealed an approximate 90% reduction, from an average of 95 nuclei per myofibre in sibs to nearly 12 nuclei per myofibre in <italic>myog</italic><sup>-/-</sup> (<xref ref-type="fig" rid="fig1">Figure 1H</xref>). Number of total nuclei in <italic>myog</italic><sup>-/-</sup> myofibres was reduced similarly at juvenile stage compared to sibs (<xref ref-type="fig" rid="fig1s1">Figure 1—figure supplement 1D</xref>). Juvenile sib myofibres had significantly more nuclei than adult <italic>myog</italic><sup>-/-</sup> myofibres, confirming ongoing myonuclear accretion defect in <italic>myog<sup>-/-</sup></italic> (<xref ref-type="fig" rid="fig1">Figure 1G,H</xref> and <xref ref-type="fig" rid="fig1s1">Figure 1—figure supplement 1D</xref>). Thus, <italic>myog</italic><sup>-/-</sup> mutant myofibres are grossly defective and show no sign of homeostatic recovery over time.</p><fig-group><fig id="fig1" position="float"><label>Figure 1.</label><caption><title>Myogenin is required for normal myofibre size and nuclear accretion.</title><p>(<bold>A</bold>) Schematic of trunk muscle processing for analysis, pink represents fish fillet. Colours identify sib (<italic>myog<sup>kg125/+</sup>,</italic> blue) or <italic>myog</italic><sup>-/-</sup> (<italic>myog<sup>kg125</sup>,</italic> red) samples throughout the figure. (<bold>B</bold>) qPCR analysis shows downregulation of <italic>myog</italic>, <italic>mymk</italic>, <italic>mymx</italic> and <italic>mrf4</italic> mRNAs in adult <italic>myog</italic><sup>-/-</sup>. Symbol shapes denote paired sib and <italic>myog</italic><sup>-/-</sup> samples, n = 4–6 fish/genotype, paired <italic>t</italic>-test. (<bold>C</bold>) Schematic of myofibre isolation for morphometric analysis (top) and representative images (bottom) showing smaller <italic>myog</italic><sup>-/-</sup> myofibre (red brackets) compared to age-matched sib. Scale bar = 100 μm. (<bold>D</bold>) Measure of absolute myofibre length, n = 3 fish/genotype, n = 110–120 myofibres/fish, unpaired <italic>t</italic>-test. (<bold>E</bold>) Representative images and measure of unaltered sarcomere length on freshly isolated myofibres, n = 3 fish/genotype, n = 10 myofibres/fish, unpaired <italic>t</italic>-test. Scale bar = 10 µm. (<bold>F</bold>) Representative images of isolated fixed adult myofibres show size reduction in <italic>myog<sup>-/-</sup></italic> (red brackets). Scale bar = 100 µm. (<bold>G–J</bold>) Quantification of number of nuclei/100 µm (<bold>G</bold>), absolute number of nuclei per myofibre (<bold>H</bold>), myofibre diameter (<bold>I</bold>), and nuclear domain size (myofibre volume per nucleus) (<bold>J</bold>) showing significant changes in myofibres from juvenile (Juv, 1 month-old) and adult (Ad, 8 months-old) stages within (coloured <italic>p</italic>) or among (black <italic>p</italic>) genotypes. n = 3 fish/genotype, n = 30–50 adult myofibres/fish, n = 15–20 juvenile myofibres/fish, one-way ANOVA. (<bold>K</bold>) Relationship of number of nuclei and log<sub>e</sub>(Surface Area) indicates different growth mode between sib and <italic>myog</italic><sup>-/-</sup> (i.e. significant slope difference, black <italic>p</italic>), despite significant correlation of log<sub>e</sub>(SA) with nuclear number within genotype (coloured <italic>p</italic>) (see Materials and methods). (<bold>L</bold>) Increase in Surface Area (SA) from juvenile to adult stage (=Ad_SA – Juv_SA) indicates reduced growth rate in <italic>myog</italic><sup>-/-</sup>. Data from <xref ref-type="fig" rid="fig1s1">Figure 1—figure supplement 1E</xref>, unpaired <italic>t</italic>-test. All graphs report mean ± SEM. Statistical significance within (coloured <italic>p</italic>) or between (black <italic>p</italic>) genotypes is indicated.</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-60445-fig1-v2.tif"/></fig><fig id="fig1s1" position="float" specific-use="child-fig"><label>Figure 1—figure supplement 1.</label><caption><title><italic>Myog<sup>kg125</sup></italic> mutant adult and juvenile myofibres are smaller.</title><p>(<bold>A</bold>) Fraction of adult myofibres (%) with indicated length in sib (blue, <italic>myog<sup>kg125/+</sup></italic>) and <italic>myog</italic><sup>-/-</sup> (red, <italic>myog<sup>kg125</sup></italic>). n = 3 fish/genotype, n = 110–120 myofibres/fish, <italic>p</italic>-value indicates probability of rejecting null hypothesis of no difference between <italic>myog</italic><sup>-/-</sup> and sib in <italic>χ</italic><sup>2</sup> test. (<bold>B</bold>) Measurement of 1-month-old juvenile myofibre length, n = 3 fish/genotype, unpaired <italic>t</italic>-test (left) and fraction of juvenile myofibres (%) with indicated length in sib (blue) and <italic>myog</italic><sup>-/-</sup> (red), n = 3 fish/genotype, n = 15–20 juvenile myofibres/fish, <italic>p</italic>-value indicates probability of rejecting null hypothesis of no difference between <italic>myog<sup>-/-</sup></italic> and sib in <italic>χ</italic><sup>2</sup> test. (right). (<bold>C</bold>) Measure of absolute adult myofibre length, n = 3 fish/genotype, n = 100 myofibres/fish, unpaired <italic>t</italic>-test; sib (blue, <italic>myog<sup>fh265/+</sup></italic>), hypomorphic mutant (cyan, <italic>myog<sup>fh265</sup></italic>). (<bold>D</bold>) Representative images showing sib and <italic>myog</italic><sup>-/-</sup> juvenile myofibres (left), scale bar = 100 µm. Quantification of absolute number of nuclei per juvenile myofibre. n = 3 fish/genotype, n = 15–20 myofibres/fish, unpaired <italic>t</italic>-test. (<bold>E–F</bold>) Quantification of average surface area/100 µm myofibre length (<bold>E</bold>) and SADS (Surface Area Domain Size) (<bold>F</bold>) showing significant changes at juvenile (Juv) and adult (Ad) stages within (coloured <italic>p</italic>) or among (black <italic>p</italic>) genotypes. n = 3 fish/genotype, n = 30–50 adult myofibre/fish, n = 15–20 juvenile myofibre/fish, one-way ANOVA.</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-60445-fig1-figsupp1-v2.tif"/></fig></fig-group><p>Further morphometric analysis revealed that lack of Myog led to an average persistent decrease of 40% in myofibre diameter resulting in 50% reduction of myofibre surface area, compared to age-matched juvenile and adult sib, respectively (<xref ref-type="fig" rid="fig1">Figure 1F,I</xref> and <xref ref-type="fig" rid="fig1s1">Figure 1—figure supplement 1E</xref>). Indeed, as expected, both the volume and surface area per fibre-associated nucleus (nuclear domain and surface area domain size (SADS), respectively) were increased by almost twofold and threefold, respectively, in <italic>myog</italic><sup>-/-</sup> (<xref ref-type="fig" rid="fig1">Figure 1J</xref> and <xref ref-type="fig" rid="fig1s1">Figure 1—figure supplement 1F</xref>) indicating both inadequate nuclear accretion, congruent with suppression of <italic>mymk</italic> and <italic>mymx</italic> mRNAs (<xref ref-type="fig" rid="fig1">Figure 1B</xref>), and a compensatory increase in nuclear domain and SADS, which remained larger in mutants throughout life, showing no sign of return to a normal size with time. Nevertheless, both genotypes displayed significant increase in both myofibre diameter, surface area (SA) and number of nuclei between juvenile and adult stages, indicating ongoing muscle growth (<xref ref-type="fig" rid="fig1">Figure 1G,I</xref> and <xref ref-type="fig" rid="fig1s1">Figure 1—figure supplement 1E</xref>). However, although myofibre SA and number of nuclei positively correlated in <italic>myog</italic><sup>-/-</sup>, we observed a reduced nuclear accretion as myofibres acquired larger area compared to sib, hence highlighting a significantly different growth mode between the two genotypes (different trend slopes) (<xref ref-type="fig" rid="fig1">Figure 1K</xref>). Coherently, the incremental increase in myofibre SA over the juvenile-to-adult time-frame was significantly reduced in <italic>myog<sup>-/-</sup>,</italic> confirming a persistent deficit in muscle growth (<xref ref-type="fig" rid="fig1">Figure 1L</xref>). Thus, loss of Myog function affects normal muscle growth, impinging on size and nuclear accretion of myofibres.</p></sec><sec id="s2-2"><title>Adult <italic>myog<sup>-/-</sup></italic> myofibres have increased number of MuSCs</title><p>Isolated myofibres have two kinds of associated nuclei, genuine muscle fibre nuclei and nuclei of resident MuSCs. To assess MuSC abundance in <italic>myog</italic><sup>-/-</sup>, we first analysed <italic>pax3</italic> and <italic>pax7</italic> mRNAs, well-known markers of MuSCs (<xref ref-type="bibr" rid="bib7">Buckingham and Relaix, 2015</xref>; <xref ref-type="bibr" rid="bib72">Pipalia et al., 2016</xref>; <xref ref-type="bibr" rid="bib30">Hammond et al., 2007</xref>). Gene expression analysis on whole muscle showed upregulation of <italic>pax7a</italic> and <italic>pax7b</italic> mRNAs of 82% and 120%, respectively, in <italic>myog</italic><sup>-/-</sup> compared to control sibs, but no change in <italic>pax3a</italic> or <italic>pax3b</italic> (<xref ref-type="fig" rid="fig2">Figure 2A</xref> and <xref ref-type="fig" rid="fig2s1">Figure 2—figure supplement 1A</xref>). <italic>Myf5</italic> mRNA, a marker of partially-activated or ‘alerted’ MuSCs in mice and MPCs in fish, and known to be a Pax7 target gene (<xref ref-type="bibr" rid="bib15">Coutelle et al., 2001</xref>; <xref ref-type="bibr" rid="bib46">Kuang et al., 2007</xref>; <xref ref-type="bibr" rid="bib91">Soleimani et al., 2012</xref>), was upregulated by over 200%, further suggesting an increase of MuSCs number in <italic>myog<sup>-/-</sup></italic>. In contrast, <italic>myod</italic> mRNA, a marker of fully-activated proliferating MuSCs (<xref ref-type="bibr" rid="bib99">Zammit et al., 2004</xref>; <xref ref-type="bibr" rid="bib98">Zammit et al., 2002</xref>; <xref ref-type="bibr" rid="bib59">Megeney et al., 1996</xref>), was unaltered (<xref ref-type="fig" rid="fig2">Figure 2A</xref>). These data raise the possibility that <italic>myog</italic><sup>-/-</sup> adults have alterations in MuSCs. To facilitate identification of <italic>bona fide</italic> MuSCs, <italic>myog<sup>kg125/+</sup></italic> fish were bred onto <italic>pax7a:GFP</italic> reporter and MuSCs identified by GFP fluorescence (<xref ref-type="fig" rid="fig2">Figure 2B,C</xref>; <xref ref-type="bibr" rid="bib72">Pipalia et al., 2016</xref>; <xref ref-type="bibr" rid="bib51">Mahalwar et al., 2014</xref>). Immunostaining of GFP-positive (GFP<sup>+ve</sup>) cells with the DP312 antibody, that recognises fish Pax3/Pax7 (<xref ref-type="bibr" rid="bib30">Hammond et al., 2007</xref>; <xref ref-type="bibr" rid="bib16">Davis et al., 2005</xref>), revealed co-labelling of virtually all GFP<sup>+ve</sup> cells, thus confirming MuSC identity (<xref ref-type="fig" rid="fig2">Figure 2D</xref>). Adult <italic>pax7a:GFP;myog</italic><sup>-/-</sup> fish showed reduced muscle compared to co-reared <italic>pax7a:GFP;myog</italic><sup>+/-</sup> sibs (<xref ref-type="fig" rid="fig2s1">Figure 2—figure supplement 1B</xref>), replicating the phenotype on a wild-type background (<xref ref-type="bibr" rid="bib26">Ganassi et al., 2018</xref>). Upon muscle dissociation, we observed that single <italic>myog</italic><sup>-/-</sup> myofibres bore around five GFP<sup>+ve</sup> cells on average, compared to only one on sib myofibres (<xref ref-type="fig" rid="fig2">Figure 2E</xref>). As we previously showed that cytoplasmic GFP diffuses throughout the cytoplasm of muscle fibres within seconds after fusion leading to a dramatic weakening of signal (<xref ref-type="bibr" rid="bib72">Pipalia et al., 2016</xref>; <xref ref-type="bibr" rid="bib2">Bajanca et al., 2015</xref>), these data show that MuSCs are more numerous on mutant myofibres. Indeed, almost 40% of nuclei associated with <italic>myog</italic><sup>-/-</sup> myofibres were in GFP<sup>+ve</sup> cells compared to less than 2% in sib (<xref ref-type="fig" rid="fig2">Figure 2G</xref> and <xref ref-type="fig" rid="fig2s1">Figure 2—figure supplement 1C</xref>). Thus, MuSCs are more abundant in <italic>myog</italic><sup>-/-</sup> mutants than in sibs. Subtraction of MuSC nuclei from the total nuclei associated with isolated adult myofibres, revealed that sib myofibres have over thirteenfold more genuine myofibre nuclei (i.e. myonuclei) than <italic>myog</italic><sup>-/-</sup> myofibres (<xref ref-type="fig" rid="fig2s1">Figure 2—figure supplement 1D</xref>). These GFP-negative (GFP<sup>-ve</sup>) myonuclei allowed calculation of a myofibre volume per true myonucleus, the notional myonuclear domain. In line with SADS, the myonuclear domain was increased by 2.3-fold in <italic>myog</italic><sup>-/-</sup> fibres (<xref ref-type="fig" rid="fig2">Figure 2F</xref>), despite the eightfold reduction in absolute myofibre volume (<xref ref-type="fig" rid="fig2s1">Figure 2—figure supplement 1E</xref>). Accordingly, corrected SADS showed an increase of almost fivefold in mutant (<xref ref-type="fig" rid="fig2s1">Figure 2—figure supplement 1F</xref>). Thus, despite <italic>myog<sup>-/-</sup></italic> fish having less muscle due to reduced fusion, Myog in the adult also regulates muscle growth by limiting both nuclear domain size and MuSC number.</p><fig-group><fig id="fig2" position="float"><label>Figure 2.</label><caption><title>Lack of Myogenin alters MuSC number and localisation.</title><p>Colours identify sib (blue) or <italic>myog<sup>-/-</sup></italic> (red) samples throughout the figure. (<bold>A</bold>) qPCR analysis showing upregulation of <italic>pax7a</italic>, <italic>pax7b</italic>, <italic>myf5</italic> and unaltered <italic>myod</italic> in adult <italic>myog</italic><sup>-/-</sup> mutant muscle. Symbol shapes denote paired sib and <italic>myog</italic><sup>-/-</sup> samples, n = 6 fish/genotype, paired <italic>t</italic>-tests. (<bold>B</bold>) Schematic of myofibre isolation for GFP<sup>+ve</sup> cells analysis from <italic>pax7a:GFP;myog</italic><sup>-/-</sup> and sib muscles. (<bold>C</bold>) Representative images showing GFP<sup>+ve</sup> cells on sib (blue arrowhead) or <italic>myog</italic><sup>-/-</sup> (red arrowheads) on isolated myofibres. Scale bar = 100 µm. (<bold>D</bold>) Representative immunodetection of GFP (green), DP312 (Pax3/Pax7; magenta) and nuclei (white) on GFP<sup>+ve</sup> (positive, green panel) cells or GFP<sup>-ve</sup> (negative, grey panel) nuclei on freshly isolated adult sib or <italic>myog</italic><sup>-/-</sup> myofibres. Scale bar = 5 µm. Quantification of DP312 immunostaining on <italic>pax7a:GFP</italic> MuSCs confirms the stem cell identity of both sib (n = 36/genotype) and <italic>myog<sup>-/-</sup></italic> (n = 67/genotype) GFP<sup>+ve</sup> cells, n = 3 fish/genotype unpaired <italic>t</italic>-test. (<bold>E,F</bold>) Quantification of absolute number of GFP<sup>+ve</sup> cells (<italic>bona fide</italic> MuSC) per myofibre and myonuclear domain size. n = 3 fish/genotype, n = 20–30 myofibres/fish, unpaired <italic>t</italic>-test. (<bold>G</bold>) Pie charts showing the fraction of nuclei (left) and fraction of myofibres (right) with the indicated number of nuclei in GFP<sup>+ve</sup> cells (left) or cells/myofibre (right) in sib (blue circles) and <italic>myog</italic><sup>-/-</sup> (red circles). Data from <xref ref-type="fig" rid="fig2s1">Figure 2—figure supplement 1G</xref>. <italic>p</italic>-values indicate probability of rejecting null hypothesis of no difference between <italic>myog</italic><sup>-/-</sup> and sib in <italic>χ</italic><sup>2</sup> tests. (<bold>H</bold>) Diagram of measurement of GFP<sup>+ve</sup> cell distance from nearest myofibre-end (top). Each myofibre was segmented into tenths, where 1/10 and 5/10 corresponded to the segments nearest to and furthest from the myofibre-end, respectively. Quantification of fraction of MuSC located within each myofibre segment (bottom, see Materials and methods and <xref ref-type="fig" rid="fig2s1">Figure 2—figure supplement 1H</xref>). n = 3 fish/genotype, n = 30–50 MuSCs, <italic>p</italic>-value indicates probability of rejecting null hypothesis of no difference between <italic>myog</italic><sup>-/-</sup> and sib in <italic>χ</italic><sup>2</sup> test. (<bold>I</bold>) Representative images showing localisation of the GFP<sup>+ve</sup> cell on sib (blue rectangle) or <italic>myog</italic><sup>-/-</sup> (red rectangle) mono-MuSC myofibres (with only one GFP<sup>+ve</sup> cell). Scale bar = 100 μm (=20 µm in 2x-zoom). (<bold>J</bold>) Quantification of fraction of MuSC located within each 10 µm segment from mono-MuSC myofibre-end. n = 3 fish/genotype, n = 15–25 MuSCs, black <italic>p</italic>-value indicates probability of rejecting null hypothesis of no difference between <italic>myog</italic><sup>-/-</sup> and sib in <italic>χ</italic><sup>2</sup> test. Coloured <italic>p</italic>-values indicate one-way ANOVA analysis of non-random MuSC distribution in 10 µm segments within each genotype. Magenta inset reports fraction of sib and <italic>myog<sup>-/-</sup></italic> MuSC within the 0–9 and 10–19 µm segments, unpaired <italic>t</italic>-test. Symbols show results for individual fish. All graphs report mean ± SEM.</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-60445-fig2-v2.tif"/></fig><fig id="fig2s1" position="float" specific-use="child-fig"><label>Figure 2—figure supplement 1.</label><caption><title><italic>pax7a:GFP;myog<sup>kg125</sup></italic> muscle is smaller and displays altered MuSC cellularity and unchanged <italic>Pax3</italic> genes expression.</title><p>(<bold>A</bold>) Schematic of trunk muscle processing for qPCR analysis (left), sib (blue), <italic>myog</italic><sup>-/-</sup> (red). Expression of <italic>pax3a</italic> and <italic>pax3b</italic> mRNAs is unchanged in <italic>myog</italic><sup>-/-</sup> muscle (right). Symbol shapes denote paired sib and <italic>myog</italic><sup>-/-</sup> samples, n = 6 fish/genotype, paired <italic>t</italic>-test. (<bold>B</bold>) Representative images of adult <italic>pax7a:GFP;myog<sup>+/-</sup></italic> (sib) and <italic>pax7a:GFP;myog</italic><sup>-/-</sup> (left). Scale bar = 1 cm. Quantification showing reduced length, weight, body mass index and standard weight in <italic>myog</italic><sup>-/-</sup> compared to co-reared sibs (right), n = 7, unpaired <italic>t</italic>-test. (<bold>C</bold>) Schematic of <italic>pax7a:GFP</italic> adult trunk muscle processing for MuSC analysis (left). Fraction of GFP<sup>+ve</sup> cells (<italic>bona fide</italic> MuSCs) per myofibre-associated nucleus is significantly increased in <italic>myog</italic><sup>-/-</sup> muscle (right). n = 3 fish/genotype, unpaired <italic>t</italic>-test. (<bold>D</bold>) Quantification of absolute number of (non-MuSC, GFP<sup>-ve</sup>) myonuclei per adult myofibre. n = 3 fish/genotype, n = 20–30 myofibres/fish, unpaired <italic>t</italic>-test. (<bold>E,F</bold>) Quantification of absolute myofibre volume and myonuclear SADS (Surface Area Domain Size). n = 3 fish/genotype, n = 20–30 myofibres/fish, unpaired <italic>t</italic>-test. (<bold>G</bold>) Fraction of myofibres (%) with indicated number of GFP<sup>+ve</sup> cells (MuSCs), n = 3 fish/genotype, n = 20–30 myofibres/fish,<italic>p</italic>-value indicates probability of rejecting null hypothesis of no difference between <italic>myog</italic><sup>-/-</sup> and sib in <italic>χ</italic><sup>2</sup> test. (<bold>H</bold>) Schematic of GFP<sup>+ve</sup> cell distance to nearest myofibre-end measurement (left). Note that while average half-length (in magenta) of sib myofibre (blue diagram) is 500 µm, <italic>myog</italic><sup>-/-</sup> myofibre average half-length is 250 µm (red diagram). To compare absolute distance to myofibre-end, each myofibre was segmented into 50 µm segments and the fraction of GFP<sup>+ve</sup> cells (%) within each distance segment from nearest myofibre-end plotted, n = 3 fish/genotype, n = 20–30 MuSCs/fish, <italic>p</italic>-value indicates probability of rejecting null hypothesis of no difference between <italic>myog</italic><sup>-/-</sup> and sib in <italic>χ</italic><sup>2</sup> test. Note that in sibs almost no GFP<sup>+ve</sup> MuSCs were located in the central 50% of their myofibre. All graphs report mean ± SEM.</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-60445-fig2-figsupp1-v2.tif"/></fig></fig-group></sec><sec id="s2-3"><title>Altered MuSC:niche relation in <italic>myog<sup>-/-</sup></italic> mutant myofibres</title><p>Myofibres from <italic>myog</italic><sup>-/-</sup> showed a striking set of alterations in MuSC distribution. In control sib, MuSCs were found mostly localised close to the myofibre end, whereas in <italic>myog</italic><sup>-/-</sup> the supernumerary MuSCs were randomly distributed along the myofibre length (<xref ref-type="fig" rid="fig2">Figure 2H</xref> and <xref ref-type="fig" rid="fig2s1">Figure 2—figure supplement 1G</xref>). In sibs, 70% of myofibres had a single associated MuSC, which was usually within 20 µm from the myofibre end (<xref ref-type="fig" rid="fig2">Figure 2G,I,J</xref> and <xref ref-type="fig" rid="fig2s1">Figure 2—figure supplement 1G,H</xref>). In contrast, only 33% of myofibres had a single MuSC in mutants (<xref ref-type="fig" rid="fig2">Figure 2G,I</xref> and <xref ref-type="fig" rid="fig2s1">Figure 2—figure supplement 1G,H</xref>), which displayed consistent random location, often far from the myofibre end (<xref ref-type="fig" rid="fig2">Figure 2I,J</xref>). Around 60% of <italic>myog</italic><sup>-/-</sup> myofibres bore two or more MuSCs, whereas only 9% of sib myofibres had two or more MuSCs, and none had over three (<xref ref-type="fig" rid="fig2">Figure 2G</xref>). Strikingly, 21% of sib myofibres had no GFP<sup>+ve</sup> cells, compared to only 5% of <italic>myog</italic><sup>-/-</sup> myofibres (<xref ref-type="fig" rid="fig2">Figure 2G</xref> and <xref ref-type="fig" rid="fig2s1">Figure 2—figure supplement 1G</xref>). The results suggest that lack of Myog either enhances MuSC proliferation, prevents MuSC differentiation or both. Data in this and the preceding section demonstrate that lack of Myog alters MuSC number, position and expression of stemness marker genes, suggestive of an alteration in their relationship to their normal myofibre end niche.</p></sec><sec id="s2-4"><title>Lack of Myog enhances mTORC1 signalling in adult muscle and MuSCs</title><p>To investigate further how Myog may influence the MuSC niche, we assessed the expression of factors that contribute to muscle growth via regulation of MuSC activation. Whole muscle analysis revealed 130% increased level of <italic>igf1</italic> mRNA and nearly 50% downregulation of <italic>myostatin b</italic> (<italic>mstnb</italic>) mRNA, both regulators of muscle growth and the mTORC1 (mechanistic Target Of Rapamycin Complex 1) pathway (<xref ref-type="bibr" rid="bib97">Yoon, 2017</xref>; <xref ref-type="bibr" rid="bib92">Trendelenburg et al., 2009</xref>), suggesting that lack of Myog triggers a growth signalling response (<xref ref-type="fig" rid="fig3">Figure 3A,B</xref>). In contrast, expression of the zebrafish IGF1 receptors, <italic>igfr1a</italic> and <italic>igfr1b</italic> was unaltered (<xref ref-type="fig" rid="fig3s1">Figure 3—figure supplement 1</xref>) indicating that <italic>myog<sup>-/-</sup></italic> myofibres, and/or MuSCs, may respond to the higher IGF1 level similarly to sib. IGF1 signalling involves phosphorylation of AKT that activates mTORC1 resulting in downstream events such as promotion of muscle growth, accompanied by phosphorylation of the ribosomal protein S6 (RPS6) (<xref ref-type="fig" rid="fig3">Figure 3C</xref> and <xref ref-type="bibr" rid="bib97">Yoon, 2017</xref>; <xref ref-type="bibr" rid="bib84">Ruvinsky et al., 2009</xref>). Western blot analysis of whole muscle extracts revealed that whereas AKT phosphorylation at Ser473 (pAKT) appeared unchanged, downstream phosphorylation of RPS6 at Ser240/244 (pRPS6) was enhanced fourfold in <italic>myog</italic><sup>-/-</sup> muscle compared to sib (<xref ref-type="fig" rid="fig3">Figure 3D</xref>). Phosphorylation of RPS6 (pRPS6) marks the onset of MuSC activation in vivo (<xref ref-type="bibr" rid="bib82">Rodgers et al., 2014</xref>). Thus, we analysed pRPS6 level in MuSCs on freshly isolated myofibres from <italic>pax7a:GFP;myog</italic><sup>-/-</sup> or control <italic>pax7a:GFP;myog</italic><sup>+/-</sup> sib. <italic>Myog</italic><sup>-/-</sup> MuSCs showed a robust twofold increase in pRPS6 level (<xref ref-type="fig" rid="fig3">Figure 3E,F</xref>), in line with quantification in whole muscle. No change was detected in myofibres themselves. As pRPS6 was increased but pAKT was not similarly altered, we reasoned that lack of Myog might control the expression level of factors that inhibit the mTORC1 pathway. Tsc1 and Tsc2 form a stabilised GTPase complex that represses the mTOR cascade (<xref ref-type="fig" rid="fig3">Figure 3C</xref>; <xref ref-type="bibr" rid="bib64">Nobukini and Thomas, 2004</xref>). Levels of <italic>tsc1a</italic> and <italic>tsc1b</italic> mRNAs were reduced by 51% and 57%, respectively, in <italic>myog</italic><sup>-/-</sup> muscle, whereas <italic>tsc2</italic> mRNA was unchanged compare to sib (<xref ref-type="fig" rid="fig3">Figure 3G</xref>), consistent with increased pRPS6. We conclude that lack of Myog triggers activation of the mTORC1 pathway in MuSCs, concomitant with <italic>tsc1a/b</italic> repression, leading to precocious MuSC activation.</p><fig-group><fig id="fig3" position="float"><label>Figure 3.</label><caption><title><italic>Myog<sup>-/-</sup></italic> mutant muscle and MuSCs display enhanced mTORC1 signalling.</title><p>(<bold>A</bold>) Schematic of adult trunk muscle processing for analysis. Colours identify sib (blue) or <italic>myog</italic><sup>-/-</sup> (red) samples throughout the figure. (<bold>B</bold>) qPCR analysis shows upregulation of <italic>igf1</italic> and downregulation of <italic>mstnb</italic> in <italic>myog</italic><sup>-/-</sup> muscle. Symbol shapes denote paired sib and <italic>myog</italic><sup>-/-</sup> samples, n = 4 fish/genotype, paired <italic>t</italic>-test. (<bold>C</bold>) Summary of mTORC1 pathway with analysed components, positive (arrows) or negative (bars) effects are indicated. Dashed lines indicate other molecules involved; red dots represent phosphorylation events. (<bold>D</bold>) Western blot (left) and quantification (right) of phosphorylated/pan AKT (pAKT, Ser473) ratio and phosphorylated/pan RPS6 (pRPS6, Ser240/244). pRPS6 is increased in <italic>myog</italic><sup>-/-</sup> muscle, n = 3 fish/genotype, unpaired <italic>t</italic>-test. Actin immunoreactivity was used to normalise pan and phospho signals to protein loading prior to calculation of sample-specific phospho/pan ratio. (<bold>E</bold>) Representative images of myofibre immunostained for GFP (green), pRPS6 (red) and nuclei (white) fixed freshy immediately after isolation. Arrowheads indicate MuSCs on sib (blue) or <italic>myog</italic><sup>-/-</sup> (red) myofibres. Dashed magenta squares highlight 4x-magnified cells. Scale bar = 100 µm (=5 µm in 4x-zoom). (<bold>F</bold>) Quantification of pRPS6 intensity shows increase in <italic>myog</italic><sup>-/-</sup> MuSCs. Symbol shapes denote paired sib and <italic>myog</italic><sup>-/-</sup> samples, n = 4 fish/genotype, n = 20–30 MuSCs/fish, paired <italic>t</italic>-test. (<bold>G</bold>) qPCR analysis showing downregulation of <italic>tsc1a</italic> and <italic>tsc1b</italic> mRNAs but unaltered <italic>tsc2</italic> mRNA in <italic>myog</italic><sup>-/-</sup> muscle. Symbol shapes denote paired sib and <italic>myog</italic><sup>-/-</sup> samples, n = 4–6 fish/genotype, paired <italic>t</italic>-test. All graphs report mean ± SEM.</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-60445-fig3-v2.tif"/></fig><fig id="fig3s1" position="float" specific-use="child-fig"><label>Figure 3—figure supplement 1.</label><caption><title><italic>Myog<sup>-/-</sup></italic> mutant muscle displays unaltered <italic>igfr1a</italic> and <italic>igfr1b</italic> mRNA expression.</title><p>Schematic of adult trunk muscle processing for qPCR analysis (left). Summary of mTORC1 pathway with analysed members, positive (arrows) or negative (bars) effects are indicated (centre). Dashed lines indicate other molecules involved, plain arrow indicate direct effect, red dots represent phosphorylation. <italic>Igfr1a</italic> and <italic>igfr1b</italic> are unchanged in <italic>myog</italic><sup>-/-</sup> muscle compared to sib (right). Symbol shapes denote paired sib and <italic>myog</italic><sup>-/-</sup> samples, n = 5 fish/genotype, paired <italic>t</italic>-test.</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-60445-fig3-figsupp1-v2.tif"/></fig></fig-group></sec><sec id="s2-5"><title>Adult <italic>myog<sup>-/-</sup></italic> MuSC-derived myoblasts exhibit faster transition to proliferation</title><p>To assess MuSC activation and proliferation potential, myofibres bearing GFP<sup>+ve</sup> cells, from either <italic>pax7a:GFP;myog</italic><sup>-/-</sup> or control <italic>pax7a:GFP;myog</italic><sup>+/-</sup> sib were individually plated, cultured for 4 days in growth medium and the number of associated myogenic cells counted (<xref ref-type="fig" rid="fig4s1">Figure 4—figure supplement 1A</xref>). <italic>Myog</italic><sup>-/-</sup> mutants yielded at least three times as many mononucleate cells than did sibs (<xref ref-type="fig" rid="fig4s1">Figure 4—figure supplement 1A</xref>), paralleling the increased number of MuSCs on freshly-isolated myofibres. The vast majority (80–90%) of cells from fish of either genotype was GFP<sup>+ve</sup>, so <italic>bona fide</italic> MPCs. <italic>Myog</italic><sup>-/-</sup> myofibres also displayed an average threefold increased GFP<sup>+ve</sup> cell yield compared to sibs (<xref ref-type="fig" rid="fig4">Figure 4A–C</xref>). Within the 4-day culture period, sib myofibres (70% of which had only a single GFP<sup>+ve</sup> MuSC) yielded around 40 MPCs, reflecting a mean doubling time of around 20 hr. Mutants yielded a slightly higher proportion of GFP<sup>+ve</sup> MPCs than sibs (<xref ref-type="fig" rid="fig4">Figure 4C</xref>), perhaps reflecting the increased number of MuSCs on each myofibre and the upregulation of <italic>pax7a</italic> mRNA in <italic>myog<sup>-/-</sup></italic> muscle. Importantly, although both genotypes yielded a GFP<sup>-ve</sup> cell population, all cells immunoreacted for Desmin, confirming their myogenic identity (<xref ref-type="fig" rid="fig4s1">Figure 4—figure supplement 1A</xref>). Notably, the relative MPC proliferation rates were not significantly different among genotypes, calculated as the ratio of the number of GFP<sup>+ve</sup> MPCs obtained after 4 days in culture to the average number of GFP<sup>+ve</sup> MuSC per myofibre at the time of isolation (<xref ref-type="fig" rid="fig4">Figure 4D</xref>). We conclude that <italic>myog</italic><sup>-/-</sup> mutant and sib MuSCs have similar proliferative potentiality when assayed in culture.</p><fig-group><fig id="fig4" position="float"><label>Figure 4.</label><caption><title><italic>Myog<sup>-/-</sup></italic> mutant MPCs exhibit faster entrance into proliferation phase.</title><p>(<bold>A</bold>) Schematic of adult single myofibre culture and representative immunodetection of GFP (green) and nuclei (white) on cultured MPCs. Colours identify sib (blue) or <italic>myog</italic><sup>-/-</sup> (red) samples throughout the figure. (<bold>B</bold>) Quantification of GFP<sup>+ve</sup> cells obtained by single myofibre culture revealed increased MPCs yield from <italic>myog</italic><sup>-/-</sup> after 4 days in growth medium, n = 3 fish/genotype, n = 8 myofibres/fish. Unpaired <italic>t</italic>-test on average MPCs/fish/genotype. (<bold>C</bold>) Fraction of GFP<sup>+ve</sup> cells out of total number of cells obtained in B. n = 3 fish/genotype, unpaired <italic>t</italic>-test. (<bold>D</bold>) Relative proliferation rate of sib or <italic>myog</italic><sup>-/-</sup> MPCs calculated as the ratio of the average number of GFP<sup>+ve</sup> MPCs/plated-myofibre obtained on day 4 in culture divided by the average number of GFP<sup>+ve</sup> MuSCs/myofibre, unpaired <italic>t</italic>-test. (<bold>E</bold>) Diagram of myofibres culture and EdU pulse regime (top). Quantification of fraction of EdU<sup>+ve</sup> MPCs at indicated time points (bottom left), symbol shapes denote MPCs obtained from paired sib and <italic>myog</italic><sup>-/-</sup> samples, n = 3. Measurement of Area Under Curve (AUC, coloured area underneath dashed blue or red lines) to compare overall proliferation dynamics indicates reduction in <italic>myog</italic><sup>-/-</sup> MPCs (bottom right), unpaired <italic>t</italic>-test. (<bold>F</bold>) Representative images of sib and <italic>myog</italic><sup>-/-</sup> MPC numbers and EdU incorporation at indicated times in culture, showing detection of EdU (red) and nuclei (blue). (<bold>G</bold>) qPCR analysis showing expression dynamics of <italic>pax7a</italic>, <italic>pax7b</italic>, <italic>myod</italic> and <italic>myf5</italic> mRNAs in sib and <italic>myog</italic><sup>-/-</sup> MPCs cultured for 2 (n = 4) or 3 days (n = 3), unpaired <italic>t</italic>-test. (<bold>H</bold>) qPCR analysis indicating upregulation of <italic>mef2d, mylpfa</italic>, <italic>flnca</italic> and <italic>mybpc1</italic> mRNAs in <italic>myog</italic><sup>-/-</sup> MPCs cultured in growth medium for 2 (n = 4) or 3 days (n = 3), unpaired <italic>t</italic>-test. (<bold>I</bold>) Representative immunodetection of MyHC (red) and nuclei (white) on sib or <italic>myog</italic><sup>-/-</sup> MPCs at 3 days in growth medium for 3 days (left). Extent of differentiation (Index (%), see Materials and methods) is higher in <italic>myog</italic><sup>-/-</sup> than in sib MPCs (right). All graphs report mean ± SEM. Statistical significance within (coloured <italic>p</italic>) or between (black <italic>p</italic>) genotypes is indicated. Scale bars = 100 µm.</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-60445-fig4-v2.tif"/></fig><fig id="fig4s1" position="float" specific-use="child-fig"><label>Figure 4—figure supplement 1.</label><caption><title>Characteristics of cultured MPCs and mRNA analysis.</title><p>(<bold>A</bold>) Schematic of single myofibre culture and analysis of derived MPCs after 4 days from plating in growth medium (left). Total number of cells (= GFP<sup>+ve</sup> + GFP<sup>-ve</sup>) is increased in <italic>myog</italic><sup>-/-</sup> (centre). n = 3 fish/genotype, n = 8 myofibre/fish. Unpaired <italic>t</italic>-test on average number of cells/fish/genotype. Representative immunostaining of Desmin (red) and nuclei (white) confirming myogenic identity of both sib and <italic>myog<sup>-/-</sup></italic> cells from single-plated myofibres at 4 days (right). (<bold>B</bold>) Schematic of 90–100 myofibres culture in growth medium (GM) and analysis of derived MPCs (left). Representative immunostaining of Desmin (red), GFP (green) and nuclei (white) confirming myogenic identity of both sib and <italic>myog</italic><sup>-/-</sup> cells after 2 days of culture (centre). <italic>Myog</italic><sup>-/-</sup> myofibres yielded higher number of Desmin<sup>+</sup> MPCs per field of view (FOV). Symbol shapes denote paired sib and <italic>myog</italic><sup>-/-</sup> samples, n = 3 fish/genotype, paired <italic>t</italic>-test (right). (<bold>C</bold>) 90–100 myofibres cultured from each genotype yielded over 90% of Desmin<sup>+</sup> cells, confirming high purity of the MPC population, n = 3 fish/genotype, unpaired <italic>t</italic>-test. (<bold>D</bold>) qPCR analysis shows expression dynamics of <italic>cdkn1a</italic> (p21) and <italic>cdkn1ca</italic> (p57) mRNAs in sib and <italic>myog</italic><sup>-/-</sup> MPCs cultured for 2 (n = 4) or 3 days (n = 3), unpaired <italic>t</italic>-test. Statistical significance within (coloured <italic>p</italic>) or between (black <italic>p</italic>) genotypes is indicated. (<bold>E</bold>) Schematic of 90–100 myofibres culture and analysis of derived MPCs cultured for 5 days in differentiation medium (DM), following expansion for 4 days in growth medium (GM) (left). Representative immunostaining of MyHC (red), nuclei (white) confirming that fusion into multinucleated myotubes occurred only in sib MCPs, whereas differentiated <italic>myog<sup>-/-</sup></italic> cells remained mostly mononucleated, as reported previously (<xref ref-type="bibr" rid="bib26">Ganassi et al., 2018</xref>) (right). Dashed cyan squares highlight 3x-magnified cells, coloured arrowheads indicate nuclei of each separate differentiated cell. All graphs report mean ± SEM. Scale bars = 100 µm.</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-60445-fig4-figsupp1-v2.tif"/></fig></fig-group><p>To explore proliferation dynamics further, MPCs were pulsed with EdU at either 2, 3 or 4 days ex vivo after myofibre plating in growth medium (<xref ref-type="fig" rid="fig4">Figure 4E</xref>). To increase MPC yield for downstream analyses, 90–100 fibres were plated per well (<xref ref-type="fig" rid="fig4">Figure 4E</xref> and <xref ref-type="fig" rid="fig4s1">Figure 4—figure supplement 1B</xref>). As expected, <italic>myog</italic><sup>-/-</sup> myofibres yielded more MPCs after 2 days in culture compared to sibs, and both genotypes produced mainly Desmin<sup>+ve</sup> muscle lineage cells (<xref ref-type="fig" rid="fig4s1">Figure 4—figure supplement 1B,C</xref>). An EdU pulse 2 days after plating revealed striking differences between <italic>myog</italic><sup>-/-</sup> MPCs, 60% of which were EdU<sup>+ve</sup>, compared to sib MPCs, only 20% of which incorporated EdU (<xref ref-type="fig" rid="fig4">Figure 4E,F</xref>). A day later (on day 3), the difference in proliferation had reversed; sib MPCs were almost 60% EdU<sup>+ve</sup>, whereas incorporation into <italic>myog</italic><sup>-/-</sup> MPCs was significantly reduced compared to both sibs on day 3 and <italic>myog</italic><sup>-/-</sup> MPCs on day 2 (<xref ref-type="fig" rid="fig4">Figure 4E,F</xref>). This difference in S-phase labelling between <italic>myog</italic><sup>-/-</sup> and sib MPCs persisted on day 4 (<xref ref-type="fig" rid="fig4">Figure 4E,F</xref>). Statistical analysis of overall EdU incorporation dynamics as Area Under Curve (AUC) revealed slightly higher proliferation rate of sib MPCs (<xref ref-type="fig" rid="fig4">Figure 4E</xref>). Although we have not analysed EdU incorporation at day 1 (when many MPCs are still on their myofibres which, being often lost during staining, prevented analysis), these data clearly reveal that proliferation is not increased in mutant MPCs, simply activated earlier. We conclude that MPCs in <italic>myog</italic><sup>-/-</sup> mutants are more readily driven into proliferation upon release from their in vivo environment.</p><p>We next explored MuSC dynamics by analysing MPCs mRNA levels at day 2 and day 3 of culture. Both <italic>pax7a</italic> and <italic>pax7b</italic> were more abundant, fourfold and threefold, respectively, in <italic>myog</italic><sup>-/-</sup> MPCs at 2 days compared to sib (<xref ref-type="fig" rid="fig4">Figure 4G</xref>), consistent with the higher percentage of MuSCs observed (<xref ref-type="fig" rid="fig4">Figure 4C</xref>). Strikingly, while <italic>pax7a</italic> mRNA reduced with time, <italic>pax7b</italic> mRNA was maintained at similar level between day 2 and day 3 across genotypes, despite confirming overall increased level in <italic>myog</italic><sup>-/-</sup> MPCs (<xref ref-type="fig" rid="fig4">Figure 4G</xref>). Moreover, <italic>myod</italic> mRNA was fifteenfold more abundant in <italic>myog</italic><sup>-/-</sup> MPCs compared to sib, again suggesting an earlier entry into activation phase. Notably, higher <italic>myod</italic> expression in <italic>myog</italic><sup>-/-</sup> MPCs lasted into day 3. In contrast, <italic>myf5</italic> mRNA level appeared similar in <italic>myog</italic><sup>-/-</sup> and sib MPCs at both 2 and 3 days, although tending to decrease at the later timepoint in sibs (<xref ref-type="fig" rid="fig4">Figure 4G</xref>), perhaps reflecting their slower activation. The data suggest that <italic>myog</italic><sup>-/-</sup> MPCs show faster activation and greater recovery from a stem-like state than MPCs from sibs.</p><p>The decreased proliferation but enhanced <italic>myod</italic> mRNA in cultured <italic>myog</italic><sup>-/-</sup> compared to sib MPCs also suggested that the mutant cultures might be entering the terminal differentiation program despite the presence of growth medium, presumably due to their rapid proliferation resulting in the formation of confluent cell clusters that consequently begin myogenic terminal differentiation prematurely. We assessed onset of differentiation by analysing expression of <italic>mef2d</italic>, <italic>mylpfa</italic> (encoding a fast myosin light chain), <italic>flnca</italic> and <italic>mybpc1</italic>, crucial players in myogenesis, which revealed significantly higher levels of all the assessed mRNAs in <italic>myog</italic><sup>-/-</sup> relative to sib MPCs on day 3, with an approximate upregulation of <italic>mef2d</italic> (twofold), <italic>mylpfa</italic> (fortyfold), <italic>flnca</italic> (fivefold) and <italic>mybpc1</italic> (thirtyfold) (<xref ref-type="fig" rid="fig4">Figure 4H</xref>). Among the four, only <italic>mylpfa</italic> showed accumulation in <italic>myog<sup>-/-</sup></italic> MPCs already at day 2. In addition, mutant MPCs significantly accumulated <italic>cdkn1a</italic> (<italic>p21</italic>) mRNA (fourfold) between day 2 and day 3, in line with reduced proliferation and myogenic progression, whereas sib MPCs did not (<xref ref-type="fig" rid="fig4s1">Figure 4—figure supplement 1D</xref>). In contrast, level of <italic>cdkn1ca</italic> (<italic>p57</italic>), which promotes terminal myogenesis (<xref ref-type="bibr" rid="bib67">Osborn et al., 2011</xref>), was unaltered in both <italic>myog<sup>-/-</sup></italic> and sib MPCs (<xref ref-type="fig" rid="fig4s1">Figure 4—figure supplement 1D</xref>), highlighting the immature state of myogenic progression. However, despite the continued exposure to growth medium, immunostaining confirmed accumulation of sarcomeric myosin heavy chain (MyHC) and significantly higher differentiation index in <italic>myog</italic><sup>-/-</sup> compared to sib MPCs at day 3, (<xref ref-type="fig" rid="fig4">Figure 4I</xref>). As reported previously (<xref ref-type="bibr" rid="bib26">Ganassi et al., 2018</xref>), upon culture under differentiation conditions, sib MPCs underwent cell fusion forming visible multinucleated myotubes, whereas differentiated <italic>myog<sup>-/-</sup></italic> MPCs remained mostly mononucleated (<xref ref-type="fig" rid="fig4s1">Figure 4—figure supplement 1E</xref>). Altogether, our data indicate that whereas Myog function is dispensable for MPC proliferation and terminal differentiation, its lack either prevents MuSCs achieving full quiescence or accelerates MuSC transition into the proliferation phase, suggesting that Myog contributes to maintaining the MuSC niche.</p></sec></sec><sec id="s3" sec-type="discussion"><title>Discussion</title><p>Here, we describe a novel function for the transcription factor Myog in regulating adult skeletal muscle growth rate and MuSC dynamics through four major findings. First, Myog influences MuSC number. Second, Myog is required for MuSCs to adopt their normal niche position. Third, Myog contributes to MuSC deep quiescence, regulating expression of genes involved in mTORC1 signalling. Lastly, Myog is required for proper myofibre growth and myonuclear accretion throughout life.</p><sec id="s3-1"><title>Myog controls MuSC number</title><p>We show that <italic>myog</italic><sup>-/-</sup> mutation causes supernumerary MuSCs/MPCs, paralleled by increased <italic>pax7a</italic> and <italic>pax7b</italic> mRNA. In addition to the fivefold increase in MuSC/adult myofibre and 50% reduction in myofibre length reported here, we previously described that adult <italic>myog</italic><sup>-/-</sup> mutants have unaltered body length and numbers of myofibre profiles/transverse body section roughly equal to their non-mutant siblings (<xref ref-type="bibr" rid="bib26">Ganassi et al., 2018</xref>). Taken together, these data suggest that total number of Pax7<sup>+</sup> MuSCs is increased around 10-fold in adult <italic>myog</italic><sup>-/-</sup> mutant myotome. In mouse, expression of Pax7 and Myog in MuSC appear to be mutually exclusive and controlled through reciprocal inhibition in in vitro studies (<xref ref-type="bibr" rid="bib65">Olguin et al., 2007</xref>; <xref ref-type="bibr" rid="bib81">Riuzzi et al., 2014</xref>). Persistent <italic>Pax7</italic> expression delays Myog accumulation in cultured myoblasts and ex vivo in MuSCs on myofibres, whereas silencing of <italic>Myog</italic> can result in retention of <italic>Pax7</italic> expression in differentiation (<xref ref-type="bibr" rid="bib65">Olguin et al., 2007</xref>; <xref ref-type="bibr" rid="bib100">Zammit et al., 2006</xref>). As Myog is required for adult myoblast fusion in vitro (<xref ref-type="bibr" rid="bib26">Ganassi et al., 2018</xref>) and <italic>mymk</italic> and <italic>mymx</italic> mRNAs are reduced in adult <italic>myog</italic><sup>-/-</sup> muscle, one must consider the possibility that some <italic>pax7a:GFP</italic><sup>+ve</sup> mononucleate cells are not MuSCs but differentiated myocytes that retain the <italic>pax7a</italic> reporter and are unable to fuse. However, we detect Pax3/7 protein in MuSCs, showing that strong GFP accumulation is not just perdurance of earlier signal. Moreover, most <italic>myog</italic><sup>-/-</sup> MuSCs enter into S-phase after 2 days ex vivo. Subsequently, <italic>myog</italic><sup>-/-</sup> MPCs quickly upregulate the differentiation marker <italic>mylpfa</italic> fortyfold, suggesting that an insignificant fraction was previously terminally differentiated. In addition, <italic>myog</italic><sup>-/-</sup> muscle expresses more <italic>myf5</italic>, a MPC marker. In post-natal rodent muscle, <italic>Myf5</italic> is expressed in MuSCs, not myofibres (<xref ref-type="bibr" rid="bib3">Beauchamp et al., 2000</xref>). Like our finding, murine <italic>Myog</italic>-knockout also led to <italic>Myf5</italic> accumulation in neonatal limb muscle, even though one-third of the total nuclei are still MuSCs/MPCs in wild type neonates (<xref ref-type="bibr" rid="bib8">Cardasis and Cooper, 1975</xref>; <xref ref-type="bibr" rid="bib78">Rawls et al., 1998</xref>). Taken together, these data argue that the abundant <italic>pax7a:GFP<sup>+ve</sup></italic> cells are MuSCs or MPCs.</p><p>We consider two possible hypotheses for the increased number of MuSC/MPCs in <italic>myog</italic><sup>-/-</sup> mutants; differentiation failure or active accumulation. We do not favour the idea that absence of Myog prevents MPCs undergoing terminal differentiation leading to the accumulation of cells blocked in differentiation for three reasons. First, <italic>myog</italic><sup>-/-</sup> MPCs readily undergo differentiation in culture and during myogenesis in the embryo (<xref ref-type="bibr" rid="bib26">Ganassi et al., 2018</xref>). Second, although muscle is reduced in size, there is enough formed to support life and sarcomere length is unaffected, so terminal differentiation is fairly efficient without Myog during larval and adult growth and any required muscle repair. Third, both in fish and amniotes, MPCs ready to differentiate express high levels of Myod, which acts in a feedforward mechanism to trigger cell cycle exit and Myog expression (<xref ref-type="bibr" rid="bib95">Weintraub et al., 1991</xref>; <xref ref-type="bibr" rid="bib33">Hinits et al., 2009</xref>). We do not, however, observe increased levels of <italic>myod</italic> mRNA in <italic>myog</italic><sup>-/-</sup> mutant muscle. Nevertheless, when <italic>myog</italic><sup>-/-</sup> MPCs are placed in culture they dramatically upregulate <italic>myod</italic>, arguing that Myod upregulation is also a characteristic of adult zebrafish MPC myogenic progression. Active accumulation of MuSCs, on the other hand, is suggested by the increase in <italic>pax7a</italic>, <italic>pax7b</italic> and <italic>myf5</italic> mRNAs in <italic>myog</italic><sup>-/-</sup> mutant muscle. Below, we raise the hypothesis that the abundance of myofibres with low numbers of nuclei may trigger MuSC accumulation as a homeostatic response to tissue insufficiency.</p></sec><sec id="s3-2"><title>Myog is required for MuSCs to adopt their normal niche position</title><p>In wild-type fish 21% of myofibres have no associated MuSCs, despite having around 95 myofibre nuclei. This finding strongly argues that, in order to grow or repair damage, MuSC/MPCs must migrate across the basal lamina between fibres, as occurs in developing rodent muscle (<xref ref-type="bibr" rid="bib39">Hughes and Blau, 1990</xref>). We observe 0.92 MuSCs/wild-type myofibre, on average. If one assumes random MuSC distribution amongst myofibres, the Poisson distribution predicts that 40% of myofibres should have no associated-MuSCs. The lower proportion of myofibres lacking MuSCs suggests that MuSCs are not distributed randomly. Conversely, Poissonian distribution would predict that 37% of myofibres should have a single MuSC. The observed value of 70% strongly suggests that MuSCs actively disperse between myofibres. Nevertheless, the system is imperfect, as the 21% of myofibres lacking MuSCs shows. Despite the fivefold increase in MuSCs in <italic>myog</italic><sup>-/-</sup> mutant, around 5% of myofibres still have no associated MuSC, which is far more than expected by the Poisson distribution (1.5%). Similarly, the 33% of <italic>myog</italic><sup>-/-</sup> myofibres with only a single MuSC compares with an expected value of 6%. In contrast, <italic>myog</italic><sup>-/-</sup> myofibres with over 10 MuSCs are over-represented, perhaps due to rare local regenerative events. In the absence of Myog, MuSCs tend to cluster on some myofibres, while also showing a tendency to be present at just one per myofibre more often than expected. These observations raise the possibility that myofibres in both wild-type and <italic>myog</italic><sup>-/-</sup> mutant contain a single specific niche for MuSCs.</p><p>Most MuSCs associated with isolated myofibres in zebrafish are located near myofibre ends, which would be attached to the vertical myoseptum tendon-like structure in vivo. We hypothesise that the fibre end provides a special niche in which MuSCs accumulate, perhaps formed in association with the myotendinous junction (MTJ). Strikingly, the preferred location of MuSCs in wild-type myofibres is between 10 and 20 µm from the myofibre end, suggesting that MuSCs locate not on the MTJ surface itself, but on the immediately adjacent cylindrical sarcolemma, retaining a potential physical contact with the MTJ. Moreover, this suggested location of the MuSC niche may relate to evidence that addition of new nuclei occurs preferentially at the ends of myofibres during growth (<xref ref-type="bibr" rid="bib44">Kitiyakara and Angevine, 1963</xref>; <xref ref-type="bibr" rid="bib1">Aziz and Goldspink, 1974</xref>). Upon explant ex vivo, MuSCs activate and begin to migrate away from myofibre ends. In <italic>myog</italic><sup>-/-</sup> mutants, the increased number of MuSCs are almost randomly distributed along the fibre, but the slightly higher abundance at myofibre ends might suggest that cells disperse once the MTJ niche is filled. However, when the fraction of myofibres in <italic>myog</italic><sup>-/-</sup> mutants that have only a single MuSC were analysed separately, significant dispersal was still observed. An additional possibility is that loss of MTJ contact by the short myofibres in <italic>myog<sup>-/-</sup></italic> mutants contributes to niche disruption. We conclude that Myog is required for assembly of the myofibre end MuSC:niche complex.</p><p>Mammalian MuSCs are generally not associated with myofibre ends, perhaps because myofibres are longer. Zebrafish myofibres are on average 1 mm long and rarely exceed 2 mm. In contrast, in the murine muscles most frequently analysed, those of the limbs, myofibres are up to 1 cm long. We suggest that the more numerous nuclei and larger number of MuSCs required for efficient growth and repair have allowed (or selected for) the MuSC niche to disperse along the myofibre.</p></sec><sec id="s3-3"><title>Myog contributes to MuSC deep quiescence</title><p>Numerous lines of evidence argue that MuSCs in <italic>myog</italic><sup>-/-</sup> zebrafish fail to enter full quiescence. First, MuSCs are more numerous in <italic>myog</italic><sup>-/-</sup> mutant adults. Second, they are often not in their normal niche. Third, they contain more pRPS6 upon acute isolation. Fourth, they activate and proliferate more rapidly upon ex vivo culture. Three hypotheses could explain the MuSC <italic>myog<sup>-/-</sup></italic> phenotype. (1) Lack of Myog function in early development. However, MuSCs are not increased in mutant larvae (<xref ref-type="bibr" rid="bib26">Ganassi et al., 2018</xref>) so it seems the defect worsens over the life course, suggesting a continuous need for Myog. (2) Lack of Myog within myofibre nuclei, which might lead to signals promoting MuSC proliferation (see below). (3) Myog could also function within MuSC themselves to control the balance between quiescence and activation. Whereas most literature describes <italic>Myog</italic> expression at the differentiation step following MuSC proliferation, various reports that noted Myog<sup>+</sup> MuSCs support a Myog MuSC-specific function. An early study investigating differential expression of <italic>Myod</italic> and <italic>Myog</italic> in rat muscle observed rare but intense accumulation of Myog mRNA along myofibre edges, anatomically reminiscent of MuSC niche (<xref ref-type="bibr" rid="bib37">Hughes et al., 1993</xref>). Notably, Myog expression predominates in oxidative myofibres also characterised by higher MuSC density (<xref ref-type="bibr" rid="bib29">Gibson and Schultz, 1982</xref>; <xref ref-type="bibr" rid="bib37">Hughes et al., 1993</xref>). Rantanen et al. identified a population of dormant Myog<sup>+</sup> MuSCs which may contribute to muscle repair bypassing the proliferation step (<xref ref-type="bibr" rid="bib77">Rantanen et al., 1995</xref>). Co-expression of Pax7 and Myog was observed in a satellite-cell study in transverse sections of both mouse soleus and EDL muscles (<xref ref-type="bibr" rid="bib86">Schultz et al., 2006</xref>) and in rare cells in fish dermomyotome (<xref ref-type="bibr" rid="bib17">Devoto et al., 2006</xref>). Likewise, immunohistochemistry on human resting muscle biopsies found <italic>Myog</italic> expression in MuSC but not in myonuclei (<xref ref-type="bibr" rid="bib48">Lindström et al., 2010</xref>). More recently, the Blau group reported a low but detectable level of Myog protein in both resting murine MuSCs and in MPCs returning to quiescence after recovery from injury (<xref ref-type="bibr" rid="bib73">Porpiglia et al., 2017</xref>). In addition, datasets show that <italic>Myog</italic> mRNA is present in quiescent MuSCs and rapidly decreases significantly during the 3 hours of myofibre isolation (<xref ref-type="bibr" rid="bib50">Machado et al., 2017</xref>). Interestingly, <italic>Mrf4</italic> expression in MuSC was downregulated in the same time frame, concomitant with exit from quiescence marked by the upregulation of <italic>Myod</italic>, demonstrating the presence of two well-known muscle ‘differentiation-specific’ markers in dormant stem cells. Together, such observations prompt re-evaluation of an intrinsic Myog function in quiescent MuSC.</p></sec><sec id="s3-4"><title>Myog is required for proper myofibre growth</title><p>MRFs including Myog are required in the adult to restrict murine myofibre size (<xref ref-type="bibr" rid="bib60">Moresi et al., 2010</xref>; <xref ref-type="bibr" rid="bib61">Moretti et al., 2016</xref>). We find that, in zebrafish, Myog is required both for myocyte fusion that permits increase in nuclear number and consequent growth to the normal fibre size. We also show that Myog limits myonuclear domain size both in juvenile and adult muscle. Conditional depletion of Myog in adult mouse muscle decreased myofibre cross-sectional area, although further morphometric analysis of myofibre nuclear domains was not reported (<xref ref-type="bibr" rid="bib58">Meadows et al., 2008</xref>). It therefore seems that, in addition to its role in promoting MPC differentiation and fusion, Myog restricts the volume of sarcoplasm supported by each myonucleus, both in denervated (<xref ref-type="bibr" rid="bib60">Moresi et al., 2010</xref>) and innervated (this study) adult muscle. Both adult mouse and zebrafish <italic>Myog</italic> mutants show reduction in <italic>Mrf4</italic> mRNA (<xref ref-type="bibr" rid="bib58">Meadows et al., 2008</xref>; <xref ref-type="bibr" rid="bib93">Venuti et al., 1995</xref>; <xref ref-type="bibr" rid="bib45">Knapp et al., 2006</xref>; <xref ref-type="bibr" rid="bib78">Rawls et al., 1998</xref>; <xref ref-type="bibr" rid="bib26">Ganassi et al., 2018</xref>). Mrf4 itself restricts murine myofibre growth (<xref ref-type="bibr" rid="bib61">Moretti et al., 2016</xref>), although no myofibre size change was reported in the various <italic>Mrf4</italic> knockout mice (<xref ref-type="bibr" rid="bib103">Zhang et al., 1995</xref>; <xref ref-type="bibr" rid="bib70">Patapoutian et al., 1995</xref>). So Myog may either restrict myonuclear domain size directly or by regulating <italic>Mrf4</italic> expression.</p><p>Unlike fish, which grow to some extent throughout life, mice do not require MuSCs to maintain adult muscle size (<xref ref-type="bibr" rid="bib41">Keefe et al., 2015</xref>). Nevertheless, during murine adult myogenesis myonuclear accretion from MuSC-derived MPC fusion is required for myofibre growth and regeneration, as in fish (<xref ref-type="bibr" rid="bib69">Pallafacchina et al., 2013</xref>). Congruently, expression of fusogenic genes <italic>myomixer</italic> (<italic>mymx</italic>) and <italic>myomaker</italic> (<italic>mymk</italic>) is reduced in both <italic>myog</italic><sup>-/-</sup> adult and embryonic muscles (<xref ref-type="bibr" rid="bib26">Ganassi et al., 2018</xref>). Depletion of zebrafish Mymk leads to fewer myofibre nuclei in the surviving adults (<xref ref-type="bibr" rid="bib90">Shi et al., 2018</xref>). Likewise, <italic>Mymk</italic>-KO in murine MuSCs at P0 led to 75% reduction of myonuclear number in extensor digitorum longus (EDL) myofibres measured at P28 (<xref ref-type="bibr" rid="bib63">Nikolaou et al., 2019</xref>). Although severely reduced, accretion of myonuclei does occur in growing <italic>myog</italic><sup>-/-</sup> zebrafish, thus confirming the persistence of a Myog-independent pathway to fusion (<xref ref-type="bibr" rid="bib26">Ganassi et al., 2018</xref>), which appears to allow a fraction of MPCs to sustain some muscle growth.</p><p>Addition of myonuclei to growing muscle relies on interactive signals between MuSCs and myofibres. Fish lacking Myog have increased <italic>igf1</italic> and decreased <italic>mstnb</italic> expression. Both changes are predicted to enhance muscle size (<xref ref-type="bibr" rid="bib27">Gao et al., 2016</xref>; <xref ref-type="bibr" rid="bib74">Powell-Braxton et al., 1993</xref>; <xref ref-type="bibr" rid="bib12">Coleman et al., 1995</xref>; <xref ref-type="bibr" rid="bib19">Durieux et al., 2007</xref>; <xref ref-type="bibr" rid="bib92">Trendelenburg et al., 2009</xref>; <xref ref-type="bibr" rid="bib105">Zimmers et al., 2002</xref>; <xref ref-type="bibr" rid="bib57">McPherron et al., 1997</xref>), and both may be important in our <italic>myog</italic> mutants. As we observe in <italic>myog</italic><sup>-/-</sup> fish, loss of Mstn increases MuSCs in amniotes (<xref ref-type="bibr" rid="bib56">McCroskery et al., 2003</xref>; <xref ref-type="bibr" rid="bib52">Manceau et al., 2008</xref>). MuSC contribution is, however, dispensable for myofibre hypertrophy in <italic>Mstn</italic> knockout mice, in which growth derives from increased myonuclear domain size. <italic>Mstn</italic> knockouts thus resemble both the MuSC increase and myofibre domain size increase in <italic>myog</italic> mutant fish. On the other hand, IGF1 has been shown to increase MPC proliferation and differentiation and thereby enhance myofibre growth, but without change in nuclear domain size (<xref ref-type="bibr" rid="bib22">Fiorotto et al., 2003</xref>; <xref ref-type="bibr" rid="bib55">McCall et al., 1998</xref>). <italic>Igf1</italic> increase might thus enhance the number of MuSCs in <italic>myog</italic> mutants.</p><p>IGF1 and Myostatin signalling also affect MuSC activation status in mice (<xref ref-type="bibr" rid="bib14">Cornelison and Wold, 1997</xref>; <xref ref-type="bibr" rid="bib56">McCroskery et al., 2003</xref>; <xref ref-type="bibr" rid="bib104">Zhang et al., 2010</xref>; <xref ref-type="bibr" rid="bib9">Chakravarthy et al., 2001</xref>) and other fish (<xref ref-type="bibr" rid="bib28">Garikipati and Rodgers, 2012</xref>). Both can act through the mTORC1 pathway (<xref ref-type="bibr" rid="bib92">Trendelenburg et al., 2009</xref>; <xref ref-type="bibr" rid="bib47">Latres et al., 2005</xref>). The IGF1 signal cascade phosphorylates AKT and activates mTORC1 leading to phosphorylation of RPS6 and eIF4EBPs, with downstream effects on both MuSCs and adult myofibres (<xref ref-type="bibr" rid="bib85">Schiaffino and Mammucari, 2011</xref>). Loss of Mstn also activates the mTORC1/RPS6 pathway (<xref ref-type="bibr" rid="bib92">Trendelenburg et al., 2009</xref>). Our data show enhanced RPS6 phosphorylation (pRPS6) both in <italic>myog</italic><sup>-/-</sup> muscle and MuSC analysis ex vivo. Interestingly, mTORC1 controls the transition from deep G<sub>0</sub> quiescence to an intermediate pseudo-activated state defined as G<sub>alert</sub>, in which MuSCs that accumulate pRPS6 are primed for activation compared to their quiescent counterparts (<xref ref-type="bibr" rid="bib82">Rodgers et al., 2014</xref>; <xref ref-type="bibr" rid="bib73">Porpiglia et al., 2017</xref>). Similar to zebrafish <italic>myog</italic><sup>-/-</sup> MuSCs, ‘alerted’ mouse MuSCs display accelerated transition to proliferation ex-vivo compared to the quiescent population (<xref ref-type="bibr" rid="bib82">Rodgers et al., 2014</xref>). As we detected no difference in Akt activation and unaltered levels of the receptors <italic>igfr1a</italic> and <italic>igfr1b</italic>, we deduce that increased phosphorylation of RPS6 is unlikely to result from enhanced upstream IGF1 cascade. However, <italic>myog</italic><sup>-/-</sup> muscle showed significant downregulation of <italic>tsc1a</italic> and <italic>tsc1b</italic> mRNAs, that encode functional orthologues of mammalian TSC1, a mTORC1 inhibitor highly conserved from fly to human (<xref ref-type="bibr" rid="bib18">DiBella et al., 2009</xref>; <xref ref-type="bibr" rid="bib64">Nobukini and Thomas, 2004</xref>) that promotes stemness in various tissues (<xref ref-type="bibr" rid="bib11">Chen et al., 2008</xref>; <xref ref-type="bibr" rid="bib76">Quan et al., 2013</xref>). Mouse <italic>Tsc<sup>-/-</sup></italic> MuSCs display enhanced pRPS6 and accelerated entry into proliferation in vivo and in vitro (<xref ref-type="bibr" rid="bib82">Rodgers et al., 2014</xref>). Murine Myog can bind to conserved regions in <italic>Tsc1</italic> gene, whereas Myod does not, thus suggesting direct transcriptional regulation (Barbara Wold laboratory, Caltech; <ext-link ext-link-type="uri" xlink:href="https://www.encodeproject.org/experiments/ENCSR000AID/">https://www.encodeproject.org/experiments/ENCSR000AID/</ext-link>) (<xref ref-type="bibr" rid="bib21">ENCODE Project Consortium, 2012</xref>). These observations raise the hypothesis that loss of Myog leads to mTORC1 activation in MuSCs, exit from G<sub>0</sub> into G<sub>alert</sub> and subsequent increase in MuSC number. Taken together, our findings suggest that loss of Myog acts in adult animals to influence both MuSCs and muscle fibres, thus acting as a coordinator of tissue homeostasis.</p></sec></sec><sec id="s4" sec-type="materials|methods"><title>Materials and methods</title><table-wrap id="keyresource" position="anchor"><label>Key resources table</label><table frame="hsides" rules="groups"><thead><tr><th>Reagent type <break/>(species) or resource</th><th>Designation</th><th>Source or reference</th><th>Identifiers</th><th>Additional information</th></tr></thead><tbody><tr><td>Genetic reagent (<italic>D. rerio</italic>)</td><td><italic>myog<sup>fh265</sup>,</italic> (AB)</td><td>Hughes/Moens Labs, <xref ref-type="bibr" rid="bib34">Hinits et al., 2011</xref></td><td><italic>myog<sup>fh265</sup></italic>; RRID:<ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/ZFIN_ZDB-GENO-200128-7">ZFIN_ZDB-GENO-200128-7</ext-link></td><td/></tr><tr><td>Genetic reagent (<italic>D. rerio</italic>)</td><td><italic>myog<sup>kg125</sup></italic>, (TL)</td><td>Hughes Lab, <xref ref-type="bibr" rid="bib26">Ganassi et al., 2018</xref></td><td><italic>myog<sup>kg125/+</sup></italic> <break/>(sib) <italic>myog<sup>-/-</sup> (mut);</italic> RRID:<ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/ZFIN_ZDB-GENO-200128-8">ZFIN_ZDB-GENO-200128-8</ext-link></td><td/></tr><tr><td>Genetic reagent (<italic>D. rerio</italic>)</td><td><italic>TgBAC(pax7a:GFP)<sup>t32239Tg</sup></italic>, (AB)</td><td>Nüsslein-Volhard Lab, <xref ref-type="bibr" rid="bib51">Mahalwar et al., 2014</xref></td><td><italic>pax7a:GFP</italic>; RRID:<ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/ZFIN_ZDB-GENO-170316-2">ZFIN_ZDB-GENO-170316-2</ext-link></td><td/></tr><tr><td>Genetic reagent (<italic>D. rerio</italic>)</td><td><italic>myog<sup>kg125</sup>;TgBAC</italic> <break/><italic>(pax7a:GFP)<sup>t32239Tg</sup>, (AB)</italic></td><td>This paper</td><td><italic>pax7a:GFP</italic>;<italic>myog<sup>kg125</sup></italic></td><td>Generated from outcrossing <italic>myog<sup>kg125</sup></italic> onto <italic>pax7a:GFP</italic></td></tr><tr><td>Antibody</td><td>Anti-phospho-S6 ribosomal protein <break/>(Ser 240/244) (Rabbit monoclonal)</td><td>Cell Signalling</td><td>#5364; D68F8; RRID:<ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/AB_10694233">AB_10694233</ext-link></td><td>(1:1000) IF <break/>(1:2000) WB</td></tr><tr><td>Antibody</td><td>Anti-S6 ribosomal protein (pan) (Mouse monoclonal)</td><td>Cell Signalling</td><td>#2317; 54D2; RRID:<ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/AB_2238583">AB_2238583</ext-link></td><td>(1:1000)</td></tr><tr><td>Antibody</td><td>Anti-phospho-Akt (Ser473) (Rabbit monoclonal)</td><td>Cell Signalling</td><td>#4060; D9E; RRID:<ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/AB_2315049">AB_2315049</ext-link></td><td>(1:1000)</td></tr><tr><td>Antibody</td><td>Anti-Akt (pan) <break/>(Mouse monoclonal)</td><td>Cell Signalling</td><td>#2920; 40D4; RRID:<ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/AB_1147620">AB_1147620</ext-link></td><td>(1:1000)</td></tr><tr><td>Antibody</td><td>Anti-beta-Actin (Mouse monoclonal)</td><td>Sigma Aldrich</td><td>#A5316; AC-74; RRID:<ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/AB_476743">AB_476743</ext-link></td><td>(1:500)</td></tr><tr><td>Antibody</td><td>HRP goat-anti mouse IgG(H+L) <break/>(Goat polyclonal)</td><td>Sigma Aldrich</td><td>#AP308P; RRID:<ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/AB_92635">AB_92635</ext-link></td><td>(1:5000)</td></tr><tr><td>Antibody</td><td>HRP goat anti -abbit IgG (H+L) <break/>(Goat polyclonal)</td><td>Sigma Aldrich</td><td>#AP307P; RRID:<ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/AB_11212848">AB_11212848</ext-link></td><td>(1:5000)</td></tr><tr><td>Antibody</td><td>Anti-Pax3/Pax7 DP312 (Mouse monoclonal)</td><td>Nipam Patel, UC Berkeley, USA</td><td>DP312</td><td>(1:50)</td></tr><tr><td>Antibody</td><td>A4.1025 anti-Myosin heavy chain (Mouse monoclonal)</td><td>Hughes Lab, <xref ref-type="bibr" rid="bib5">Blagden et al., 1997</xref> <break/>Developmental Studies Hybridoma Bank (DSHB) <break/>Merck</td><td>DSHB #A4.1025; <break/>Merck #05–716; RRID:<ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/AB_309930">AB_309930</ext-link></td><td>(1:5)</td></tr><tr><td>Antibody</td><td>MF20 anti-Myosin heavy chain (Mouse monoclonal)</td><td>Developmental Studies Hybridoma Bank (DSHB)</td><td>#MF20; <break/>RRID:<ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/AB_2147781">AB_2147781</ext-link></td><td>(1:300)</td></tr><tr><td>Antibody</td><td>Anti-Desmin (Mouse monoclonal)</td><td>Sigma Aldrich</td><td>#D8281; RRID:<ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/AB_476910">AB_476910</ext-link></td><td>(1:100)</td></tr><tr><td>Antibody</td><td>Anti-GFP (Chicken polyclonal)</td><td>Abcam</td><td>#13970; RRID:<ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/AB_300798">AB_300798</ext-link></td><td>(1:400)</td></tr><tr><td>Antibody</td><td>Alexa Fluor 488 goat anti-chicken IgY (H+L) (Goat polyclonal)</td><td>Invitrogen</td><td>#A11039; RRID:<ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/AB_2534096">AB_2534096</ext-link></td><td>(1:1000)</td></tr><tr><td>Antibody</td><td>Alexa Fluor 555 goat anti-rabbit IgG (H+L) <break/>(Rabbit polyclonal)</td><td>Invitrogen</td><td>#A27039; RRID:<ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/AB_2536100">AB_2536100</ext-link></td><td>(1:1000)</td></tr><tr><td>Other</td><td>Hoechst 33342 nuclear stain</td><td>Thermo Fisher</td><td>#H3570</td><td>(10 µg/ml)</td></tr><tr><td>Commercial assay or kit</td><td>Click-iT Plus EdU Cell Proliferation Kit for Imaging, Alexa Fluor 594 dye</td><td>Invitrogen</td><td>#C10639</td><td>Used according to supplier instruction</td></tr><tr><td>Software, algorithm</td><td>Generalised linear models (GLS)</td><td>Adapted from: <break/><xref ref-type="bibr" rid="bib71">Pinheiro et al., 2020</xref>; <xref ref-type="bibr" rid="bib102">Zeileis, 2002</xref>; <xref ref-type="bibr" rid="bib35">Ho et al., 2011</xref> ; <xref ref-type="bibr" rid="bib89">Sekhon, 2011</xref></td><td>Growth mode analysis</td><td/></tr></tbody></table></table-wrap><sec id="s4-1"><title>Zebrafish lines and maintenance</title><p>All lines used were reared at King's College London on a 14/10 hr light/dark cycle at 28.5°C, with staging and husbandry as described (<xref ref-type="bibr" rid="bib96">Westerfield, 2000</xref>). <italic>myog<sup>fh265</sup></italic> mutant allele were maintained on AB background and genotyped by sequencing as previously described (<xref ref-type="bibr" rid="bib34">Hinits et al., 2011</xref>; <xref ref-type="bibr" rid="bib83">Roy et al., 2017</xref>). <italic>Myog<sup>kg125</sup></italic> (<italic>myog</italic><sup>-/-</sup>) were made by CRISPR/Cas9, genotyped as previously reported and maintained on TL background (<xref ref-type="bibr" rid="bib26">Ganassi et al., 2018</xref>). <italic>TgBAC(pax7a:GFP)<sup>t32239Tg</sup></italic>, a generous gift from C. Nüsslein-Volhard (MPI Tübingen) (<xref ref-type="bibr" rid="bib51">Mahalwar et al., 2014</xref>), and the newly generated <italic>myog<sup>kg125</sup>;TgBAC(pax7a:GFP)<sup>t32239Tg</sup></italic> were maintained on AB background. All experiments were performed on zebrafish derived from F2 or later filial generation, in accordance with licences held under the UK Animals (Scientific Procedures) Act 1986 and later modifications and conforming to all relevant guidelines and regulations. Adult zebrafish measurement and analysis of weight, length, body mass index, and standard weight were performed as previously described (<xref ref-type="bibr" rid="bib26">Ganassi et al., 2018</xref>).</p></sec><sec id="s4-2"><title>Isolation of zebrafish myofibres and culture of MuSCs from adult tissue</title><p>Isolation and culture of zebrafish adult muscle fibres was previously described (<xref ref-type="bibr" rid="bib26">Ganassi et al., 2018</xref>). Zebrafish aged 8–9 months (adult) or 1 month (juvenile) were culled in high-dose tricaine (Sigma Aldrich), immersed for 5 min in 1% Virkon (3S Healthcare) diluted in dH<sub>2</sub>O, washed in PBS for 5 min followed by 70% ethanol rinse, eviscerated and skinned. Fifteen-month-old adult were used for the <italic>myog<sup>fh265</sup></italic> allele. For myofibre dissociation, trunk muscle was incubated in 0.2% Collagenase (C0130, Sigma Aldrich), 1% Penicillin/Streptomycin DMEM supplemented with 50 µg/ml gentamycin (Thermo Fisher) at 28.5°C for at least 2 hours. Single muscle myofibres were released by trituration using heat-polished glass pipettes and washed three times with DMEM Glutamax High Glucose (Gibco). Myofibres were then imaged for total length measure or plated on Matrigel (Invitrogen) coated 96- or 24-well plates and cultured in growth medium (20% Fetal Bovine Serum in 1% Penicillin/Streptomycin/DMEM GlutaMAX High Glucose supplemented with 10 µg/ml gentamycin). At indicated time points, MPCs were washed twice with PBS to remove plated myofibres, EdU pulsed (10 μM, Invitrogen Life Technologies) for 8 hr in fresh media and then fixed with 4% PFA for 15 min. For immunostaining myofibres were fixed in 4% PFA in PBS immediately after dissociation to reduce processing time and avoid MuSC activation.</p></sec><sec id="s4-3"><title>Myofibre morphometry and growth mode analysis</title><p>Absolute myofibre length was measured for viable (i.e. non-fixed) myofibres imaged immediately after isolation on Leica M stereo-microscope using x1.6 magnification. Measurement of Surface Area (SA) and number of nuclei was performed on fixed myofibres at x10 or x20 magnification using an Axiovert 200M microscope (Zeiss). Myofibre diameter was measured at two locations over total myofibre length. Morphometric calculation were carried out as described in <xref ref-type="bibr" rid="bib6">Brack et al., 2005</xref>. Briefly, SA/unit length = myofibre segment length x π x mean myofibre diameter; surface area domain size (SADS) = SA/myofibre nuclei in segment (Hoechst<sup>+ve</sup>); Myofibre volume/unit length = myofibre segment length x π x (radius)<sup>2</sup>; myonuclear domain = myofibre segment length x π x (radius)<sup>2</sup> /myonuclei (i.e. GFP<sup>-ve</sup> nuclei) in segment. MuSC (GFP<sup>+ve</sup> cell) distance to nearest myofibre-end was measured as schematised in <xref ref-type="fig" rid="fig2s1">Figure 2—figure supplement 1G</xref>. To graph frequency distribution, absolute nearest myofibre-end distances were normalised for myofibre length difference across genotype. Each myofibre was virtually divided in tenths where 1/10 and 5/10 corresponded to nearest segment to myofibre-end or segment at the myofibre half-length, respectively. Each tenth measured either 100 µm in sib or 50 µm in <italic>myog</italic><sup>-/-</sup>.</p><p>Generalised linear models (GLS) were used to explore growth assessing genotype differences in the relationship between SA and number of nuclei per 100 µm length (NoN), using the GLS function of NMLE package in R version 3.6.1 ‘Action of the Toes’ (<ext-link ext-link-type="uri" xlink:href="https://www.R-project.org/">https://www.R-project.org/</ext-link> <xref ref-type="bibr" rid="bib71">Pinheiro et al., 2020</xref>). SA was log<sub>e</sub>-transformed prior to analysis to generate a linear relationship with NoN, in a dataset pooling both juvenile and adult data. The dependent variable was set as NoN and the model included main effects of log<sub>e</sub>(SA) and genotype, as well as an interaction term. The dataset was then split by genotype and separate GLS models were run to analyse the relationship between log<sub>e</sub>(SA) and NoN for each genotype. <italic>t</italic>, <italic>p</italic>, and DF values were extracted for these models with the ‘summary’ function and were as follow:</p><list list-type="bullet"><list-item><p>Interaction between genotype and log<sub>e</sub>(SA): <italic>t</italic> = 7.332, <italic>p</italic>&lt;0.0001, DF = 1164</p> </list-item> <list-item><p>Siblings only, effect of log<sub>e</sub>(SA): <italic>t</italic> = 11.448, <italic>p</italic>&lt;0.0001, DF = 1,97</p> </list-item> <list-item><p>Mutants only, effect of log<sub>e</sub>(SA): <italic>t</italic> = 4.515, <italic>p</italic>&lt;0.0001, DF = 1,67</p> </list-item></list><p>Detailed steps of the GLS analysis are reported:</p><list list-type="bullet"><list-item><p>Decision to pool age groups</p></list-item></list><p>Initial analyses showed no effect of age on the relationship between log<sub>e</sub>(SA) and NoN, therefore different age groups were pooled to study the effect of mutation. Note that these initial analyses suffered from high confounding correlation between SA and age in siblings; however, visual analysis of the few datapoints where juvenile and adult SA values overlapped gave no indication that age was affecting the NoN directly.</p><list list-type="bullet"><list-item><p>Decision to use Generalised Linear Model instead of General Linear Model</p></list-item></list><p>Significant heteroscedasticity was identified in simple linear models using R package lmtest (<xref ref-type="bibr" rid="bib102">Zeileis, 2002</xref>), primarily because variance in NoN increased with log<sub>e</sub>(SA). GLS models were used to weight explained variance by the value of the dependent variables, controlling for this heteroscedasticity. For each step of analysis, every combination of weighting (weighting by log<sub>e</sub>(SA), genotype, both, or neither) was compared and the model with the lowest AIC was selected.</p><list list-type="bullet"><list-item><p>Issue of Correlation between log<sub>e</sub>(SA) and Genotype</p></list-item></list><p>In the final model, there was a significant correlation between explanatory variables log<sub>e</sub>(SA) and genotype, which may have confounded interpretations. This correlation was removed by subsetting with the ‘Matchit’ and ‘Matching’ R packages, and qualitatively identical results were found by re-running the analysis using this smaller dataset (<xref ref-type="bibr" rid="bib35">Ho et al., 2011</xref>; <xref ref-type="bibr" rid="bib89">Sekhon, 2011</xref>).</p></sec><sec id="s4-4"><title>Protein extraction and western blot analysis</title><p>Western blot was performed as described (<xref ref-type="bibr" rid="bib25">Ganassi et al., 2014</xref>; <xref ref-type="bibr" rid="bib42">Kelu et al., 2019</xref>; <xref ref-type="bibr" rid="bib43">Kelu et al., 2020</xref>). Briefly, dissected trunk muscle was submerged in lysis buffer (Tissue Extraction Reagent I [Invitrogen], Complete EDTA-free Protease Inhibitor Cocktail Tablets [Roche], 1 mM PMSF, 50 mM NaF, 1 mM Na<sub>3</sub>VO<sub>4</sub> [Sigma Aldrich]) and triturated using TissueRuptor (Qiagen) followed by 5 min of sonication. Lysates were then pelleted by centrifugation, after which the supernatant protein extract was quantified, mixed with Laemmli Sample Buffer 4X (Bio-rad) complemented with 2-mercaptoethanol (Bio-rad) and heated at 95°C for 5 min, before subjecting to SDS-PAGE analysis. Protein extract equivalent to 50 µg was loaded per lane onto precast gradient gels (4–20% Bio-rad). Separated proteins were then transferred to nitrocellulose membranes, blocked in either 5% non-fat dry milk or 5% BSA in Tris-buffered saline and 0.1% Tween (TBST), incubated in primary and secondary antibodies at 4°C overnight and at room temperature for 2 hr, respectively. Primary antibodies used were: S6 ribosomal protein (pan) (1:1000; #2317; Cell Signaling), phospho-S6 ribosomal protein (Ser240/244) (1:2000; #5364; Cell Signaling), phospho-Akt (Ser473) 1:1000; #4060; Cell Signaling, Akt (pan) (1:1000; #2920; Cell Signaling), beta-Actin (1:500; #A5316; Sigma Aldrich). Secondary antibodies used were: HRP goat anti mouse IgG(H+L) (1:5000; #AP308P; Sigma Aldrich) and HRP goat anti rabbit IgG (H+L) (1:5000; #AP307P; Sigma Aldrich). Signal detection was performed using ChemiDoc Imaging System and analysed on Image Lab Software (Bio-rad). Phospho/pan (total) ratios were calculated following normalisation to membrane-matched and sample-matched Actin signals.</p></sec><sec id="s4-5"><title>Immunostaining on myofibres or cultured MPCs</title><p>For immunostaining, either myofibres or MPCs were permeabilised in PBS 0.5% Triton X-100 (PBST) for 15 min, blocked in Goat Serum 5% (Sigma Aldrich) in PBST and incubated with primary antibodies at indicated concentrations overnight in Goat Serum 2% in either PBST (0.1% TritonX) (myofibres) or PBS (MPCs). Primary antibodies used were against: phospho-S6 ribosomal protein (Ser240/244), (1:1000; #5364; Cell Signaling), GFP (13970 (1:400), Abcam), Myosin (A4.1025 (1:5), <xref ref-type="bibr" rid="bib5">Blagden et al., 1997</xref>), MF20 (1:300, DSHB), Pax3/7 (DP312 (1:50), Nipam Patel, UC Berkeley, USA) and Desmin (D8281 (1:100), Sigma Aldrich). Samples were then washed three times in PBS prior to incubation with secondary antibodies in Goat Serum 2% in PBS. Secondary antibodies were Alexa Fluor 555 goat anti-rabbit IgG (H+L) (1:1000; #A27039; Invitrogen) and Alexa Fluor 488 goat anti-chicken IgY (H+L) (1:1000; #A11039; Invitrogen). Nuclei were counterstained with 10 µg/ml Hoechst 33342 (Thermo Fisher). EdU incorporation was revealed using a Click-iT EdU Imaging Kit (Invitrogen Life Technologies) as per manufacturer's instructions. Myofibres were imaged on LSM Exciter confocal microscope (Zeiss) equipped with x40 objective. MPCs were imaged at x10 or x20 using an Axiovert 200M microscope (Zeiss). At least three random fields were acquired in each of three technical replicates. Differentiation index was calculated as: nuclei in MyHC<sup>+</sup> myocytes x 100/total nuclei.</p></sec><sec id="s4-6"><title>RNA extraction, RT-PCR and qPCR</title><p>Genotyped <italic>myog<sup>kg125/+</sup></italic> (sib) or <italic>myog<sup>kg125</sup></italic> (<italic>myog</italic><sup>-/-</sup>) adult trunk muscles were triturated and processed for RNA extraction using RNA Purification Plus Kit (Norgen) following supplier’s instructions. Total RNA was reverse transcribed using Superscript III reverse transcriptase (Invitrogen) following supplier’s instructions. For MPCs, RNA extraction was performed at indicated time point using micro-RNA kit (Qiagen). Prior to collection, culture wells were washed three times with PBS to remove myofibres, followed by MPCs detachment using Accutase (Sigma Aldrich) for 10 min at 28.5°C. QPCR on technical triplicates for each sample was performed on 5 ng of relative RNA using Takyon Low ROX SYBR 2X MasterMix blue dTTP (Takyon) on a ViiAseven thermal cycler (Applied Biosystems). Ct values of all genes analysed were normalised to the geometrical mean of Ct values of three housekeeping genes (<italic>actinb2, sep15</italic> and <italic>b2m</italic>) and fold changes were calculated using ΔΔCt method (<xref ref-type="bibr" rid="bib49">Livak and Schmittgen, 2001</xref>). Results are presented as mean value ± SEM of fold changes from independent experiments as indicated. Used primers, purchased from Sigma-Aldrich (KiCqStart SYBR Green Primers Predesigned, Sigma Aldrich) are listed in <xref ref-type="supplementary-material" rid="supp1">Supplementary file 1</xref>.</p></sec><sec id="s4-7"><title>Statistical analyses</title><p>Quantitative analysis on images was performed with Fiji (NIH, <ext-link ext-link-type="uri" xlink:href="http://www.Fiji.sc">www.Fiji.sc</ext-link>) and ZEN (2009 + 2012) software. Statistical analyses were performed using GraphPad (Prism 6 or 8) or Microsoft Excel (v16) for unpaired or paired two-tailed Student’s <italic>t</italic>-test as indicated and one-way ANOVA followed by Holm-Sidak’s posthoc (growth mode analysis) or Bonferroni (MuSC analysis). <italic>χ</italic><sup>2</sup> test was performed on raw data and used to assess difference between distributions.</p></sec></sec></body><back><ack id="ack"><title>Acknowledgements</title><p>We are grateful to all members of the Hughes lab and Zammit lab for advice and to Bruno Correia da Silva and his staff for care of the fish. This work is supported by grants from the Medical Research Council to SMH (MRC Programme Grants G1001029 and MR/N021231/1) and PSZ (MR/P023215/1 and MR/S002472/1), and from Muscular Dystrophy UK (RA3/3052), Association Française contre les Myopathies (AFM17865) and the FSH Society (FSHS-82013–06 and FSHS-82017–05) to PSZ.</p></ack><sec id="s5" sec-type="additional-information"><title>Additional information</title><fn-group content-type="competing-interest"><title>Competing interests</title><fn fn-type="COI-statement" id="conf1"><p>No competing interests declared</p></fn></fn-group><fn-group content-type="author-contribution"><title>Author contributions</title><fn fn-type="con" id="con1"><p>Conceptualization, Investigation, Methodology, Writing - original draft, Project administration</p></fn><fn fn-type="con" id="con2"><p>Investigation, Writing - review and editing</p></fn><fn fn-type="con" id="con3"><p>Data curation, Software</p></fn><fn fn-type="con" id="con4"><p>Funding acquisition, Writing - review and editing</p></fn><fn fn-type="con" id="con5"><p>Conceptualization, Formal analysis, Supervision, Funding acquisition, Writing - review and editing</p></fn></fn-group><fn-group content-type="ethics-information"><title>Ethics</title><fn fn-type="other"><p>Animal experimentation: All experiments were performed on zebrafish derived from F2 or later filial generation, in accordance with licence held under the UK Animals (Scientific Procedures) Act 1986 and later modifications and conforming to all relevant guidelines and regulations.</p></fn></fn-group></sec><sec id="s6" sec-type="supplementary-material"><title>Additional files</title><supplementary-material id="supp1"><label>Supplementary file 1.</label><caption><title>List of qPCR primers used in the study.</title></caption><media mime-subtype="docx" mimetype="application" xlink:href="elife-60445-supp1-v2.docx"/></supplementary-material><supplementary-material id="transrepform"><label>Transparent reporting form</label><media mime-subtype="docx" mimetype="application" xlink:href="elife-60445-transrepform-v2.docx"/></supplementary-material></sec><sec id="s7" sec-type="data-availability"><title>Data availability</title><p>All data generated or analysed during this study are included in the manuscript and supporting files.</p></sec><ref-list><title>References</title><ref id="bib1"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Aziz</surname> <given-names>U</given-names></name><name><surname>Goldspink</surname> <given-names>G</given-names></name></person-group><year iso-8601-date="1974">1974</year><article-title>Distribution of mitotic nuclei in the biceps brachii of the mouse during post-natal growth</article-title><source>The Anatomical Record</source><volume>179</volume><fpage>115</fpage><lpage>118</lpage><pub-id pub-id-type="doi">10.1002/ar.1091790109</pub-id><pub-id pub-id-type="pmid">4821357</pub-id></element-citation></ref><ref id="bib2"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bajanca</surname> <given-names>F</given-names></name><name><surname>Gonzalez-Perez</surname> <given-names>V</given-names></name><name><surname>Gillespie</surname> <given-names>SJ</given-names></name><name><surname>Beley</surname> <given-names>C</given-names></name><name><surname>Garcia</surname> <given-names>L</given-names></name><name><surname>Theveneau</surname> <given-names>E</given-names></name><name><surname>Sear</surname> <given-names>RP</given-names></name><name><surname>Hughes</surname> <given-names>SM</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>In vivo dynamics of skeletal muscle dystrophin in zebrafish embryos revealed by improved FRAP analysis</article-title><source>eLife</source><volume>4</volume><elocation-id>e06541</elocation-id><pub-id pub-id-type="doi">10.7554/eLife.06541</pub-id></element-citation></ref><ref id="bib3"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Beauchamp</surname> <given-names>JR</given-names></name><name><surname>Heslop</surname> <given-names>L</given-names></name><name><surname>Yu</surname> <given-names>DS</given-names></name><name><surname>Tajbakhsh</surname> <given-names>S</given-names></name><name><surname>Kelly</surname> <given-names>RG</given-names></name><name><surname>Wernig</surname> <given-names>A</given-names></name><name><surname>Buckingham</surname> <given-names>ME</given-names></name><name><surname>Partridge</surname> <given-names>TA</given-names></name><name><surname>Zammit</surname> <given-names>PS</given-names></name></person-group><year iso-8601-date="2000">2000</year><article-title>Expression of CD34 and Myf5 defines the majority of quiescent adult skeletal muscle satellite cells</article-title><source>The Journal of Cell Biology</source><volume>151</volume><fpage>1221</fpage><lpage>1234</lpage><pub-id pub-id-type="doi">10.1083/jcb.151.6.1221</pub-id><pub-id pub-id-type="pmid">11121437</pub-id></element-citation></ref><ref id="bib4"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Berberoglu</surname> <given-names>MA</given-names></name><name><surname>Gallagher</surname> <given-names>TL</given-names></name><name><surname>Morrow</surname> <given-names>ZT</given-names></name><name><surname>Talbot</surname> <given-names>JC</given-names></name><name><surname>Hromowyk</surname> <given-names>KJ</given-names></name><name><surname>Tenente</surname> <given-names>IM</given-names></name><name><surname>Langenau</surname> <given-names>DM</given-names></name><name><surname>Amacher</surname> <given-names>SL</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>Satellite-like cells contribute to pax7-dependent skeletal muscle repair in adult zebrafish</article-title><source>Developmental Biology</source><volume>424</volume><fpage>162</fpage><lpage>180</lpage><pub-id pub-id-type="doi">10.1016/j.ydbio.2017.03.004</pub-id><pub-id pub-id-type="pmid">28279710</pub-id></element-citation></ref><ref id="bib5"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Blagden</surname> <given-names>CS</given-names></name><name><surname>Currie</surname> <given-names>PD</given-names></name><name><surname>Ingham</surname> <given-names>PW</given-names></name><name><surname>Hughes</surname> <given-names>SM</given-names></name></person-group><year iso-8601-date="1997">1997</year><article-title>Notochord induction of zebrafish slow muscle mediated by sonic hedgehog</article-title><source>Genes &amp; Development</source><volume>11</volume><fpage>2163</fpage><lpage>2175</lpage><pub-id pub-id-type="doi">10.1101/gad.11.17.2163</pub-id><pub-id pub-id-type="pmid">9303533</pub-id></element-citation></ref><ref id="bib6"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Brack</surname> <given-names>AS</given-names></name><name><surname>Bildsoe</surname> <given-names>H</given-names></name><name><surname>Hughes</surname> <given-names>SM</given-names></name></person-group><year iso-8601-date="2005">2005</year><article-title>Evidence that satellite cell decrement contributes to preferential decline in nuclear number from large fibres during murine age-related muscle atrophy</article-title><source>Journal of Cell Science</source><volume>118</volume><fpage>4813</fpage><lpage>4821</lpage><pub-id pub-id-type="doi">10.1242/jcs.02602</pub-id><pub-id pub-id-type="pmid">16219688</pub-id></element-citation></ref><ref id="bib7"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Buckingham</surname> <given-names>M</given-names></name><name><surname>Relaix</surname> <given-names>F</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>PAX3 and PAX7 as upstream regulators of myogenesis</article-title><source>Seminars in Cell &amp; Developmental Biology</source><volume>44</volume><fpage>115</fpage><lpage>125</lpage><pub-id pub-id-type="doi">10.1016/j.semcdb.2015.09.017</pub-id><pub-id pub-id-type="pmid">26424495</pub-id></element-citation></ref><ref id="bib8"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cardasis</surname> <given-names>CA</given-names></name><name><surname>Cooper</surname> <given-names>GW</given-names></name></person-group><year iso-8601-date="1975">1975</year><article-title>An analysis of nuclear numbers in individual muscle fibers during differentiation and growth: a satellite cell-muscle fiber growth unit</article-title><source>Journal of Experimental Zoology</source><volume>191</volume><fpage>347</fpage><lpage>357</lpage><pub-id pub-id-type="doi">10.1002/jez.1401910305</pub-id><pub-id pub-id-type="pmid">1127400</pub-id></element-citation></ref><ref id="bib9"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chakravarthy</surname> <given-names>MV</given-names></name><name><surname>Booth</surname> <given-names>FW</given-names></name><name><surname>Spangenburg</surname> <given-names>EE</given-names></name></person-group><year iso-8601-date="2001">2001</year><article-title>The molecular responses of skeletal muscle satellite cells to continuous expression of IGF-1: implications for the rescue of induced muscular atrophy in aged rats</article-title><source>International Journal of Sport Nutrition and Exercise Metabolism</source><volume>11</volume><fpage>S44</fpage><lpage>S48</lpage><pub-id pub-id-type="doi">10.1123/ijsnem.11.s1.s44</pub-id><pub-id pub-id-type="pmid">11915927</pub-id></element-citation></ref><ref id="bib10"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chen</surname> <given-names>Y</given-names></name><name><surname>Lin</surname> <given-names>G</given-names></name><name><surname>Slack</surname> <given-names>JM</given-names></name></person-group><year iso-8601-date="2006">2006</year><article-title>Control of muscle regeneration in the <italic>Xenopus</italic> tadpole tail by Pax7</article-title><source>Development</source><volume>133</volume><fpage>2303</fpage><lpage>2313</lpage><pub-id pub-id-type="doi">10.1242/dev.02397</pub-id><pub-id pub-id-type="pmid">16687446</pub-id></element-citation></ref><ref id="bib11"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chen</surname> <given-names>C</given-names></name><name><surname>Liu</surname> <given-names>Y</given-names></name><name><surname>Liu</surname> <given-names>R</given-names></name><name><surname>Ikenoue</surname> <given-names>T</given-names></name><name><surname>Guan</surname> <given-names>KL</given-names></name><name><surname>Liu</surname> <given-names>Y</given-names></name><name><surname>Zheng</surname> <given-names>P</given-names></name></person-group><year iso-8601-date="2008">2008</year><article-title>TSC-mTOR maintains quiescence and function of hematopoietic stem cells by repressing mitochondrial biogenesis and reactive oxygen species</article-title><source>Journal of Experimental Medicine</source><volume>205</volume><fpage>2397</fpage><lpage>2408</lpage><pub-id pub-id-type="doi">10.1084/jem.20081297</pub-id><pub-id pub-id-type="pmid">18809716</pub-id></element-citation></ref><ref id="bib12"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Coleman</surname> <given-names>ME</given-names></name><name><surname>DeMayo</surname> <given-names>F</given-names></name><name><surname>Yin</surname> <given-names>KC</given-names></name><name><surname>Lee</surname> <given-names>HM</given-names></name><name><surname>Geske</surname> <given-names>R</given-names></name><name><surname>Montgomery</surname> <given-names>C</given-names></name><name><surname>Schwartz</surname> <given-names>RJ</given-names></name></person-group><year iso-8601-date="1995">1995</year><article-title>Myogenic vector expression of insulin-like growth factor I stimulates muscle cell differentiation and myofiber hypertrophy in transgenic mice</article-title><source>Journal of Biological Chemistry</source><volume>270</volume><fpage>12109</fpage><lpage>12116</lpage><pub-id pub-id-type="doi">10.1074/jbc.270.20.12109</pub-id><pub-id pub-id-type="pmid">7744859</pub-id></element-citation></ref><ref id="bib13"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cooper</surname> <given-names>RN</given-names></name><name><surname>Tajbakhsh</surname> <given-names>S</given-names></name><name><surname>Mouly</surname> <given-names>V</given-names></name><name><surname>Cossu</surname> <given-names>G</given-names></name><name><surname>Buckingham</surname> <given-names>M</given-names></name><name><surname>Butler-Browne</surname> <given-names>GS</given-names></name></person-group><year iso-8601-date="1999">1999</year><article-title>In vivo satellite cell activation via Myf5 and MyoD in regenerating mouse skeletal muscle</article-title><source>Journal of Cell Science</source><volume>112</volume><fpage>2895</fpage><lpage>2901</lpage><pub-id pub-id-type="pmid">10444384</pub-id></element-citation></ref><ref id="bib14"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cornelison</surname> <given-names>DD</given-names></name><name><surname>Wold</surname> <given-names>BJ</given-names></name></person-group><year iso-8601-date="1997">1997</year><article-title>Single-cell analysis of regulatory gene expression in quiescent and activated mouse skeletal muscle satellite cells</article-title><source>Developmental Biology</source><volume>191</volume><fpage>270</fpage><lpage>283</lpage><pub-id pub-id-type="doi">10.1006/dbio.1997.8721</pub-id><pub-id pub-id-type="pmid">9398440</pub-id></element-citation></ref><ref id="bib15"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Coutelle</surname> <given-names>O</given-names></name><name><surname>Blagden</surname> <given-names>CS</given-names></name><name><surname>Hampson</surname> <given-names>R</given-names></name><name><surname>Halai</surname> <given-names>C</given-names></name><name><surname>Rigby</surname> <given-names>PW</given-names></name><name><surname>Hughes</surname> <given-names>SM</given-names></name></person-group><year iso-8601-date="2001">2001</year><article-title>Hedgehog signalling is required for maintenance of myf5 and myoD expression and timely terminal differentiation in zebrafish adaxial myogenesis</article-title><source>Developmental Biology</source><volume>236</volume><fpage>136</fpage><lpage>150</lpage><pub-id pub-id-type="doi">10.1006/dbio.2001.0193</pub-id><pub-id pub-id-type="pmid">11456450</pub-id></element-citation></ref><ref id="bib16"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Davis</surname> <given-names>GK</given-names></name><name><surname>D'Alessio</surname> <given-names>JA</given-names></name><name><surname>Patel</surname> <given-names>NH</given-names></name></person-group><year iso-8601-date="2005">2005</year><article-title>Pax3/7 genes reveal conservation and divergence in the arthropod segmentation hierarchy</article-title><source>Developmental Biology</source><volume>285</volume><fpage>169</fpage><lpage>184</lpage><pub-id pub-id-type="doi">10.1016/j.ydbio.2005.06.014</pub-id><pub-id pub-id-type="pmid">16083872</pub-id></element-citation></ref><ref id="bib17"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Devoto</surname> <given-names>SH</given-names></name><name><surname>Stoiber</surname> <given-names>W</given-names></name><name><surname>Hammond</surname> <given-names>CL</given-names></name><name><surname>Steinbacher</surname> <given-names>P</given-names></name><name><surname>Haslett</surname> <given-names>JR</given-names></name><name><surname>Barresi</surname> <given-names>MJ</given-names></name><name><surname>Patterson</surname> <given-names>SE</given-names></name><name><surname>Adiarte</surname> <given-names>EG</given-names></name><name><surname>Hughes</surname> <given-names>SM</given-names></name></person-group><year iso-8601-date="2006">2006</year><article-title>Generality of vertebrate developmental patterns: evidence for a dermomyotome in fish</article-title><source>Evolution Development</source><volume>8</volume><fpage>101</fpage><lpage>110</lpage><pub-id pub-id-type="doi">10.1111/j.1525-142X.2006.05079.x</pub-id><pub-id pub-id-type="pmid">16409387</pub-id></element-citation></ref><ref id="bib18"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>DiBella</surname> <given-names>LM</given-names></name><name><surname>Park</surname> <given-names>A</given-names></name><name><surname>Sun</surname> <given-names>Z</given-names></name></person-group><year iso-8601-date="2009">2009</year><article-title>Zebrafish Tsc1 reveals functional interactions between the cilium and the TOR pathway</article-title><source>Human Molecular Genetics</source><volume>18</volume><fpage>595</fpage><lpage>606</lpage><pub-id pub-id-type="doi">10.1093/hmg/ddn384</pub-id><pub-id pub-id-type="pmid">19008302</pub-id></element-citation></ref><ref id="bib19"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Durieux</surname> <given-names>AC</given-names></name><name><surname>Amirouche</surname> <given-names>A</given-names></name><name><surname>Banzet</surname> <given-names>S</given-names></name><name><surname>Koulmann</surname> <given-names>N</given-names></name><name><surname>Bonnefoy</surname> <given-names>R</given-names></name><name><surname>Pasdeloup</surname> <given-names>M</given-names></name><name><surname>Mouret</surname> <given-names>C</given-names></name><name><surname>Bigard</surname> <given-names>X</given-names></name><name><surname>Peinnequin</surname> <given-names>A</given-names></name><name><surname>Freyssenet</surname> <given-names>D</given-names></name></person-group><year iso-8601-date="2007">2007</year><article-title>Ectopic expression of myostatin induces atrophy of adult skeletal muscle by decreasing muscle gene expression</article-title><source>Endocrinology</source><volume>148</volume><fpage>3140</fpage><lpage>3147</lpage><pub-id pub-id-type="doi">10.1210/en.2006-1500</pub-id><pub-id pub-id-type="pmid">17395701</pub-id></element-citation></ref><ref id="bib20"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ekmark</surname> <given-names>M</given-names></name><name><surname>Grønevik</surname> <given-names>E</given-names></name><name><surname>Schjerling</surname> <given-names>P</given-names></name><name><surname>Gundersen</surname> <given-names>K</given-names></name></person-group><year iso-8601-date="2003">2003</year><article-title>Myogenin induces higher oxidative capacity in pre-existing mouse muscle fibres after somatic DNA transfer</article-title><source>The Journal of Physiology</source><volume>548</volume><fpage>259</fpage><lpage>269</lpage><pub-id pub-id-type="doi">10.1113/jphysiol.2002.036228</pub-id><pub-id pub-id-type="pmid">12598590</pub-id></element-citation></ref><ref id="bib21"><element-citation publication-type="journal"><person-group person-group-type="author"><collab>ENCODE Project Consortium</collab></person-group><year iso-8601-date="2012">2012</year><article-title>An integrated encyclopedia of DNA elements in the human genome</article-title><source>Nature</source><volume>489</volume><fpage>57</fpage><lpage>74</lpage><pub-id pub-id-type="doi">10.1038/nature11247</pub-id><pub-id pub-id-type="pmid">22955616</pub-id></element-citation></ref><ref id="bib22"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fiorotto</surname> <given-names>ML</given-names></name><name><surname>Schwartz</surname> <given-names>RJ</given-names></name><name><surname>Delaughter</surname> <given-names>MC</given-names></name></person-group><year iso-8601-date="2003">2003</year><article-title>Persistent IGF-I overexpression in skeletal muscle transiently enhances DNA accretion and growth</article-title><source>The FASEB Journal</source><volume>17</volume><fpage>59</fpage><lpage>60</lpage><pub-id pub-id-type="doi">10.1096/fj.02-0289fje</pub-id><pub-id pub-id-type="pmid">12528713</pub-id></element-citation></ref><ref id="bib23"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Flynn</surname> <given-names>JM</given-names></name><name><surname>Meadows</surname> <given-names>E</given-names></name><name><surname>Fiorotto</surname> <given-names>M</given-names></name><name><surname>Klein</surname> <given-names>WH</given-names></name></person-group><year iso-8601-date="2010">2010</year><article-title>Myogenin regulates exercise capacity and skeletal muscle metabolism in the adult mouse</article-title><source>PLOS ONE</source><volume>5</volume><elocation-id>e13535</elocation-id><pub-id pub-id-type="doi">10.1371/journal.pone.0013535</pub-id><pub-id pub-id-type="pmid">21042574</pub-id></element-citation></ref><ref id="bib24"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Forcina</surname> <given-names>L</given-names></name><name><surname>Miano</surname> <given-names>C</given-names></name><name><surname>Pelosi</surname> <given-names>L</given-names></name><name><surname>Musarò</surname> <given-names>A</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>An overview about the biology of skeletal muscle satellite cells</article-title><source>Current Genomics</source><volume>20</volume><fpage>24</fpage><lpage>37</lpage><pub-id pub-id-type="doi">10.2174/1389202920666190116094736</pub-id><pub-id pub-id-type="pmid">31015789</pub-id></element-citation></ref><ref id="bib25"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ganassi</surname> <given-names>M</given-names></name><name><surname>Badodi</surname> <given-names>S</given-names></name><name><surname>Polacchini</surname> <given-names>A</given-names></name><name><surname>Baruffaldi</surname> <given-names>F</given-names></name><name><surname>Battini</surname> <given-names>R</given-names></name><name><surname>Hughes</surname> <given-names>SM</given-names></name><name><surname>Hinits</surname> <given-names>Y</given-names></name><name><surname>Molinari</surname> <given-names>S</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>Distinct functions of alternatively spliced isoforms encoded by zebrafish mef2ca and mef2cb</article-title><source>Biochimica Et Biophysica Acta (BBA) - Gene Regulatory Mechanisms</source><volume>1839</volume><fpage>559</fpage><lpage>570</lpage><pub-id pub-id-type="doi">10.1016/j.bbagrm.2014.05.003</pub-id></element-citation></ref><ref id="bib26"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ganassi</surname> <given-names>M</given-names></name><name><surname>Badodi</surname> <given-names>S</given-names></name><name><surname>Ortuste Quiroga</surname> <given-names>HP</given-names></name><name><surname>Zammit</surname> <given-names>PS</given-names></name><name><surname>Hinits</surname> <given-names>Y</given-names></name><name><surname>Hughes</surname> <given-names>SM</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Myogenin promotes myocyte fusion to balance fibre number and size</article-title><source>Nature Communications</source><volume>9</volume><elocation-id>4232</elocation-id><pub-id pub-id-type="doi">10.1038/s41467-018-06583-6</pub-id><pub-id pub-id-type="pmid">30315160</pub-id></element-citation></ref><ref id="bib27"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gao</surname> <given-names>Y</given-names></name><name><surname>Dai</surname> <given-names>Z</given-names></name><name><surname>Shi</surname> <given-names>C</given-names></name><name><surname>Zhai</surname> <given-names>G</given-names></name><name><surname>Jin</surname> <given-names>X</given-names></name><name><surname>He</surname> <given-names>J</given-names></name><name><surname>Lou</surname> <given-names>Q</given-names></name><name><surname>Yin</surname> <given-names>Z</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Depletion of myostatin b promotes somatic growth and lipid metabolism in zebrafish</article-title><source>Frontiers in Endocrinology</source><volume>7</volume><elocation-id>88</elocation-id><pub-id pub-id-type="doi">10.3389/fendo.2016.00088</pub-id><pub-id pub-id-type="pmid">27458428</pub-id></element-citation></ref><ref id="bib28"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Garikipati</surname> <given-names>DK</given-names></name><name><surname>Rodgers</surname> <given-names>BD</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>Myostatin inhibits myosatellite cell proliferation and consequently activates differentiation: evidence for endocrine-regulated transcript processing</article-title><source>Journal of Endocrinology</source><volume>215</volume><fpage>177</fpage><lpage>187</lpage><pub-id pub-id-type="doi">10.1530/JOE-12-0260</pub-id><pub-id pub-id-type="pmid">22872758</pub-id></element-citation></ref><ref id="bib29"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gibson</surname> <given-names>MC</given-names></name><name><surname>Schultz</surname> <given-names>E</given-names></name></person-group><year iso-8601-date="1982">1982</year><article-title>The distribution of satellite cells and their relationship to specific fiber types in Soleus and extensor digitorum longus muscles</article-title><source>The Anatomical Record</source><volume>202</volume><fpage>329</fpage><lpage>337</lpage><pub-id pub-id-type="doi">10.1002/ar.1092020305</pub-id><pub-id pub-id-type="pmid">7072981</pub-id></element-citation></ref><ref id="bib30"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hammond</surname> <given-names>CL</given-names></name><name><surname>Hinits</surname> <given-names>Y</given-names></name><name><surname>Osborn</surname> <given-names>DP</given-names></name><name><surname>Minchin</surname> <given-names>JE</given-names></name><name><surname>Tettamanti</surname> <given-names>G</given-names></name><name><surname>Hughes</surname> <given-names>SM</given-names></name></person-group><year iso-8601-date="2007">2007</year><article-title>Signals and myogenic regulatory factors restrict pax3 and pax7 expression to dermomyotome-like tissue in zebrafish</article-title><source>Developmental Biology</source><volume>302</volume><fpage>504</fpage><lpage>521</lpage><pub-id pub-id-type="doi">10.1016/j.ydbio.2006.10.009</pub-id><pub-id pub-id-type="pmid">17094960</pub-id></element-citation></ref><ref id="bib31"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hasty</surname> <given-names>P</given-names></name><name><surname>Bradley</surname> <given-names>A</given-names></name><name><surname>Morris</surname> <given-names>JH</given-names></name><name><surname>Edmondson</surname> <given-names>DG</given-names></name><name><surname>Venuti</surname> <given-names>JM</given-names></name><name><surname>Olson</surname> <given-names>EN</given-names></name><name><surname>Klein</surname> <given-names>WH</given-names></name></person-group><year iso-8601-date="1993">1993</year><article-title>Muscle deficiency and neonatal death in mice with a targeted mutation in the myogenin gene</article-title><source>Nature</source><volume>364</volume><fpage>501</fpage><lpage>506</lpage><pub-id pub-id-type="doi">10.1038/364501a0</pub-id><pub-id pub-id-type="pmid">8393145</pub-id></element-citation></ref><ref id="bib32"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hernández-Hernández</surname> <given-names>JM</given-names></name><name><surname>García-González</surname> <given-names>EG</given-names></name><name><surname>Brun</surname> <given-names>CE</given-names></name><name><surname>Rudnicki</surname> <given-names>MA</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>The myogenic regulatory factors, determinants of muscle development, cell identity and regeneration</article-title><source>Seminars in Cell &amp; Developmental Biology</source><volume>72</volume><fpage>10</fpage><lpage>18</lpage><pub-id pub-id-type="doi">10.1016/j.semcdb.2017.11.010</pub-id><pub-id pub-id-type="pmid">29127045</pub-id></element-citation></ref><ref id="bib33"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hinits</surname> <given-names>Y</given-names></name><name><surname>Osborn</surname> <given-names>DPS</given-names></name><name><surname>Hughes</surname> <given-names>SM</given-names></name></person-group><year iso-8601-date="2009">2009</year><article-title>Differential requirements for myogenic regulatory factors distinguish medial and lateral somitic, cranial and fin muscle fibre populations</article-title><source>Development</source><volume>136</volume><fpage>403</fpage><lpage>414</lpage><pub-id pub-id-type="doi">10.1242/dev.028019</pub-id></element-citation></ref><ref id="bib34"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hinits</surname> <given-names>Y</given-names></name><name><surname>Williams</surname> <given-names>VC</given-names></name><name><surname>Sweetman</surname> <given-names>D</given-names></name><name><surname>Donn</surname> <given-names>TM</given-names></name><name><surname>Ma</surname> <given-names>TP</given-names></name><name><surname>Moens</surname> <given-names>CB</given-names></name><name><surname>Hughes</surname> <given-names>SM</given-names></name></person-group><year iso-8601-date="2011">2011</year><article-title>Defective cranial skeletal development, larval lethality and haploinsufficiency in myod mutant zebrafish</article-title><source>Developmental Biology</source><volume>358</volume><fpage>102</fpage><lpage>112</lpage><pub-id pub-id-type="doi">10.1016/j.ydbio.2011.07.015</pub-id><pub-id pub-id-type="pmid">21798255</pub-id></element-citation></ref><ref id="bib35"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ho</surname> <given-names>DE</given-names></name><name><surname>Imai</surname> <given-names>K</given-names></name><name><surname>King</surname> <given-names>G</given-names></name><name><surname>Stuart</surname> <given-names>EA</given-names></name></person-group><year iso-8601-date="2011">2011</year><article-title>MatchIt: nonparametric preprocessing for parametric causal inference</article-title><source>Journal of Statistical Software</source><volume>42</volume><fpage>1</fpage><lpage>28</lpage><pub-id pub-id-type="doi">10.18637/jss.v042.i08</pub-id></element-citation></ref><ref id="bib36"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hollway</surname> <given-names>GE</given-names></name><name><surname>Bryson-Richardson</surname> <given-names>RJ</given-names></name><name><surname>Berger</surname> <given-names>S</given-names></name><name><surname>Cole</surname> <given-names>NJ</given-names></name><name><surname>Hall</surname> <given-names>TE</given-names></name><name><surname>Currie</surname> <given-names>PD</given-names></name></person-group><year iso-8601-date="2007">2007</year><article-title>Whole-somite rotation generates muscle progenitor cell compartments in the developing zebrafish embryo</article-title><source>Developmental Cell</source><volume>12</volume><fpage>207</fpage><lpage>219</lpage><pub-id pub-id-type="doi">10.1016/j.devcel.2007.01.001</pub-id><pub-id pub-id-type="pmid">17276339</pub-id></element-citation></ref><ref id="bib37"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hughes</surname> <given-names>SM</given-names></name><name><surname>Taylor</surname> <given-names>JM</given-names></name><name><surname>Tapscott</surname> <given-names>SJ</given-names></name><name><surname>Gurley</surname> <given-names>CM</given-names></name><name><surname>Carter</surname> <given-names>WJ</given-names></name><name><surname>Peterson</surname> <given-names>CA</given-names></name></person-group><year iso-8601-date="1993">1993</year><article-title>Selective accumulation of MyoD and myogenin mRNAs in fast and slow adult skeletal muscle is controlled by innervation and hormones</article-title><source>Development</source><volume>118</volume><fpage>1137</fpage><lpage>1147</lpage><pub-id pub-id-type="pmid">8269844</pub-id></element-citation></ref><ref id="bib38"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hughes</surname> <given-names>SM</given-names></name><name><surname>Chi</surname> <given-names>MM</given-names></name><name><surname>Lowry</surname> <given-names>OH</given-names></name><name><surname>Gundersen</surname> <given-names>K</given-names></name></person-group><year iso-8601-date="1999">1999</year><article-title>Myogenin induces a shift of enzyme activity from glycolytic to oxidative metabolism in muscles of transgenic mice</article-title><source>Journal of Cell Biology</source><volume>145</volume><fpage>633</fpage><lpage>642</lpage><pub-id pub-id-type="doi">10.1083/jcb.145.3.633</pub-id><pub-id pub-id-type="pmid">10225962</pub-id></element-citation></ref><ref id="bib39"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hughes</surname> <given-names>SM</given-names></name><name><surname>Blau</surname> <given-names>HM</given-names></name></person-group><year iso-8601-date="1990">1990</year><article-title>Migration of myoblasts across basal Lamina during skeletal muscle development</article-title><source>Nature</source><volume>345</volume><fpage>350</fpage><lpage>353</lpage><pub-id pub-id-type="doi">10.1038/345350a0</pub-id><pub-id pub-id-type="pmid">2111464</pub-id></element-citation></ref><ref id="bib40"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kawakami</surname> <given-names>A</given-names></name><name><surname>Kimura-Kawakami</surname> <given-names>M</given-names></name><name><surname>Nomura</surname> <given-names>T</given-names></name><name><surname>Fujisawa</surname> <given-names>H</given-names></name></person-group><year iso-8601-date="1997">1997</year><article-title>Distributions of PAX6 and PAX7 proteins suggest their involvement in both early and late phases of chick brain development</article-title><source>Mechanisms of Development</source><volume>66</volume><fpage>119</fpage><lpage>130</lpage><pub-id pub-id-type="doi">10.1016/S0925-4773(97)00097-X</pub-id><pub-id pub-id-type="pmid">9376315</pub-id></element-citation></ref><ref id="bib41"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Keefe</surname> <given-names>AC</given-names></name><name><surname>Lawson</surname> <given-names>JA</given-names></name><name><surname>Flygare</surname> <given-names>SD</given-names></name><name><surname>Fox</surname> <given-names>ZD</given-names></name><name><surname>Colasanto</surname> <given-names>MP</given-names></name><name><surname>Mathew</surname> <given-names>SJ</given-names></name><name><surname>Yandell</surname> <given-names>M</given-names></name><name><surname>Kardon</surname> <given-names>G</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>Muscle stem cells contribute to myofibres in sedentary adult mice</article-title><source>Nature Communications</source><volume>6</volume><elocation-id>7087</elocation-id><pub-id pub-id-type="doi">10.1038/ncomms8087</pub-id><pub-id pub-id-type="pmid">25971691</pub-id></element-citation></ref><ref id="bib42"><element-citation publication-type="preprint"><person-group person-group-type="author"><name><surname>Kelu</surname> <given-names>JJ</given-names></name><name><surname>Pipalia</surname> <given-names>TG</given-names></name><name><surname>Hughes</surname> <given-names>SM</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Circadian regulation of muscle growth independent of locomotor activity</article-title><source>bioRxiv</source><pub-id pub-id-type="doi">10.1101/778787</pub-id></element-citation></ref><ref id="bib43"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kelu</surname> <given-names>JJ</given-names></name><name><surname>Pipalia</surname> <given-names>TG</given-names></name><name><surname>Hughes</surname> <given-names>SM</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Circadian regulation of muscle growth independent of locomotor activity</article-title><source>PNAS</source><comment>In press</comment></element-citation></ref><ref id="bib44"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kitiyakara</surname> <given-names>A</given-names></name><name><surname>Angevine</surname> <given-names>DM</given-names></name></person-group><year iso-8601-date="1963">1963</year><article-title>A study of the pattern of postembryonic growth of M. gracilis in mice</article-title><source>Developmental Biology</source><volume>8</volume><fpage>322</fpage><lpage>340</lpage><pub-id pub-id-type="doi">10.1016/0012-1606(63)90033-2</pub-id><pub-id pub-id-type="pmid">14084729</pub-id></element-citation></ref><ref id="bib45"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Knapp</surname> <given-names>JR</given-names></name><name><surname>Davie</surname> <given-names>JK</given-names></name><name><surname>Myer</surname> <given-names>A</given-names></name><name><surname>Meadows</surname> <given-names>E</given-names></name><name><surname>Olson</surname> <given-names>EN</given-names></name><name><surname>Klein</surname> <given-names>WH</given-names></name></person-group><year iso-8601-date="2006">2006</year><article-title>Loss of myogenin in postnatal life leads to normal skeletal muscle but reduced body size</article-title><source>Development</source><volume>133</volume><fpage>601</fpage><lpage>610</lpage><pub-id pub-id-type="doi">10.1242/dev.02249</pub-id><pub-id pub-id-type="pmid">16407395</pub-id></element-citation></ref><ref id="bib46"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kuang</surname> <given-names>S</given-names></name><name><surname>Kuroda</surname> <given-names>K</given-names></name><name><surname>Le Grand</surname> <given-names>F</given-names></name><name><surname>Rudnicki</surname> <given-names>MA</given-names></name></person-group><year iso-8601-date="2007">2007</year><article-title>Asymmetric self-renewal and commitment of satellite stem cells in muscle</article-title><source>Cell</source><volume>129</volume><fpage>999</fpage><lpage>1010</lpage><pub-id pub-id-type="doi">10.1016/j.cell.2007.03.044</pub-id><pub-id pub-id-type="pmid">17540178</pub-id></element-citation></ref><ref id="bib47"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Latres</surname> <given-names>E</given-names></name><name><surname>Amini</surname> <given-names>AR</given-names></name><name><surname>Amini</surname> <given-names>AA</given-names></name><name><surname>Griffiths</surname> <given-names>J</given-names></name><name><surname>Martin</surname> <given-names>FJ</given-names></name><name><surname>Wei</surname> <given-names>Y</given-names></name><name><surname>Lin</surname> <given-names>HC</given-names></name><name><surname>Yancopoulos</surname> <given-names>GD</given-names></name><name><surname>Glass</surname> <given-names>DJ</given-names></name></person-group><year iso-8601-date="2005">2005</year><article-title>Insulin-like growth factor-1 (IGF-1) inversely regulates atrophy-induced genes via the phosphatidylinositol 3-kinase/Akt/mammalian target of rapamycin (PI3K/Akt/mTOR) pathway</article-title><source>Journal of Biological Chemistry</source><volume>280</volume><fpage>2737</fpage><lpage>2744</lpage><pub-id pub-id-type="doi">10.1074/jbc.M407517200</pub-id><pub-id pub-id-type="pmid">15550386</pub-id></element-citation></ref><ref id="bib48"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lindström</surname> <given-names>M</given-names></name><name><surname>Pedrosa-Domellöf</surname> <given-names>F</given-names></name><name><surname>Thornell</surname> <given-names>LE</given-names></name></person-group><year iso-8601-date="2010">2010</year><article-title>Satellite cell heterogeneity with respect to expression of MyoD, Myogenin, Dlk1 and c-Met in human skeletal muscle: application to a cohort of power lifters and sedentary men</article-title><source>Histochemistry and Cell Biology</source><volume>134</volume><fpage>371</fpage><lpage>385</lpage><pub-id pub-id-type="doi">10.1007/s00418-010-0743-5</pub-id><pub-id pub-id-type="pmid">20878332</pub-id></element-citation></ref><ref id="bib49"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Livak</surname> <given-names>KJ</given-names></name><name><surname>Schmittgen</surname> <given-names>TD</given-names></name></person-group><year iso-8601-date="2001">2001</year><article-title>Analysis of relative gene expression data using Real-Time quantitative PCR and the 2−δδct method</article-title><source>Methods</source><volume>25</volume><fpage>402</fpage><lpage>408</lpage><pub-id pub-id-type="doi">10.1006/meth.2001.1262</pub-id></element-citation></ref><ref id="bib50"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Machado</surname> <given-names>L</given-names></name><name><surname>Esteves de Lima</surname> <given-names>J</given-names></name><name><surname>Fabre</surname> <given-names>O</given-names></name><name><surname>Proux</surname> <given-names>C</given-names></name><name><surname>Legendre</surname> <given-names>R</given-names></name><name><surname>Szegedi</surname> <given-names>A</given-names></name><name><surname>Varet</surname> <given-names>H</given-names></name><name><surname>Ingerslev</surname> <given-names>LR</given-names></name><name><surname>Barrès</surname> <given-names>R</given-names></name><name><surname>Relaix</surname> <given-names>F</given-names></name><name><surname>Mourikis</surname> <given-names>P</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>In situ fixation redefines quiescence and early activation of skeletal muscle stem cells</article-title><source>Cell Reports</source><volume>21</volume><fpage>1982</fpage><lpage>1993</lpage><pub-id pub-id-type="doi">10.1016/j.celrep.2017.10.080</pub-id><pub-id pub-id-type="pmid">29141227</pub-id></element-citation></ref><ref id="bib51"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mahalwar</surname> <given-names>P</given-names></name><name><surname>Walderich</surname> <given-names>B</given-names></name><name><surname>Singh</surname> <given-names>AP</given-names></name><name><surname>Nusslein-Volhard</surname> <given-names>C</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>Local reorganization of xanthophores fine-tunes and colors the striped pattern of zebrafish</article-title><source>Science</source><volume>345</volume><fpage>1362</fpage><lpage>1364</lpage><pub-id pub-id-type="doi">10.1126/science.1254837</pub-id></element-citation></ref><ref id="bib52"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Manceau</surname> <given-names>M</given-names></name><name><surname>Gros</surname> <given-names>J</given-names></name><name><surname>Savage</surname> <given-names>K</given-names></name><name><surname>Thomé</surname> <given-names>V</given-names></name><name><surname>McPherron</surname> <given-names>A</given-names></name><name><surname>Paterson</surname> <given-names>B</given-names></name><name><surname>Marcelle</surname> <given-names>C</given-names></name></person-group><year iso-8601-date="2008">2008</year><article-title>Myostatin promotes the terminal differentiation of embryonic muscle progenitors</article-title><source>Genes &amp; Development</source><volume>22</volume><fpage>668</fpage><lpage>681</lpage><pub-id pub-id-type="doi">10.1101/gad.454408</pub-id><pub-id pub-id-type="pmid">18316481</pub-id></element-citation></ref><ref id="bib53"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mashinchian</surname> <given-names>O</given-names></name><name><surname>Pisconti</surname> <given-names>A</given-names></name><name><surname>Le Moal</surname> <given-names>E</given-names></name><name><surname>Bentzinger</surname> <given-names>CF</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>The muscle stem cell niche in health and disease</article-title><source>Current Topics in Developmental Biology</source><volume>126</volume><fpage>23</fpage><lpage>65</lpage><pub-id pub-id-type="doi">10.1016/bs.ctdb.2017.08.003</pub-id><pub-id pub-id-type="pmid">29305000</pub-id></element-citation></ref><ref id="bib54"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mauro</surname> <given-names>A</given-names></name></person-group><year iso-8601-date="1961">1961</year><article-title>Satellite cell of skeletal muscle fibers</article-title><source>The Journal of Biophysical and Biochemical Cytology</source><volume>9</volume><fpage>493</fpage><lpage>495</lpage><pub-id pub-id-type="doi">10.1083/jcb.9.2.493</pub-id><pub-id pub-id-type="pmid">13768451</pub-id></element-citation></ref><ref id="bib55"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>McCall</surname> <given-names>GE</given-names></name><name><surname>Allen</surname> <given-names>DL</given-names></name><name><surname>Linderman</surname> <given-names>JK</given-names></name><name><surname>Grindeland</surname> <given-names>RE</given-names></name><name><surname>Roy</surname> <given-names>RR</given-names></name><name><surname>Mukku</surname> <given-names>VR</given-names></name><name><surname>Edgerton</surname> <given-names>VR</given-names></name></person-group><year iso-8601-date="1998">1998</year><article-title>Maintenance of myonuclear domain size in rat soleus after overload and growth hormone/IGF-I treatment</article-title><source>Journal of Applied Physiology</source><volume>84</volume><fpage>1407</fpage><lpage>1412</lpage><pub-id pub-id-type="doi">10.1152/jappl.1998.84.4.1407</pub-id><pub-id pub-id-type="pmid">9516210</pub-id></element-citation></ref><ref id="bib56"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>McCroskery</surname> <given-names>S</given-names></name><name><surname>Thomas</surname> <given-names>M</given-names></name><name><surname>Maxwell</surname> <given-names>L</given-names></name><name><surname>Sharma</surname> <given-names>M</given-names></name><name><surname>Kambadur</surname> <given-names>R</given-names></name></person-group><year iso-8601-date="2003">2003</year><article-title>Myostatin negatively regulates satellite cell activation and self-renewal</article-title><source>Journal of Cell Biology</source><volume>162</volume><fpage>1135</fpage><lpage>1147</lpage><pub-id pub-id-type="doi">10.1083/jcb.200207056</pub-id><pub-id pub-id-type="pmid">12963705</pub-id></element-citation></ref><ref id="bib57"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>McPherron</surname> <given-names>AC</given-names></name><name><surname>Lawler</surname> <given-names>AM</given-names></name><name><surname>Lee</surname> <given-names>SJ</given-names></name></person-group><year iso-8601-date="1997">1997</year><article-title>Regulation of skeletal muscle mass in mice by a new TGF-beta superfamily member</article-title><source>Nature</source><volume>387</volume><fpage>83</fpage><lpage>90</lpage><pub-id pub-id-type="doi">10.1038/387083a0</pub-id><pub-id pub-id-type="pmid">9139826</pub-id></element-citation></ref><ref id="bib58"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Meadows</surname> <given-names>E</given-names></name><name><surname>Cho</surname> <given-names>JH</given-names></name><name><surname>Flynn</surname> <given-names>JM</given-names></name><name><surname>Klein</surname> <given-names>WH</given-names></name></person-group><year iso-8601-date="2008">2008</year><article-title>Myogenin regulates a distinct genetic program in adult muscle stem cells</article-title><source>Developmental Biology</source><volume>322</volume><fpage>406</fpage><lpage>414</lpage><pub-id pub-id-type="doi">10.1016/j.ydbio.2008.07.024</pub-id><pub-id pub-id-type="pmid">18721801</pub-id></element-citation></ref><ref id="bib59"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Megeney</surname> <given-names>LA</given-names></name><name><surname>Kablar</surname> <given-names>B</given-names></name><name><surname>Garrett</surname> <given-names>K</given-names></name><name><surname>Anderson</surname> <given-names>JE</given-names></name><name><surname>Rudnicki</surname> <given-names>MA</given-names></name></person-group><year iso-8601-date="1996">1996</year><article-title>MyoD is required for myogenic stem cell function in adult skeletal muscle</article-title><source>Genes &amp; Development</source><volume>10</volume><fpage>1173</fpage><lpage>1183</lpage><pub-id pub-id-type="doi">10.1101/gad.10.10.1173</pub-id><pub-id pub-id-type="pmid">8675005</pub-id></element-citation></ref><ref id="bib60"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Moresi</surname> <given-names>V</given-names></name><name><surname>Williams</surname> <given-names>AH</given-names></name><name><surname>Meadows</surname> <given-names>E</given-names></name><name><surname>Flynn</surname> <given-names>JM</given-names></name><name><surname>Potthoff</surname> <given-names>MJ</given-names></name><name><surname>McAnally</surname> <given-names>J</given-names></name><name><surname>Shelton</surname> <given-names>JM</given-names></name><name><surname>Backs</surname> <given-names>J</given-names></name><name><surname>Klein</surname> <given-names>WH</given-names></name><name><surname>Richardson</surname> <given-names>JA</given-names></name><name><surname>Bassel-Duby</surname> <given-names>R</given-names></name><name><surname>Olson</surname> <given-names>EN</given-names></name></person-group><year iso-8601-date="2010">2010</year><article-title>Myogenin and class II HDACs control neurogenic muscle atrophy by inducing E3 ubiquitin ligases</article-title><source>Cell</source><volume>143</volume><fpage>35</fpage><lpage>45</lpage><pub-id pub-id-type="doi">10.1016/j.cell.2010.09.004</pub-id><pub-id pub-id-type="pmid">20887891</pub-id></element-citation></ref><ref id="bib61"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Moretti</surname> <given-names>I</given-names></name><name><surname>Ciciliot</surname> <given-names>S</given-names></name><name><surname>Dyar</surname> <given-names>KA</given-names></name><name><surname>Abraham</surname> <given-names>R</given-names></name><name><surname>Murgia</surname> <given-names>M</given-names></name><name><surname>Agatea</surname> <given-names>L</given-names></name><name><surname>Akimoto</surname> <given-names>T</given-names></name><name><surname>Bicciato</surname> <given-names>S</given-names></name><name><surname>Forcato</surname> <given-names>M</given-names></name><name><surname>Pierre</surname> <given-names>P</given-names></name><name><surname>Uhlenhaut</surname> <given-names>NH</given-names></name><name><surname>Rigby</surname> <given-names>PW</given-names></name><name><surname>Carvajal</surname> <given-names>JJ</given-names></name><name><surname>Blaauw</surname> <given-names>B</given-names></name><name><surname>Calabria</surname> <given-names>E</given-names></name><name><surname>Schiaffino</surname> <given-names>S</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>MRF4 negatively regulates adult skeletal muscle growth by repressing MEF2 activity</article-title><source>Nature Communications</source><volume>7</volume><elocation-id>12397</elocation-id><pub-id pub-id-type="doi">10.1038/ncomms12397</pub-id><pub-id pub-id-type="pmid">27484840</pub-id></element-citation></ref><ref id="bib62"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nabeshima</surname> <given-names>Y</given-names></name><name><surname>Hanaoka</surname> <given-names>K</given-names></name><name><surname>Hayasaka</surname> <given-names>M</given-names></name><name><surname>Esumi</surname> <given-names>E</given-names></name><name><surname>Li</surname> <given-names>S</given-names></name><name><surname>Nonaka</surname> <given-names>I</given-names></name><name><surname>Nabeshima</surname> <given-names>Y</given-names></name></person-group><year iso-8601-date="1993">1993</year><article-title>Myogenin gene disruption results in perinatal lethality because of severe muscle defect</article-title><source>Nature</source><volume>364</volume><fpage>532</fpage><lpage>535</lpage><pub-id pub-id-type="doi">10.1038/364532a0</pub-id><pub-id pub-id-type="pmid">8393146</pub-id></element-citation></ref><ref id="bib63"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nikolaou</surname> <given-names>S</given-names></name><name><surname>Cramer</surname> <given-names>AAW</given-names></name><name><surname>Hu</surname> <given-names>L</given-names></name><name><surname>Goh</surname> <given-names>Q</given-names></name><name><surname>Millay</surname> <given-names>DP</given-names></name><name><surname>Cornwall</surname> <given-names>R</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Proteasome inhibition preserves longitudinal growth of denervated muscle and prevents neonatal neuromuscular contractures</article-title><source>JCI Insight</source><volume>4</volume><elocation-id>e128454</elocation-id><pub-id pub-id-type="doi">10.1172/jci.insight.128454</pub-id></element-citation></ref><ref id="bib64"><element-citation publication-type="confproc"><person-group person-group-type="author"><name><surname>Nobukini</surname> <given-names>T</given-names></name><name><surname>Thomas</surname> <given-names>G</given-names></name></person-group><year iso-8601-date="2004">2004</year><article-title>The mTOR/S6K signalling pathway: the role of the TSC1/2 tumour suppressor complex and the proto-oncogene rheb</article-title><conf-name>Novartis Foundation Symposium</conf-name><fpage>148</fpage><lpage>154</lpage></element-citation></ref><ref id="bib65"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Olguin</surname> <given-names>HC</given-names></name><name><surname>Yang</surname> <given-names>Z</given-names></name><name><surname>Tapscott</surname> <given-names>SJ</given-names></name><name><surname>Olwin</surname> <given-names>BB</given-names></name></person-group><year iso-8601-date="2007">2007</year><article-title>Reciprocal inhibition between Pax7 and muscle regulatory factors modulates myogenic cell fate determination</article-title><source>Journal of Cell Biology</source><volume>177</volume><fpage>769</fpage><lpage>779</lpage><pub-id pub-id-type="doi">10.1083/jcb.200608122</pub-id><pub-id pub-id-type="pmid">17548510</pub-id></element-citation></ref><ref id="bib66"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Olguin</surname> <given-names>HC</given-names></name><name><surname>Olwin</surname> <given-names>BB</given-names></name></person-group><year iso-8601-date="2004">2004</year><article-title>Pax-7 up-regulation inhibits myogenesis and cell cycle progression in satellite cells: a potential mechanism for self-renewal</article-title><source>Developmental Biology</source><volume>275</volume><fpage>375</fpage><lpage>388</lpage><pub-id pub-id-type="doi">10.1016/j.ydbio.2004.08.015</pub-id><pub-id pub-id-type="pmid">15501225</pub-id></element-citation></ref><ref id="bib67"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Osborn</surname> <given-names>DP</given-names></name><name><surname>Li</surname> <given-names>K</given-names></name><name><surname>Hinits</surname> <given-names>Y</given-names></name><name><surname>Hughes</surname> <given-names>SM</given-names></name></person-group><year iso-8601-date="2011">2011</year><article-title>Cdkn1c drives muscle differentiation through a positive feedback loop with myod</article-title><source>Developmental Biology</source><volume>350</volume><fpage>464</fpage><lpage>475</lpage><pub-id pub-id-type="doi">10.1016/j.ydbio.2010.12.010</pub-id><pub-id pub-id-type="pmid">21147088</pub-id></element-citation></ref><ref id="bib68"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Oustanina</surname> <given-names>S</given-names></name><name><surname>Hause</surname> <given-names>G</given-names></name><name><surname>Braun</surname> <given-names>T</given-names></name></person-group><year iso-8601-date="2004">2004</year><article-title>Pax7 directs postnatal renewal and propagation of myogenic satellite cells but not their specification</article-title><source>The EMBO Journal</source><volume>23</volume><fpage>3430</fpage><lpage>3439</lpage><pub-id pub-id-type="doi">10.1038/sj.emboj.7600346</pub-id><pub-id pub-id-type="pmid">15282552</pub-id></element-citation></ref><ref id="bib69"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pallafacchina</surname> <given-names>G</given-names></name><name><surname>Blaauw</surname> <given-names>B</given-names></name><name><surname>Schiaffino</surname> <given-names>S</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>Role of satellite cells in muscle growth and maintenance of muscle mass</article-title><source>Nutrition, Metabolism and Cardiovascular Diseases</source><volume>23</volume><fpage>S12</fpage><lpage>S18</lpage><pub-id pub-id-type="doi">10.1016/j.numecd.2012.02.002</pub-id></element-citation></ref><ref id="bib70"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Patapoutian</surname> <given-names>A</given-names></name><name><surname>Yoon</surname> <given-names>JK</given-names></name><name><surname>Miner</surname> <given-names>JH</given-names></name><name><surname>Wang</surname> <given-names>S</given-names></name><name><surname>Stark</surname> <given-names>K</given-names></name><name><surname>Wold</surname> <given-names>B</given-names></name></person-group><year iso-8601-date="1995">1995</year><article-title>Disruption of the mouse MRF4 gene identifies multiple waves of myogenesis in the myotome</article-title><source>Development</source><volume>121</volume><fpage>3347</fpage><lpage>3358</lpage><pub-id pub-id-type="pmid">7588068</pub-id></element-citation></ref><ref id="bib71"><element-citation publication-type="software"><person-group person-group-type="author"><name><surname>Pinheiro</surname> <given-names>J</given-names></name><name><surname>Bates</surname> <given-names>D</given-names></name><name><surname>DebRoy</surname> <given-names>S</given-names></name><name><surname>Sarkar</surname> <given-names>D</given-names></name><collab>R Core Team</collab></person-group><year iso-8601-date="2020">2020</year><data-title>nlme: Linear and Nonlinear Mixed Effects Models</data-title><version designator="3.1">3.1</version><publisher-name>R package </publisher-name><ext-link ext-link-type="uri" xlink:href="https://svn.r-project.org/R-packages/trunk/nlme/">https://svn.r-project.org/R-packages/trunk/nlme/</ext-link></element-citation></ref><ref id="bib72"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pipalia</surname> <given-names>TG</given-names></name><name><surname>Koth</surname> <given-names>J</given-names></name><name><surname>Roy</surname> <given-names>SD</given-names></name><name><surname>Hammond</surname> <given-names>CL</given-names></name><name><surname>Kawakami</surname> <given-names>K</given-names></name><name><surname>Hughes</surname> <given-names>SM</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Cellular dynamics of regeneration reveals role of two distinct Pax7 stem cell populations in larval zebrafish muscle repair</article-title><source>Disease Models &amp; Mechanisms</source><volume>9</volume><fpage>671</fpage><lpage>684</lpage><pub-id pub-id-type="doi">10.1242/dmm.022251</pub-id><pub-id pub-id-type="pmid">27149989</pub-id></element-citation></ref><ref id="bib73"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Porpiglia</surname> <given-names>E</given-names></name><name><surname>Samusik</surname> <given-names>N</given-names></name><name><surname>Ho</surname> <given-names>ATV</given-names></name><name><surname>Cosgrove</surname> <given-names>BD</given-names></name><name><surname>Mai</surname> <given-names>T</given-names></name><name><surname>Davis</surname> <given-names>KL</given-names></name><name><surname>Jager</surname> <given-names>A</given-names></name><name><surname>Nolan</surname> <given-names>GP</given-names></name><name><surname>Bendall</surname> <given-names>SC</given-names></name><name><surname>Fantl</surname> <given-names>WJ</given-names></name><name><surname>Blau</surname> <given-names>HM</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>High-resolution myogenic lineage mapping by single-cell mass cytometry</article-title><source>Nature Cell Biology</source><volume>19</volume><fpage>558</fpage><lpage>567</lpage><pub-id pub-id-type="doi">10.1038/ncb3507</pub-id><pub-id pub-id-type="pmid">28414312</pub-id></element-citation></ref><ref id="bib74"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Powell-Braxton</surname> <given-names>L</given-names></name><name><surname>Hollingshead</surname> <given-names>P</given-names></name><name><surname>Warburton</surname> <given-names>C</given-names></name><name><surname>Dowd</surname> <given-names>M</given-names></name><name><surname>Pitts-Meek</surname> <given-names>S</given-names></name><name><surname>Dalton</surname> <given-names>D</given-names></name><name><surname>Gillett</surname> <given-names>N</given-names></name><name><surname>Stewart</surname> <given-names>TA</given-names></name></person-group><year iso-8601-date="1993">1993</year><article-title>IGF-I is required for normal embryonic growth in mice</article-title><source>Genes &amp; Development</source><volume>7</volume><fpage>2609</fpage><lpage>2617</lpage><pub-id pub-id-type="doi">10.1101/gad.7.12b.2609</pub-id><pub-id pub-id-type="pmid">8276243</pub-id></element-citation></ref><ref id="bib75"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Purohit</surname> <given-names>G</given-names></name><name><surname>Dhawan</surname> <given-names>J</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Adult muscle stem cells: exploring the links between systemic and cellular metabolism</article-title><source>Frontiers in Cell and Developmental Biology</source><volume>7</volume><elocation-id>312</elocation-id><pub-id pub-id-type="doi">10.3389/fcell.2019.00312</pub-id><pub-id pub-id-type="pmid">31921837</pub-id></element-citation></ref><ref id="bib76"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Quan</surname> <given-names>Z</given-names></name><name><surname>Sun</surname> <given-names>P</given-names></name><name><surname>Lin</surname> <given-names>G</given-names></name><name><surname>Xi</surname> <given-names>R</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>TSC1/2 regulates intestinal stem cell maintenance and lineage differentiation through Rheb-TORC1-S6K but independently of nutritional status or notch regulation</article-title><source>Journal of Cell Science</source><volume>126</volume><fpage>3884</fpage><lpage>3892</lpage><pub-id pub-id-type="doi">10.1242/jcs.125294</pub-id><pub-id pub-id-type="pmid">23843608</pub-id></element-citation></ref><ref id="bib77"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rantanen</surname> <given-names>J</given-names></name><name><surname>Hurme</surname> <given-names>T</given-names></name><name><surname>Lukka</surname> <given-names>R</given-names></name><name><surname>Heino</surname> <given-names>J</given-names></name><name><surname>Kalimo</surname> <given-names>H</given-names></name></person-group><year iso-8601-date="1995">1995</year><article-title>Satellite cell proliferation and the expression of myogenin and desmin in regenerating skeletal muscle: evidence for two different populations of satellite cells</article-title><source>Laboratory Investigation; a Journal of Technical Methods and Pathology</source><volume>72</volume><fpage>341</fpage><lpage>347</lpage><pub-id pub-id-type="pmid">7898053</pub-id></element-citation></ref><ref id="bib78"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rawls</surname> <given-names>A</given-names></name><name><surname>Valdez</surname> <given-names>MR</given-names></name><name><surname>Zhang</surname> <given-names>W</given-names></name><name><surname>Richardson</surname> <given-names>J</given-names></name><name><surname>Klein</surname> <given-names>WH</given-names></name><name><surname>Olson</surname> <given-names>EN</given-names></name></person-group><year iso-8601-date="1998">1998</year><article-title>Overlapping functions of the myogenic bHLH genes MRF4 and MyoD revealed in double mutant mice</article-title><source>Development</source><volume>125</volume><fpage>2349</fpage><lpage>2358</lpage></element-citation></ref><ref id="bib79"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Relaix</surname> <given-names>F</given-names></name><name><surname>Montarras</surname> <given-names>D</given-names></name><name><surname>Zaffran</surname> <given-names>S</given-names></name><name><surname>Gayraud-Morel</surname> <given-names>B</given-names></name><name><surname>Rocancourt</surname> <given-names>D</given-names></name><name><surname>Tajbakhsh</surname> <given-names>S</given-names></name><name><surname>Mansouri</surname> <given-names>A</given-names></name><name><surname>Cumano</surname> <given-names>A</given-names></name><name><surname>Buckingham</surname> <given-names>M</given-names></name></person-group><year iso-8601-date="2006">2006</year><article-title>Pax3 and Pax7 have distinct and overlapping functions in adult muscle progenitor cells</article-title><source>The Journal of Cell Biology</source><volume>172</volume><fpage>91</fpage><lpage>102</lpage><pub-id pub-id-type="doi">10.1083/jcb.200508044</pub-id><pub-id pub-id-type="pmid">16380438</pub-id></element-citation></ref><ref id="bib80"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Relaix</surname> <given-names>F</given-names></name><name><surname>Zammit</surname> <given-names>PS</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>Satellite cells are essential for skeletal muscle regeneration: the cell on the edge returns centre stage</article-title><source>Development</source><volume>139</volume><fpage>2845</fpage><lpage>2856</lpage><pub-id pub-id-type="doi">10.1242/dev.069088</pub-id><pub-id pub-id-type="pmid">22833472</pub-id></element-citation></ref><ref id="bib81"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Riuzzi</surname> <given-names>F</given-names></name><name><surname>Sorci</surname> <given-names>G</given-names></name><name><surname>Sagheddu</surname> <given-names>R</given-names></name><name><surname>Sidoni</surname> <given-names>A</given-names></name><name><surname>Alaggio</surname> <given-names>R</given-names></name><name><surname>Ninfo</surname> <given-names>V</given-names></name><name><surname>Donato</surname> <given-names>R</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>RAGE signaling deficiency in Rhabdomyosarcoma cells causes upregulation of PAX7 and uncontrolled proliferation</article-title><source>Journal of Cell Science</source><volume>127</volume><fpage>1699</fpage><lpage>1711</lpage><pub-id pub-id-type="doi">10.1242/jcs.136259</pub-id><pub-id pub-id-type="pmid">24554430</pub-id></element-citation></ref><ref id="bib82"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rodgers</surname> <given-names>JT</given-names></name><name><surname>King</surname> <given-names>KY</given-names></name><name><surname>Brett</surname> <given-names>JO</given-names></name><name><surname>Cromie</surname> <given-names>MJ</given-names></name><name><surname>Charville</surname> <given-names>GW</given-names></name><name><surname>Maguire</surname> <given-names>KK</given-names></name><name><surname>Brunson</surname> <given-names>C</given-names></name><name><surname>Mastey</surname> <given-names>N</given-names></name><name><surname>Liu</surname> <given-names>L</given-names></name><name><surname>Tsai</surname> <given-names>CR</given-names></name><name><surname>Goodell</surname> <given-names>MA</given-names></name><name><surname>Rando</surname> <given-names>TA</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>mTORC1 controls the adaptive transition of quiescent stem cells from G0 to G(Alert)</article-title><source>Nature</source><volume>510</volume><fpage>393</fpage><lpage>396</lpage><pub-id pub-id-type="doi">10.1038/nature13255</pub-id><pub-id pub-id-type="pmid">24870234</pub-id></element-citation></ref><ref id="bib83"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Roy</surname> <given-names>SD</given-names></name><name><surname>Williams</surname> <given-names>VC</given-names></name><name><surname>Pipalia</surname> <given-names>TG</given-names></name><name><surname>Li</surname> <given-names>K</given-names></name><name><surname>Hammond</surname> <given-names>CL</given-names></name><name><surname>Knappe</surname> <given-names>S</given-names></name><name><surname>Knight</surname> <given-names>RD</given-names></name><name><surname>Hughes</surname> <given-names>SM</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>Myotome adaptability confers developmental robustness to somitic myogenesis in response to fibre number alteration</article-title><source>Developmental Biology</source><volume>431</volume><fpage>321</fpage><lpage>335</lpage><pub-id pub-id-type="doi">10.1016/j.ydbio.2017.08.029</pub-id></element-citation></ref><ref id="bib84"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ruvinsky</surname> <given-names>I</given-names></name><name><surname>Katz</surname> <given-names>M</given-names></name><name><surname>Dreazen</surname> <given-names>A</given-names></name><name><surname>Gielchinsky</surname> <given-names>Y</given-names></name><name><surname>Saada</surname> <given-names>A</given-names></name><name><surname>Freedman</surname> <given-names>N</given-names></name><name><surname>Mishani</surname> <given-names>E</given-names></name><name><surname>Zimmerman</surname> <given-names>G</given-names></name><name><surname>Kasir</surname> <given-names>J</given-names></name><name><surname>Meyuhas</surname> <given-names>O</given-names></name></person-group><year iso-8601-date="2009">2009</year><article-title>Mice deficient in ribosomal protein S6 phosphorylation suffer from muscle weakness that reflects a growth defect and energy deficit</article-title><source>PLOS ONE</source><volume>4</volume><elocation-id>e5618</elocation-id><pub-id pub-id-type="doi">10.1371/journal.pone.0005618</pub-id><pub-id pub-id-type="pmid">19479038</pub-id></element-citation></ref><ref id="bib85"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schiaffino</surname> <given-names>S</given-names></name><name><surname>Mammucari</surname> <given-names>C</given-names></name></person-group><year iso-8601-date="2011">2011</year><article-title>Regulation of skeletal muscle growth by the IGF1-Akt/PKB pathway: insights from genetic models</article-title><source>Skeletal Muscle</source><volume>1</volume><elocation-id>4</elocation-id><pub-id pub-id-type="doi">10.1186/2044-5040-1-4</pub-id><pub-id pub-id-type="pmid">21798082</pub-id></element-citation></ref><ref id="bib86"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schultz</surname> <given-names>E</given-names></name><name><surname>Chamberlain</surname> <given-names>C</given-names></name><name><surname>McCormick</surname> <given-names>KM</given-names></name><name><surname>Mozdziak</surname> <given-names>PE</given-names></name></person-group><year iso-8601-date="2006">2006</year><article-title>Satellite cells express distinct patterns of myogenic proteins in immature skeletal muscle</article-title><source>Developmental Dynamics</source><volume>235</volume><fpage>3230</fpage><lpage>3239</lpage><pub-id pub-id-type="doi">10.1002/dvdy.20976</pub-id></element-citation></ref><ref id="bib87"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Seale</surname> <given-names>P</given-names></name><name><surname>Sabourin</surname> <given-names>LA</given-names></name><name><surname>Girgis-Gabardo</surname> <given-names>A</given-names></name><name><surname>Mansouri</surname> <given-names>A</given-names></name><name><surname>Gruss</surname> <given-names>P</given-names></name><name><surname>Rudnicki</surname> <given-names>MA</given-names></name></person-group><year iso-8601-date="2000">2000</year><article-title>Pax7 is required for the specification of myogenic satellite cells</article-title><source>Cell</source><volume>102</volume><fpage>777</fpage><lpage>786</lpage><pub-id pub-id-type="doi">10.1016/S0092-8674(00)00066-0</pub-id><pub-id pub-id-type="pmid">11030621</pub-id></element-citation></ref><ref id="bib88"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Seger</surname> <given-names>C</given-names></name><name><surname>Hargrave</surname> <given-names>M</given-names></name><name><surname>Wang</surname> <given-names>X</given-names></name><name><surname>Chai</surname> <given-names>RJ</given-names></name><name><surname>Elworthy</surname> <given-names>S</given-names></name><name><surname>Ingham</surname> <given-names>PW</given-names></name></person-group><year iso-8601-date="2011">2011</year><article-title>Analysis of Pax7 expressing myogenic cells in zebrafish muscle development, injury, and models of disease</article-title><source>Developmental Dynamics</source><volume>240</volume><fpage>2440</fpage><lpage>2451</lpage><pub-id pub-id-type="doi">10.1002/dvdy.22745</pub-id><pub-id pub-id-type="pmid">21954137</pub-id></element-citation></ref><ref id="bib89"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sekhon</surname> <given-names>JS</given-names></name></person-group><year iso-8601-date="2011">2011</year><article-title>Multivariate and propensity score matching software with automated balance optimization: The Matching Package for R</article-title><source>Journal of Statistical Software</source><volume>42</volume><fpage>1</fpage><lpage>52</lpage><pub-id pub-id-type="doi">10.18637/jss.v042.i07</pub-id></element-citation></ref><ref id="bib90"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shi</surname> <given-names>J</given-names></name><name><surname>Cai</surname> <given-names>M</given-names></name><name><surname>Si</surname> <given-names>Y</given-names></name><name><surname>Zhang</surname> <given-names>J</given-names></name><name><surname>Du</surname> <given-names>S</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Knockout of myomaker results in defective myoblast fusion, reduced muscle growth and increased adipocyte infiltration in zebrafish skeletal muscle</article-title><source>Human Molecular Genetics</source><volume>27</volume><fpage>3542</fpage><lpage>3554</lpage><pub-id pub-id-type="doi">10.1093/hmg/ddy268</pub-id><pub-id pub-id-type="pmid">30016436</pub-id></element-citation></ref><ref id="bib91"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Soleimani</surname> <given-names>VD</given-names></name><name><surname>Punch</surname> <given-names>VG</given-names></name><name><surname>Kawabe</surname> <given-names>Y</given-names></name><name><surname>Jones</surname> <given-names>AE</given-names></name><name><surname>Palidwor</surname> <given-names>GA</given-names></name><name><surname>Porter</surname> <given-names>CJ</given-names></name><name><surname>Cross</surname> <given-names>JW</given-names></name><name><surname>Carvajal</surname> <given-names>JJ</given-names></name><name><surname>Kockx</surname> <given-names>CE</given-names></name><name><surname>van IJcken</surname> <given-names>WF</given-names></name><name><surname>Perkins</surname> <given-names>TJ</given-names></name><name><surname>Rigby</surname> <given-names>PW</given-names></name><name><surname>Grosveld</surname> <given-names>F</given-names></name><name><surname>Rudnicki</surname> <given-names>MA</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>Transcriptional dominance of Pax7 in adult myogenesis is due to high-affinity recognition of homeodomain motifs</article-title><source>Developmental Cell</source><volume>22</volume><fpage>1208</fpage><lpage>1220</lpage><pub-id pub-id-type="doi">10.1016/j.devcel.2012.03.014</pub-id><pub-id pub-id-type="pmid">22609161</pub-id></element-citation></ref><ref id="bib92"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Trendelenburg</surname> <given-names>AU</given-names></name><name><surname>Meyer</surname> <given-names>A</given-names></name><name><surname>Rohner</surname> <given-names>D</given-names></name><name><surname>Boyle</surname> <given-names>J</given-names></name><name><surname>Hatakeyama</surname> <given-names>S</given-names></name><name><surname>Glass</surname> <given-names>DJ</given-names></name></person-group><year iso-8601-date="2009">2009</year><article-title>Myostatin reduces akt/TORC1/p70S6K signaling, inhibiting myoblast differentiation and myotube size</article-title><source>American Journal of Physiology-Cell Physiology</source><volume>296</volume><fpage>C1258</fpage><lpage>C1270</lpage><pub-id pub-id-type="doi">10.1152/ajpcell.00105.2009</pub-id><pub-id pub-id-type="pmid">19357233</pub-id></element-citation></ref><ref id="bib93"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Venuti</surname> <given-names>JM</given-names></name><name><surname>Morris</surname> <given-names>JH</given-names></name><name><surname>Vivian</surname> <given-names>JL</given-names></name><name><surname>Olson</surname> <given-names>EN</given-names></name><name><surname>Klein</surname> <given-names>WH</given-names></name></person-group><year iso-8601-date="1995">1995</year><article-title>Myogenin is required for late but not early aspects of myogenesis during mouse development</article-title><source>The Journal of Cell Biology</source><volume>128</volume><fpage>563</fpage><lpage>576</lpage><pub-id pub-id-type="doi">10.1083/jcb.128.4.563</pub-id><pub-id pub-id-type="pmid">7532173</pub-id></element-citation></ref><ref id="bib94"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Voytik</surname> <given-names>SL</given-names></name><name><surname>Przyborski</surname> <given-names>M</given-names></name><name><surname>Badylak</surname> <given-names>SF</given-names></name><name><surname>Konieczny</surname> <given-names>SF</given-names></name></person-group><year iso-8601-date="1993">1993</year><article-title>Differential expression of muscle regulatory factor genes in normal and denervated adult rat hindlimb muscles</article-title><source>Developmental Dynamics</source><volume>198</volume><fpage>214</fpage><lpage>224</lpage><pub-id pub-id-type="doi">10.1002/aja.1001980307</pub-id><pub-id pub-id-type="pmid">8136525</pub-id></element-citation></ref><ref id="bib95"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Weintraub</surname> <given-names>H</given-names></name><name><surname>Dwarki</surname> <given-names>VJ</given-names></name><name><surname>Verma</surname> <given-names>I</given-names></name><name><surname>Davis</surname> <given-names>R</given-names></name><name><surname>Hollenberg</surname> <given-names>S</given-names></name><name><surname>Snider</surname> <given-names>L</given-names></name><name><surname>Lassar</surname> <given-names>A</given-names></name><name><surname>Tapscott</surname> <given-names>SJ</given-names></name></person-group><year iso-8601-date="1991">1991</year><article-title>Muscle-specific transcriptional activation by MyoD</article-title><source>Genes &amp; Development</source><volume>5</volume><fpage>1377</fpage><lpage>1386</lpage><pub-id pub-id-type="doi">10.1101/gad.5.8.1377</pub-id><pub-id pub-id-type="pmid">1651276</pub-id></element-citation></ref><ref id="bib96"><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Westerfield</surname> <given-names>M</given-names></name></person-group><year iso-8601-date="2000">2000</year><source>The Zebrafish Book - A guide for the laboratory use of zebrafish</source><publisher-name>University of Oregon Press</publisher-name></element-citation></ref><ref id="bib97"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yoon</surname> <given-names>MS</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>mTOR as a key regulator in maintaining skeletal muscle mass</article-title><source>Frontiers in Physiology</source><volume>8</volume><elocation-id>788</elocation-id><pub-id pub-id-type="doi">10.3389/fphys.2017.00788</pub-id><pub-id pub-id-type="pmid">29089899</pub-id></element-citation></ref><ref id="bib98"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zammit</surname> <given-names>PS</given-names></name><name><surname>Heslop</surname> <given-names>L</given-names></name><name><surname>Hudon</surname> <given-names>V</given-names></name><name><surname>Rosenblatt</surname> <given-names>JD</given-names></name><name><surname>Tajbakhsh</surname> <given-names>S</given-names></name><name><surname>Buckingham</surname> <given-names>ME</given-names></name><name><surname>Beauchamp</surname> <given-names>JR</given-names></name><name><surname>Partridge</surname> <given-names>TA</given-names></name></person-group><year iso-8601-date="2002">2002</year><article-title>Kinetics of myoblast proliferation show that resident satellite cells are competent to fully regenerate skeletal muscle fibers</article-title><source>Experimental Cell Research</source><volume>281</volume><fpage>39</fpage><lpage>49</lpage><pub-id pub-id-type="doi">10.1006/excr.2002.5653</pub-id><pub-id pub-id-type="pmid">12441128</pub-id></element-citation></ref><ref id="bib99"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zammit</surname> <given-names>PS</given-names></name><name><surname>Golding</surname> <given-names>JP</given-names></name><name><surname>Nagata</surname> <given-names>Y</given-names></name><name><surname>Hudon</surname> <given-names>V</given-names></name><name><surname>Partridge</surname> <given-names>TA</given-names></name><name><surname>Beauchamp</surname> <given-names>JR</given-names></name></person-group><year iso-8601-date="2004">2004</year><article-title>Muscle satellite cells adopt divergent fates: a mechanism for self-renewal?</article-title><source>The Journal of Cell Biology</source><volume>166</volume><fpage>347</fpage><lpage>357</lpage><pub-id pub-id-type="doi">10.1083/jcb.200312007</pub-id><pub-id pub-id-type="pmid">15277541</pub-id></element-citation></ref><ref id="bib100"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zammit</surname> <given-names>PS</given-names></name><name><surname>Relaix</surname> <given-names>F</given-names></name><name><surname>Nagata</surname> <given-names>Y</given-names></name><name><surname>Ruiz</surname> <given-names>AP</given-names></name><name><surname>Collins</surname> <given-names>CA</given-names></name><name><surname>Partridge</surname> <given-names>TA</given-names></name><name><surname>Beauchamp</surname> <given-names>JR</given-names></name></person-group><year iso-8601-date="2006">2006</year><article-title>Pax7 and myogenic progression in skeletal muscle satellite cells</article-title><source>Journal of Cell Science</source><volume>119</volume><fpage>1824</fpage><lpage>1832</lpage><pub-id pub-id-type="doi">10.1242/jcs.02908</pub-id><pub-id pub-id-type="pmid">16608873</pub-id></element-citation></ref><ref id="bib101"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zammit</surname> <given-names>PS</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>Function of the myogenic regulatory factors Myf5, MyoD, myogenin and MRF4 in skeletal muscle, satellite cells and regenerative myogenesis</article-title><source>Seminars in Cell &amp; Developmental Biology</source><volume>72</volume><fpage>19</fpage><lpage>32</lpage><pub-id pub-id-type="doi">10.1016/j.semcdb.2017.11.011</pub-id><pub-id pub-id-type="pmid">29127046</pub-id></element-citation></ref><ref id="bib102"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zeileis</surname> <given-names>AH</given-names></name></person-group><year iso-8601-date="2002">2002</year><article-title>Diagnostic checking in regression relationships</article-title><source>R News</source><volume>2</volume><fpage>7</fpage><lpage>10</lpage></element-citation></ref><ref id="bib103"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname> <given-names>W</given-names></name><name><surname>Behringer</surname> <given-names>RR</given-names></name><name><surname>Olson</surname> <given-names>EN</given-names></name></person-group><year iso-8601-date="1995">1995</year><article-title>Inactivation of the myogenic bHLH gene MRF4 results in up-regulation of myogenin and rib anomalies</article-title><source>Genes &amp; Development</source><volume>9</volume><fpage>1388</fpage><lpage>1399</lpage><pub-id pub-id-type="doi">10.1101/gad.9.11.1388</pub-id><pub-id pub-id-type="pmid">7797078</pub-id></element-citation></ref><ref id="bib104"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname> <given-names>L</given-names></name><name><surname>Wang</surname> <given-names>XH</given-names></name><name><surname>Wang</surname> <given-names>H</given-names></name><name><surname>Du</surname> <given-names>J</given-names></name><name><surname>Mitch</surname> <given-names>WE</given-names></name></person-group><year iso-8601-date="2010">2010</year><article-title>Satellite cell dysfunction and impaired IGF-1 signaling cause CKD-induced muscle atrophy</article-title><source>Journal of the American Society of Nephrology</source><volume>21</volume><fpage>419</fpage><lpage>427</lpage><pub-id pub-id-type="doi">10.1681/ASN.2009060571</pub-id><pub-id pub-id-type="pmid">20056750</pub-id></element-citation></ref><ref id="bib105"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zimmers</surname> <given-names>TA</given-names></name><name><surname>Davies</surname> <given-names>MV</given-names></name><name><surname>Koniaris</surname> <given-names>LG</given-names></name><name><surname>Haynes</surname> <given-names>P</given-names></name><name><surname>Esquela</surname> <given-names>AF</given-names></name><name><surname>Tomkinson</surname> <given-names>KN</given-names></name><name><surname>McPherron</surname> <given-names>AC</given-names></name><name><surname>Wolfman</surname> <given-names>NM</given-names></name><name><surname>Lee</surname> <given-names>SJ</given-names></name></person-group><year iso-8601-date="2002">2002</year><article-title>Induction of cachexia in mice by systemically administered myostatin</article-title><source>Science</source><volume>296</volume><fpage>1486</fpage><lpage>1488</lpage><pub-id pub-id-type="doi">10.1126/science.1069525</pub-id><pub-id pub-id-type="pmid">12029139</pub-id></element-citation></ref></ref-list></back><sub-article article-type="decision-letter" id="sa1"><front-stub><article-id pub-id-type="doi">10.7554/eLife.60445.sa1</article-id><title-group><article-title>Decision letter</article-title></title-group><contrib-group><contrib contrib-type="editor"><name><surname>Munsterberg</surname><given-names>Andrea</given-names></name><role>Reviewing Editor</role><aff><institution>University of East Anglia</institution><country>United Kingdom</country></aff></contrib></contrib-group><contrib-group><contrib contrib-type="reviewer"><name><surname>Henry</surname><given-names>Clarissa</given-names> </name><role>Reviewer</role><aff><institution>University of Maine</institution><country>United States</country></aff></contrib></contrib-group></front-stub><body><boxed-text><p>In the interests of transparency, eLife publishes the most substantive revision requests and the accompanying author responses.</p></boxed-text><p><bold>Acceptance summary:</bold></p><p>This paper makes important contributions to our understanding of muscle homeostatic maintenance and muscle growth. In particular, using zebrafish mutants, the work shows that Myog is required for full quiescence of muscle stem cells and to locate to their proper 'niche' near the ends of myofibres. These insights may help to clarify causes of muscle decline in ageing and disease.</p><p><bold>Decision letter after peer review:</bold></p><p>Thank you for submitting your article &quot;Myogenin is an Essential Regulator of Adult Myofibre Growth and Muscle Stem Cell Homeostasis&quot; for consideration by <italic>eLife</italic>. Your article has been reviewed by three peer reviewers, one of whom is a member of our Board of Reviewing Editors, and the evaluation has been overseen by Didier Stainier as the Senior Editor. The following individual involved in review of your submission has agreed to reveal their identity: Clarissa Henry (Reviewer #2).</p><p>The reviewers have discussed the reviews with one another and the Reviewing Editor has drafted this decision to help you prepare a revised submission.</p><p>As the editors have judged that your manuscript is of interest, but as described below that additional analysis and quantifications of the experiments are required before it is published, we would like to draw your attention to changes in our revision policy that we have made in response to COVID-19 (https://elifesciences.org/articles/57162). First, because many researchers have temporarily lost access to the labs, we will give authors as much time as they need to submit revised manuscripts. We are also offering, if you choose, to post the manuscript to bioRxiv (if it is not already there) along with this decision letter and a formal designation that the manuscript is &quot;in revision at <italic>eLife</italic>&quot;. Please let us know if you would like to pursue this option. (If your work is more suitable for medRxiv, you will need to post the preprint yourself, as the mechanisms for us to do so are still in development.)</p><p>Summary:</p><p>This manuscript uncovers an unexpected role for Myogenin in muscle stem/progenitor cells in adult zebrafish. Further analysis of a previously characterised mutant makes novel contributions to the field of muscle growth. The authors show that Myog helps keep MuSCs quiescent and provide mechanistic insights into how Myog controls MuSC activation. Intriguingly, their work suggests that Myog mutants have increased differentiation markers compared to wild-type siblings. They also offer new models for MuSC positioning within a fiber.</p><p>Essential revisions:</p><p>1) In their previous publication (Ganassi, 2018), the authors showed that the differentiation index of cultured adult myoblasts does not differ between WT and <italic>myog<sup>-/-</sup></italic>, but in the current study myog mutant cells show a much higher degree of differentiation compared to their wild-type siblings. Please clarify why these findings differ.</p><p>2) The authors claim that the pax7a:GFP+VE cells represent bona fide MuSCs, which can only be determined by co-label of GFP and an anti Pax7 (or Anti Pax3+7) antibody. Although the authors do provide this co-label in one panel, they only show one cell per genotype. Please provide quantification of how often the GFP+VE cells are also positive for the anti-Pax3/7 antibody. Unless this co-label is extremely common in both genotypes, or confirmed in each experiment, the authors should soften their language about the GFP expressing cells being verified MuSCs.</p><p>3) Related to the previous point: The authors show that MPCs behave differently in culture and although they show increased pax7a and pax7b expression they also express higher levels of differentiation markers and enter terminal differentiation. This is puzzling and inconsistent with the reduced number of myonuclei and smaller myofibres that are seen in the mutant fish. Furthermore, it is not clear how the increased number of MuSCs per fibre is reached. A plausible explanation for both observations (fewer myonuclei/smaller fibres and more MPCs), is that these cells are myocytes that do not fuse efficiently. The authors raise this possibility in the Discussion, however, this should be better assessed and either excluded or supported.</p><p>4) The surface area domain size measurement in Figure 1 is a strange proxy for myonuclear domain. which is best thought of as a volume, as shown in Figure 2. However, Figure 2 omits all pax7:GFP+VE cells, some of which may have fused recently enough to retain their GFP label. Please replace the SADS calculation in Figure 1 with a volumetric calculation. This will be important for interpreting and comparing the two findings.</p><p>5) Culture of mononucleated MPCs from plated fibres was used to investigate whether lack of Myog enhanced MPC proliferation. The relative proliferation rates were not significantly different, however, EdU pulse experiments suggest that mutant MPC are more readily entering S-phase. Overall the authors suggest that lack of myog accelerates MuSC transition into the proliferation phase. At present this is not supported convincingly. Indeed, the data shows reduced proliferation and AUC (4E) in mutants. An additional EdU pulse at an earlier time after plating (day 1) should be included to potentially strengthen this idea. Alternatively the statement should be modified and toned down.</p><p>6) The authors want to assess whether there is an earlier onset of differentiation of MPCs in culture. However, they only show expression of <italic>mef2d</italic> and <italic>mylpfa</italic> at day 3 (Figure 4H) and day 2 should be included here as well. Overall the differentiation index of MPCs is increased, can they comment on whether the cells remain mononucleated.</p><p>7) In the Discussion the subsection “Myog is required for MuSCs to adopt their normal niche position” regarding the niche is very speculative and should be toned down/amended. In particular, the conclusion that Myog is required for assembly of the MTJ MuSC:niche complex is not well supported, there are no MTJ markers shown.</p></body></sub-article><sub-article article-type="reply" id="sa2"><front-stub><article-id pub-id-type="doi">10.7554/eLife.60445.sa2</article-id><title-group><article-title>Author response</article-title></title-group></front-stub><body><disp-quote content-type="editor-comment"><p>Essential revisions:</p><p>1) In their previous publication (Ganassi, 2018), the authors showed that the differentiation index of cultured adult myoblasts does not differ between WT and myog<sup>-/-</sup>, but in the current study myog mutant cells show a much higher degree of differentiation compared to their wild-type siblings. Please clarify why these findings differ.</p></disp-quote><p>We think this result reflects the non-uniform distribution of MPCs in single fibre culture. In our previous analysis, similar numbers of MPCs from both mutant and sibling were replated and then triggered to differentiate by serum removal as a fair test of terminal differentiation capacity of myoblasts and yielded the result stated in Ganassi et al., 2018 of ‘no difference’. The reviewers are perspicacious to pick up the difference in the current analysis. When one plates cells in these 100 single fibre-derived cultures, MPC distribution is very non-random. The higher density of MPCs in mutant fibre cultures, and their rapid proliferation lead to a distribution in dense confluent clusters in the dish, which likely triggers their premature differentiation even in the presence of growth medium. In contrast, sibling cultures have fewer MuSCs to start with, slower proliferation and thus end up with fewer ‘colonies’ and at lower cell density. As a consequence, sibling MuSCs barely differentiate at 3 days in growth medium (Figure 4I). We believe this explains the difference and have now made this clear in the subsection “Adult <italic>myog<sup>-/-</sup></italic> MuSC-derived myoblasts exhibit faster transition to proliferation”. Please note that in Figure 4—figure supplement 1E we show that the sibling cells in such cultures differentiate well in Differentiation Medium.</p><disp-quote content-type="editor-comment"><p>2) The authors claim that the pax7a:GFP+VE cells represent bona fide MuSCs, which can only be determined by co-label of GFP and an anti Pax7 (or Anti Pax3+7) antibody. Although the authors do provide this co-label in one panel, they only show one cell per genotype. Please provide quantification of how often the GFP+VE cells are also positive for the anti-Pax3/7 antibody. Unless this co-label is extremely common in both genotypes, or confirmed in each experiment, the authors should soften their language about the GFP expressing cells being verified MuSCs.</p></disp-quote><p>We take the reviewer’s point and have now performed such quantification. The answer is that 98.3%±1.7 (Sib) and 96%±1.9 (Mut; <italic>myog<sup>-/-</sup></italic>) of GFP+ve cells are also co-labelled with DP312 (Pax3/Pax7) and are therefore real MuSCs. These data are now reported in Figure 2D and described in the subsection “Adult <italic>myog<sup>-/-</sup></italic> myofibres have increased number of MuSCs”. An important additional point is that many GFP+ve cells go on to become EdU positive, and so are not myocytes, which are defined as having undergone irreversible cell cycle exit.</p><disp-quote content-type="editor-comment"><p>3) Related to the previous point: The authors show that MPCs behave differently in culture and although they show increased pax7a and pax7b expression they also express higher levels of differentiation markers and enter terminal differentiation. This is puzzling and inconsistent with the reduced number of myonuclei and smaller myofibres that are seen in the mutant fish. Furthermore, it is not clear how the increased number of MuSCs per fibre is reached. A plausible explanation for both observations (fewer myonuclei/smaller fibres and more MPCs), is that these cells are myocytes that do not fuse efficiently. The authors raise this possibility in the Discussion, however, this should be better assessed and either excluded or supported.</p></disp-quote><p>We suspect that mutant MuSCs are semi-quiescent (‘alerted’) in vivo, as indicated by accumulation of phosphorylated RPS6 in whole muscle analysis (Figure 3D), but become fully activated and rapidly enter the high proliferation phase ex vivo in culture, much faster than sib MuSCs. Our ex vivo DP312 staining on fibres fixed immediately upon dissection (Figure 2D) now confirms that virtually all of GFP+ve cells are MuSCs, thus not myocytes, with robust accumulation of RPS6 (Figure 3E). This, along with the high percentage of cells incorporating EdU at day 2 in proliferation medium, excludes the possibility that most mutant GFP+ve cells in vivo are unfused myocytes. Moreover, mutant MuSCs, similarly to Sib MuSCs, continue to proliferate on days 3 and 4 in culture, confirming a substantial proportion of myoblasts in both genotypes.</p><disp-quote content-type="editor-comment"><p>4) The surface area domain size measurement in Figure 1 is a strange proxy for myonuclear domain. which is best thought of as a volume, as shown in Figure 2. However, Figure 2 omits all pax7:GFP+VE cells, some of which may have fused recently enough to retain their GFP label. Please replace the SADS calculation in Figure 1 with a volumetric calculation. This will be important for interpreting and comparing the two findings.</p></disp-quote><p>We have now replaced SADS with the volume nuclear domain measure (Figure 1J), and relegated the SADS graph to supplementary Figure 1—figure supplement 1F. We call it ‘Nuclear Domain’, not ‘Myonuclear Domain’ to make it clear that it is calculated including MuSC nuclei.</p><p>Regarding the important recent-fusion suggestion, we do not believe this is confounding our results. We previously showed by FRAP (Bajanca et al., 2015) and by watching fusion in timelapse confocal microscopy (Pipalia et al., 2016) that cytoplasmic GFP diffuses rapidly (within seconds) throughout muscle fibre cytoplasm upon fusion. Due to the very high dilution factor, this effectively makes GFP from fused MPCs invisible without ultra-sensitive analysis (see videos in Pipalia et al., 2016). We have now made this logic clear in the subsection “Adult <italic>myog<sup>-/-</sup></italic> myofibres have increased number of MuSCs”.</p><disp-quote content-type="editor-comment"><p>5) Culture of mononucleated MPCs from plated fibres was used to investigate whether lack of Myog enhanced MPC proliferation. The relative proliferation rates were not significantly different, however, EdU pulse experiments suggest that mutant MPC are more readily entering S-phase. Overall the authors suggest that lack of myog accelerates MuSC transition into the proliferation phase. At present this is not supported convincingly. Indeed, the data shows reduced proliferation and AUC (4E) in mutants. An additional EdU pulse at an earlier time after plating (day 1) should be included to potentially strengthen this idea. Alternatively the statement should be modified and toned down.</p></disp-quote><p>We may have confused readers by including the AUC analysis because, as the reviewers point out, such analysis may not reflect in detail the proliferation dynamics (i.e. is not the ‘whole’ proliferation curve). The main point we wanted to make is that <italic>myog<sup>-/-</sup></italic> cells do not appear to proliferate <italic>more</italic> (i.e. this is not a terminal differentiation defect). The EdU data are very clear that there are almost threefold more EdU+ cells at day 2 in mutants compared to sibs, making a strong argument that entry into S-phase is temporally advanced in mutants compared to sibs. Combining this result with the alerted/pre-activated state revealed in Figure 3, the observations that sib cells reach a highly proliferative stage by day 3 (Figure 4E), and that differentiation is not reduced in mutants (Figure 4H, I) clearly shows that mutant MuSCs are entering the highly proliferative phase faster than those from sibs.</p><p>A practical problem is that on day 1 the isolated fibres do not yet bind Matrigel strongly enough to permit efficient MPC migration onto the dish surface, making the EdU analysis at day 1 technically difficult; too many fibres and associated MPCs get lost during labelling and staining. This is why we cannot include day 1 data, and is something commonly observed in single fibre cultures from mouse. We have now modified the subsection “Adult <italic>myog<sup>-/-</sup></italic> MuSC-derived myoblasts exhibit faster transition to proliferation”, to make our argument more clear.</p><disp-quote content-type="editor-comment"><p>6) The authors want to assess whether there is an earlier onset of differentiation of MPCs in culture. However, they only show expression of mef2d and mylpfa at day 3 (Figure 4H) and day 2 should be included here as well. Overall the differentiation index of MPCs is increased, can they comment on whether the cells remain mononucleated.</p></disp-quote><p>We have now added further data to address both these points. Firstly, we have included an analysis of <italic>mef2d</italic> and <italic>mylpfa</italic> at day 2, as requested. Secondly, we have analysed other differentiation markers, including <italic>cdkn1a</italic> (p21), <italic>cdkn1c</italic> (p57), <italic>flnca</italic> (filamin C) and <italic>mybpc1</italic> (Myosin binding protein C1) at both day 2 and day 3. We report the new results in the subsection “Adult <italic>myog<sup>-/-</sup></italic> MuSC-derived myoblasts exhibit faster transition to proliferation”, and Figure 4H and Figure 4—figure supplement 1D. Thirdly, we now include images showing that, after 5 days in differentiation condition (reduced serum), both sib and mutant MPCs differentiate but mutant myocytes remain largely mononucleated (Figure 4—figure supplement 1E), confirming our previous report (Ganassi et al., 2018). We have now made this clear in the aforementioned subsection.</p><disp-quote content-type="editor-comment"><p>7) In the Discussion the subsection “Myog is required for MuSCs to adopt their normal niche position” regarding the niche is very speculative and should be toned down/amended. In particular, the conclusion that Myog is required for assembly of the MTJ MuSC:niche complex is not well supported, there are no MTJ markers shown.</p></disp-quote><p>We have modified this discussion throughout the Discussion section to make it clear that we hypothesise MTJ involvement. The reviewers are correct that we have only shown that the immediately MTJ-adjacent fibre end forms the niche.</p></body></sub-article></article>